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ABSTRACT 
Tuberculosis (TB) causes over a million mortalities annually. The disease is caused 
by the intracellular bacterial species Mycobacterium tuberculosis, and currently no 
completely preventive vaccination against the infection exists. Additionally, since the 
drug-sensitive TB is challenging to cure and the amount of drug-resistant 
M. tuberculosis strains is increasing, novel drug candidates against the disease need to 
be developed. The influence of the genetic variation of the host on the susceptibility 
against TB is well-established. Therefore, screening for novel candidate genes in a 
mycobacterial infection and studying them systemically in an appropriate model 
organism provides a powerful starting point for drug development. 
With the advent of commercially available mutant zebrafish lines as well as 
efficient genome modification tools, such as the clustered regularly interspaced short 
palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) system, the zebrafish 
provides an interesting genetically controllable alternative for studying gene specific 
effects in vivo. Furthermore, the zebrafish Mycobacterium marinum infection 
recapitulates several aspects of human TB, providing a safe and a cost-efficient 
model for studying mycobacterial pathogenesis. This study examined the genetic 
component of TB susceptibility using the zebrafish M. marinum infection model. 
Specifically, the aims were: to set up an in-house CRISPR/Cas9 mutagenesis method 
in the zebrafish, and to verify that this system can be efficiently used to create 
targeted genomic mutations, as well as to study the roles of an important regulator 
of T cell function FURIN, and of microbial recognition proteins, Intelectins 
(ITLNs), in vivo in the zebrafish host response against mycobacteria. 
Using a commercially available furinAtd204e zebrafish line, it was found that the 
expression levels of the T helper (Th) cell subtype specific transcription factors 
tbx21, gata3 and foxp3a were elevated in the furinAtd204e/+ mutant fish in steady state 
compared to the wild type (WT) fish. In addition, it was observed that the 
furinAtd204e/+ mutants had reduced furinA mRNA levels compared to the WT 
controls and that furinA expression was induced upon a mycobacterial challenge. 
Finally, we demonstrated that the furinAtd204e/+ mutant fish had an infection-
inducible proinflammatory phenotype, characterized by the increased expression of 
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tnfa, lta and il17a/f3, which was associated with a reduced mycobacterial burden in a 
chronic M. marinum infection. 
Demonstrating that the CRISPR/Cas9 mutagenesis system is feasible in our 
hands, an enhanced green fluorescent protein gene (egfp) was efficiently mutated in a 
transgenic tg(fli1a:egfp) zebrafish line. Moreover, also the endogenous ca10a and ca10b 
genes could be modified in the zebrafish embryos using the CRISPR/Cas9 
technology. 
Based on a genome-wide gene expression analysis, intelectin 3 (itln3) was 
identified as one of the most up-regulated zebrafish genes in a M. marinum infection. 
Consequently, the CRISPR/Cas9 system was utilized to create itln3uta145 and itln3uta148 
mutant zebrafish lines, and to characterize the effects of itln3 deficiency in a 
mycobacterial infection. Despite its strongly induced expression during an infection, 
itln3 was found dispensable for the protective immune response against M. marinum 
as was suggested by the comparable mycobacterial burden and survival of itln3 
mutants and WT controls. Further studies are warranted to assess if FURIN and 
ITLN levels could be used as novel diagnostic measures in TB, and whether FURIN-
inhibitors have the potential to be used as anti-mycobacterial drugs. 
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TIIVISTELMÄ 
Tuberkuloosi aiheuttaa vuosittain yli miljoona kuolonuhria. Taudin aiheuttaja on 
solunsisäinen bakteeri Mycobacterium tuberculosis, eikä sen aiheuttamaa infektiota 
vastaan ole täysin estävää rokotetta. Koska tuberkuloosi-infektio on hankala parantaa 
nykyisillä lääkkeillä ja lääkeresistenssien M. tuberculosis -kantojen määrä on kasvussa, 
uusien tuberkuloosihoitojen kehittäminen on tarpeellista.  Ihmisen geneettiset tekijät 
vaikuttavat tuberkuloosialttiuteen, minkä vuoksi uusien mykobakteeri-infektioon 
vaikuttavien geenien seulominen sekä niiden tutkiminen systeemisesti sopivissa 
malliorganismeissa toimii hyvänä lähtökohtana lääkekehitykselle. 
Saatavilla olevien kaupallisten mutanttikalalinjojen ja tehokkaiden 
genominmuokkaustyökalujen, kuten clustered regularly interspaced short 
palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) -systeemin, vuoksi 
seeprakala (Danio rerio) on geneettisesti muokattavissa oleva vaihtoehto 
geenikohtaisten vaikutusten tutkimiseksi eliötasolla. Tämän lisäksi seeprakalan 
Mycobacterium marinum -infektio mallintaa useita piirteitä ihmisen tuberkuloosi-
infektiosta, tarjoten turvallisen ja taloudellisen mallin mykobakteeripatogeneesin 
tutkimiseksi. Tässä tutkimuksessa selvitettiin tuberkuloosialttiuteen vaikuttavia 
geenejä käyttäen seeprakalan M. marinum -infektiomallia. Tutkimuksen tavoitteina oli 
pystyttää tiedekunnan sisäinen seeprakalan CRISPR/Cas9-mutageneesimenetelmä ja 
varmentaa, että menetelmällä voidaan tehokkaasti luoda kohdennettuja mutaatioita 
seeprakalan genomiin, sekä tutkia T-solujen toiminnalle tärkeää FURIN-
säätelyproteiinia ja mikrobien tunnistusproteiineja, Intelektiinejä, seeprakalan 
mykobakteeri-immuniteetissä. 
Käyttämällä kaupallisesti saatavilla olevaa furinAtd204e -seeprakalalinjaa, 
furinAtd204e/+ -mutanteilla osoitettiin olevan normaaliolosuhteissa yli-ilmentyneet 
auttaja-T-soluille tyypilliset transkriptiotekijät tbx21, gata3 ja foxp3a verrattuna 
villityypin kaloihin. Sen lisäksi furinAtd204e/+ mutanteilla havaittiin olevan alentuneet 
furinA-lähetti-RNA-tasot ja furinA-geenin olevan indusoitunut M. marinum -
infektiossa. Osoitimme myös, että furinAtd204e/+ -mutanttikaloilla oli infektiossa 
lisääntynyt tulehdusvaste, jota kuvasti kasvaneet tnfa, lta ja il17a/f3 ilmentymistasot, 
ja joka assosioitui matalampiin mykobakteerimääriin kroonisessa infektiossa. 
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CRISPR/Cas9-menetelmän toimivuuden osoitimme mutatoimalla enhanced green 
fluorescent protein –geenin transgeenisessä tg(fli1a:egfp) seeprakalalinjassa. Tämän lisäksi 
onnistuimme CRISPR/Cas9-teknologian avulla muokkaamaan endogeeniset ca10a ja 
ca10b geenit seeprakalan alkioissa. 
Pohjautuen genominlaajuiseen ilmentymisanalyysiin itln3-geenin havaittiin 
olevan eräs korkeimmin ilmentyneistä seeprakalan geeneistä M. marinum -infektiossa. 
Tästä johtuen CRISPR/Cas9-menetelmää käytettiin itln3uta145 ja itln3uta148 -
mutanttiseeprakalalinjojen tuottamiseksi ja itln3-puutoksen vaikutuksen 
selvittämiseksi mykobakteeri-infektiossa. Huolimatta selkeästi kohonneesta 
ilmentymistasosta, itln3-geenin havaittiin olevan merkityksetön immuunivasteessa 
M. marinumia vastaan, sillä homotsygooteilla itln3-mutanteilla oli infektiossa 
verrattavissa olevat mykobakteerimäärät sekä selviytyminen villityypin 
kontrollikaloihin nähden. Lisätutkimuksia tarvitaan arvioimaan voitaisiinko FURIN- 
ja ITLN-proteiinitasoja käyttää uusina diagnostisina mittareina tuberkuloosissa ja 
olisiko FURIN-inhibiittoreita mahdollista käyttää mykobakteerilääkkeinä.
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1 INTRODUCTION 
Despite the availability of effective antibiotics since the 1940´s, tuberculosis (TB) 
persists as one of the deadliest human infectious diseases leading to more than a 
million casualties annually. Making matters even worse, there are no completely 
preventive vaccines against TB and the relative amount of antibiotic resistant 
M. tuberculosis strains is increasing. While environmental factors, as well as 
M. tuberculosis virulence can affect immunity against mycobacteria, also host genetics 
have proven important in determining mycobacterial host-pathogen interactions. In 
fact, new insights into how genetics influence the mycobacterial host response can 
promote the development of novel diagnostic methods as well as drugs against TB. 
To this end, genetically tractable animal models are required. 
The zebrafish (Danio rerio) is a versatile model organism for studying biological 
processes such as immunity. The zebrafish immune system has cellular and humoral 
components comparable to those of humans, and both zebrafish embryos as well as 
adult fish can be used in experimental immunological research, making zebrafish a 
versatile tool for answering scientific questions. Also, commercial mutant zebrafish 
lines and the recently developed CRISPR/Cas9 genome modification system 
provide the means to create knockout zebrafish for studying individual genes at a 
whole organism level. Importantly, the zebrafish M. marinum infection model 
provides a safe non-mammalian alternative for TB research. 
FURIN is a prototypical member of the proprotein convertase subtilisin/kexin 
(PCSK) enzyme family, and it converts immature proproteins into their active forms 
by proteolytic cleavage. FURIN has been identified in vertebrates and in 
invertebrates, and numerous substrate proteins for this PCSK have been recognized 
so far. In fact, FURIN has been shown to regulate T cell function and inflammation. 
However, not much is known about its functions in the host response against 
infections. Furthermore, since FURIN controls the differentiation of T helper (Th) 
type 1 cells, a T cell subtype crucial for the immune response against TB, FURIN is 
an interesting candidate gene in mycobacterial immunity. 
Intelectins (ITLNs) are a family of the sugar-binding lectin proteins. Several 
in vitro studies have suggested that ITLNs function in the innate immune response 
by directly binding to carbohydrates of the surface of bacteria and thus acting as 
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microbial recognition proteins. In addition, the infection-inducible expression of 
ITLN genes as well as their protective role in parasitic infections have been 
demonstrated in vivo. However, the phenotype of ITLN knockout animal models 
have not been previously reported in mycobacterial infections.   
This thesis was aimed at understanding the role of the furinA and itln3 genes in 
the immune response against mycobacteria. To this end, the zebrafish M. marinum 
infection model was used together with the furinA and itln3 mutant zebrafish lines. 
While the furinAtd204e mutant line was commercially available, we initially needed to 
set up our own zebrafish CRISPR/Cas9 mutagenesis to mutate itln3. For this 
purpose, the methodology was initially tested with an exogenous egfp gene in our 
transgenic tg(fli1a:egfp) zebrafish, and further validated by mutating endogenous 
ca10a and ca10b genes in wild type (WT) fish. Subsequently the CRISPR/Cas9 system 
was used to create itln3 mutant zebrafish. 
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2 REVIEW OF THE LITERATURE 
2.1 Tuberculosis 
2.1.1 Epidemiology 
Tuberculosis (TB) is an epidemic infectious disease caused by the mycobacterial 
species Mycobacterium tuberculosis. It has been proposed that one-third of the entire 
human population is infected with M. tuberculosis (Dye et al. 1999). Predominantly, a 
M. tuberculosis infection remains in a non-transmissible and asymptomatic form called 
the latent disease, and only a fraction of the infected individuals develop active TB 
(Rangaka et al. 2015). Nonetheless, in the latest report of the World Health 
Organization (WHO) it was estimated that more than 10 million people are affected 
by TB and that approximately 1.7 million deaths were caused by the disease in 2016 
(Global Tuberculosis Report, 2017). 
As it is a multifactorial disease, several risk factors have been associated with 
TB susceptibility, including poverty and malnutrition (Dheda, Barry & Maartens 
2016; Fogel 2015; Lawn & Zumla 2011). Accordingly, the highest TB incidence rates 
are found in Sub-Saharan Africa as well as in South-East Asia in low-income 
countries such as the Democratic Republic of the Congo, South Africa, the 
Philippines and Myanmar (Figure 1). Furthermore, a high TB incidence is directly 
linked to the high prevalence of the human immunodeficiency virus (HIV), putting 
HIV-infected people at substantially higher risk of developing TB than the healthy 
individuals (Figure 2) (Global Tuberculosis Report, 2017). In fact, of the TB infected 
individuals circa 10% are simultaneously co-infected with HIV. Other risk factors 
associated with a higher susceptibility for TB include immunosuppressive treatment, 
diabetes, alcohol usage, smoking as well as indoor air pollution (Dheda, Barry & 
Maartens 2016). In addition, genetic polymorphisms are known to affect TB 
susceptibility (See chapter 2.1.4.) (Lerner, Borel & Gutierrez 2015; Meyer & Thye 
2014; Sørensen et al. 1988). 
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Figure 1. Global TB incidence rates in 2016. TB incidence per 100,000 people per year is 
depicted separately in each country with the shades of green. Figure is reprinted from the Global 
Tuberculosis Report, 2017, World Health Organization, Page 31, Copyright (2017). Translated 
with the permission of the publisher from 
http://gamapserver.who.int/mapLibrary/Files/Maps/gho_tb_incidence_2016.png (17th of 
August, 2018). 
 
Although in most cases TB is treatable with a standard anti-tubercular regimen, 
the numbers of drug- and multi-drug-resistant (MDR) M. tuberculosis infections are 
increasing with approximately 600,000 new MDR cases annually (Global 
Tuberculosis Report, 2017). Most of the MDR M. tuberculosis infections are reported 
in the Russian federation (63,000), India (147,000) and China (73,000) accounting 
for a total of 47% of the cases world-wide (Global Tuberculosis Report, 2017; Lawn 
& Zumla 2011). Moreover, for example in Russia, the fraction of MDR cases 
compared to the total amount of reported cases is increasing and was noticeable high 
(27%) in 2016. Taken together the high prevalence of M. tuberculosis infected latent 
individuals, the high susceptibility of active TB in HIV-patients as well as the 
increased incidence of MDR bacterial infections, makes the battle against TB far 
from being over. Especially, since completely preventive vaccines against the disease 
are yet to be developed.  
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Figure 2. Global HIV prevalence in TB patients in 2016. HIV prevalence (%) among the TB 
patients is depicted separately in each country with the shades of blue. Figure is reprinted from 
the Global Tuberculosis Report, 2017, World Health Organization, Page 32, Copyright (2017).  
Translated with the permission of the publisher from 
http://gamapserver.who.int/mapLibrary/Files/Maps/Global_HIVprevalence_NewRelapseTB
cases_2016.png (17th of August, 2018). 
2.1.2 Diagnosis, treatment and prevention 
The complex nature of a M. tuberculosis infection, with its latent and active diseases, 
the large proportion of HIV-co-infected individuals and drug resistance, make it 
challenging to diagnose, treat and prevent TB. Active pulmonary TB is usually 
diagnosed by lung radiography and/or sputum smear microscopy and culture 
(Table 1) (Dheda, Barry & Maartens 2016; Eddabra & Ait Benhassou 2018; Lawn & 
Zumla 2011; Zumla et al. 2013). Furthermore, nucleic acid amplification tests such 
as the Gene Xpert MTB/RIF as well as the loop-mediated isothermal amplification 
(LAMP) assay are expanding the methodology for pulmonary TB diagnostics, and 
similarly to culture based diagnostics, they provide additional means to screen for 
drug resistance (Dheda, Barry & Maartens 2016; Eddabra & Ait Benhassou 2018). 
While the aforementioned tests can be used to detect the pulmonary disease, 
computer tomography (CT) and magnetic resonance imaging (MRI) have proven 
important in identifying extra-pulmonary TB e.g. in the bones and in the central 
nervous system, respectively (Skoura, Zumla & Bomanji 2015). 
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Common diagnostic tests used to detect a latent M. tuberculosis infection include 
the tuberculin skin test (TST) and the interferon gamma release assay (IGRA) 
(Table 1). While both TST and IGRA reveal the presence of memory T cells against 
tuberculous antigens by measuring the extent of the host´s T cell response, these 
tests are not able to distinguish between the latent and active stages of the disease 
(Chee et al. 2013; Dheda, Barry & Maartens 2016). For the same reason, they fail to 
distinguish between eradicated bacilli and bacteria still present in the host. Moreover, 
both of these diagnostic measures can result in false negative results in 
immunocompromised individuals e.g. in HIV-infected people (Dheda, Barry & 
Maartens 2016) Overall, simple diagnostic tests that could differentiate between 
healthy people, latently infected individuals and active TB patients would be 
important for choosing the correct treatment strategy. To this end, at least gene 
expression profiling (Lee et al. 2016; Roe et al. 2016) and fluorescence activated cell 
sorting (FACS) (Pollock et al. 2013; Yang et al. 2015) from patient blood samples, 
as well as comparative screening of secreted M. tuberculosis proteins (Zhang et al. 
2014) have provided new diagnostic possibilities. 
Table 1. Diagnostic possibilities in human M. tuberculosis infection. 
 
 
The mortality rates of an active, untreated TB infection can be as high as 90% 
(Chiang et al. 2009). Fortunately however, active drug-susceptible TB can be treated 
with a drug combination of isoniazid, rifampin, pyrazinamide, and either ethambutol 
Diagnostic measure
Tissue specificity of the 
diagnosis
Diagnostic sample
Clinical use in diagnosis 
(Active TB vs. latent disease)
Radiography Lungs − Active TB
Microscopy Lungs Sputum smear Active TB
Bacterial culture Lungs Sputum smear Active TB
Nucleic acid amplification tests Lungs Sputum smear Active TB
Computer tomography (CT) Bones − Active TB
Magnetic resonance imaging (MRI) Central nervous system − Active TB
Tuberculin skin test (TST) Unspecific Skin reactivity Latent disease (unspecific)
Interferon gamma release assay (IGRA) Unspecific Blood Latent disease (unspecific)
Gene expression profiling Unspecific Blood Active TB and latent disease
Fluorescence activated cell sorting (FACS) Unspecific Blood Active TB and latent disease
M. tuberculosis  protein screening Unspecific Blood Active TB and latent disease
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or streptomycin (Global Tuberculosis Report, 2017; Fogel 2015). Nonetheless, the 
long duration of the regimen (at least six months) causes a large proportion (18.7%-
49.3%) of the patients to stop the treatment as soon as they feel better, already before 
the end of 2 months (Kruk, Schwalbe & Aguiar 2008). This in turn has led to 
treatment success rates of only 85%, and to the accelerated development of drug-
resistant TB (Kruk, Schwalbe & Aguiar 2008). 
Compared to the standard anti-tuberculosis regimen, the MDR TB medication 
has a lower success rate of 54% and it requires a prolonged treatment time of up to 
9-12 months (Global Tuberculosis Report, 2017). Additionally, the cost of treating 
MDR TB is approximately 25 times higher compared to the drug-sensitive infection 
(Global Tuberculosis Report, 2017). In fact, the low success rates in treating the 
MDR disease, the high cost of medication as well as the emergence of totally drug-
resistant bacteria substantiate the need for new and efficient short-term TB drugs. 
To this end, the WHO reported that in 2017 there were more than a dozen new TB 
drugs in clinical trials that will hopefully prove efficient in the fight against the TB 
epidemic. Moreover, in order to reduce the development of drug-resistance in the 
first place, drug susceptibility testing is important in choosing the correct regimen in 
treating M. tuberculosis infections (Global Tuberculosis Report, 2017; Kim 2005). 
While active TB always requires treatment, a latent M. tuberculosis infection can 
remain asymptomatic and harmless for decades (Fogel 2015). Consequently, a latent 
infection is diagnosed and treated only in individuals with a high risk of disease 
reactivation (e.g. HIV-patients), in children under five years with active household 
TB contacts or in people that have lived in high-prevalence countries and have later 
settled elsewhere in a place with a lower TB prevalence (Zumla et al. 2013). The 
recommended treatment for a latent infection is a 9-month period of isoniazid 
administration, an interval that can be extended to ensure efficient treatment (Zumla 
et al. 2013). 
Although the Bacillus Calmette–Guérin (BCG) vaccine is efficient in preventing 
severe disseminated TB (Rodrigues, Diwan & Wheeler 1993; Trunz, Fine & Dye 
2006), no completely preventive vaccine against TB exists. In fact, efficient 
vaccination strategies against TB would be highly important for the preventive 
measures against TB. The development of new TB vaccines is however problematic. 
While the high cost of clinical studies limits the amount of novel vaccine candidates 
from ever entering the developmental “pipeline”, the high disease burden and the 
different infection outcomes complicate the study design by making the proper 
control individuals difficult to choose (Voss et al. 2018). Moreover, comprehensive 
knowledge about the host immune response against M. tuberculosis is required in order 
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to induce a selective and an efficient TB immunity upon vaccination. Nevertheless, 
several new vaccines are in clinical trials and their efficacy remains to be proven 
(Global Tuberculosis Report, 2017). Overall, the factors contributing to the disease 
onset and its pathogenesis need to be understood in more detail in order to develop 
more efficient remedies against TB. 
Figure 3. Immunological life cycle of TB. M. tuberculosis is transmitted from an active disease 
carrier to a new host through inhaled aerosol droplets. If the mycobacterium is not destroyed it 
uses macrophages to multiply and spreads in the immunoprivileged niche of the alveoli. After the 
initiation of the adaptive immune response, lymphocytes traffick to the lungs, leading to 
granuloma maturation and often to containment of the infection (latency). If the host immune 
response fails to achieve latency or the disease is reactivated e.g. in a HIV co-infection, 
M. tuberculosis can disseminate from the granulomas, continue its replication and cause 
transmissive active TB. Figure is reprinted from Cell, Volume 159, Issue 7, December 18, 2014 
(doi: 10.1016/j.cell.2014.11.024), Cambier CJ, Falkow S, & Ramakrishnan L, Host Evasion and 
Exploitation Schemes of Mycobacterium tuberculosis, Pages No. 1497-1509, Copyright (2014), with 
permission from Elsevier. 
2.1.3 Immune response against Mycobacterium tuberculosis 
Referred to as the immunological life cycle of TB by Ernst (2012), the different 
stages of a M. tuberculosis infection in humans include mycobacterial entry, primary 
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disease, immunological equilibrium (latency), reactivation and transmission to new 
hosts (Figure 3). In addition, also immediate bacterial elimination has been suggested 
as a possible outcome of an infection (Ernst 2012; Meermeier & Lewinsohn 2018; 
Weiss & Schaible 2015). Collectively, the complex host immune response against the 
intracellular M. tuberculosis bacterium dictates the final infection outcome ranging 
from bacterial sterilization to latent and active TB. 
2.1.3.1 Innate immune response 
A M. tuberculosis infection is conferred from an infected individual to its new host 
through inhaled aerosol droplets (Figure 3) (Cambier, Falkow & Ramakrishnan 2014; 
Ernst 2012; Philips & Ernst 2012). Therefore, it has been proposed that the first 
cells to react to and mount an immune response against the bacterium are the 
alveolar macrophages (Philips & Ernst 2012). Albeit macrophages are able to 
recognize mycobacterial antigens directly through their pattern recognition receptors 
(PRRs) such as C-type lectin-, scavenger- or toll-like receptors (TLRs) (Figure 4) 
(Brightbill et al. 1999; Means et al. 1999; Mortaz et al. 2015; Stamm, Collins & Shiloh 
2015; Zimmerli, Edwards & Ernst 1996), also an opsonin-mediated interaction has 
been shown to contribute to mycobacterial recognition (Hirsch et al. 1994; Stamm, 
Collins & Shiloh 2015). In addition, cytoplasmic PRRs i.e. STING (or 
transmembrane protein 173, TMEM173) can recognize cytosolic mycobacterial 
DNA, further contributing to the repertoire of M. tuberculosis recognition receptors 
(Watson, Manzanillo & Cox 2012). Collectively, the stimulation of the PRRs dictates 
the following steps in the macrophage response against mycobacteria in the host. 
Noteworthy, also other professional phagocytes of the lungs, such as neutrophils, 
monocyte-derived macrophages and dendritic cells (DCs) play an important role in 
the innate immune response against M. tuberculosis (Kimmey et al. 2015; Weiss & 
Schaible 2015; Wolf et al. 2008). 
Lectins are proteins capable of binding carbohydrate moieties in different 
cellular and extracellular spaces (Sharon & Lis 2004). Consequently, lectins act as 
recognition proteins that function in homeostasis (e.g. iron transfer) as well as in the 
immune response. In fact, the C-type lectin receptor Cluster of differentiation 209 
(CD209 or DC-SIGN) has been identified as an essential protein in the DC-mediated 
binding of M. tuberculosis and the subsequent uptake of mycobacteria into these cells 
(Tailleux et al. 2003). Intelectins (ITLNs) are an evolutionarily conserved lectin sub-
family identified at least in mammals, fish and ascidians (Yan et al. 2013). Although 
several different biological functions have been suggested for ITLNs, an increasing 
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amount of studies have provided evidence for their role in the innate immunity. 
Consequently, ITLNs have been shown to bind and agglutinate a number of bacterial 
species (Chen et al. 2016; Ding et al. 2017; Nagata 2018; Wesener et al. 2015) as well 
as to aid in mycobacterial phagocytosis (Tsuji et al. 2009). 
Figure 4. Pattern recognition receptors (PRRs) involved in the recognition of 
M. tuberculosis. C-type lectin-, scavenger and toll-like receptors (TLRs) can bind to 
mycobacterial surface structures on macrophages. While bacterial recognition through the 
Mannose receptor can lead to bacterial engulfment and to intracellular killing mechanisms in the 
phago-lysosomal compartments (e.g. production of nitric oxide, NO, by the Nitric oxide 
synthase, NOS), TLR-mediated mycobacterial binding activates the MYD88/NFKB pathway 
and the production of pro-inflammatory cytokines. Figure is re-printed from Immunological 
Reviews, Volume 264, Issue 1, Pages No. 204–219, Stamm et al., (2015), Sensing of Mycobacterium 
tuberculosis and consequences to both host and bacillus, (doi: 10.1111/imr.12263), Copyright 
(2015), with permission from John Wiley & Sons A/S. 
As mentioned, the C-type lectin- and scavenger receptor mediated recognition 
or opsonization can lead to bacterial engulfment by phagocytosis. The main cell 
surface receptors that initiate phagocytosis of M. tuberculosis are the mannose 
receptors of the C-type lectin family (Stamm, Collins & Shiloh 2015). In addition, 
other C-type lectin receptors such as the C-type lectin domain containing 7A 
(CLEC7A or DECTIN-1) and CLEC4E (or MINCLE) as well as scavenger 
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receptors such as CD36 and MARCO are known to bind to M. tuberculosis (Stamm, 
Collins & Shiloh 2015). In contrast, following a TLR-mediated recognition of 
mycobacteria an intracellular signaling cascade through Myeloid differentiation 
primary response 88 (MYD88) leads to the activation of the nuclear factor kappa B 
(NFKB) and to production of immunological mediators such as cytokines and small 
lipid mediators by the macrophages (Philips & Ernst 2012; van Crevel, Ottenhoff & 
van der Meer 2003; Weiss & Schaible 2015). To date, at least TLR2, TLR4 and TLR9 
have been reported to recognize mycobacterial surface structures (Mortaz et al. 2015; 
Stamm, Collins & Shiloh 2015).  
Collectively, the activation of the PRRs can direct neutrophils to the site of 
infection, leading to the subsequent secretion of chemokines and the attraction of 
monocyte-derived macrophages (Weiss & Schaible 2015). Altogether, these three 
phagocyte populations produce proinflammatory cytokines including Tumor 
necrosis factor (TNF), IL1B, IL6 and IL12, which are important for macrophage 
activation and mycobacterial killing mechanisms, but also for the activation of 
natural killer (NK) cells and the adaptive immune system (Philips & Ernst 2012; 
Weiss & Schaible 2015). In fact, the activation of macrophages is classically thought 
to require stimulation from TNF, but also from Interferon gamma (IFNG), that can 
be produced by NK cells and T helper type 1 (Th1) cells (Mosser & Edwards 2008). 
As a result, macrophage activation leads to the production of nitric oxide (NO) and 
reactive oxygen species (ROS), and consequently can result in the oxidative 
destruction of engulfed mycobacteria inside the phago-lysosomal compartments 
(Nathan & Hibbs 1991; Roca & Ramakrishnan 2013; Weiss & Schaible 2015). 
Although the activation of phagocytes can lead to bacterial destruction (Weiss 
& Schaible 2015), virulent mycobacteria can also actively avoid lysis by escaping from 
the phago-lysosomes (McDonough, Kress & Bloom 1993) as well as by inhibiting 
phagosome-lysosome fusion (Malik, Denning & Kusner 2000). More specifically, 
mycobacterial effectors such as ESAT6 and CFP-10 (or ESAT-6-like protein, EsxB) 
encoded by the Esx-1 loci have been found to cause damage to the phagosomal 
membrane and to promote the relocation of M. tuberculosis to the macrophage or DC 
cytosol (van der Wel et al. 2007). Additionally, inhibition of calcium-ion (Ca2+) 
signaling by mycobacteria was demonstrated to prevent the fusion of the lysosome 
with the phagosomal compartment (Malik, Denning & Kusner 2000). M. tuberculosis 
also uses other mechanisms to avoid destruction by macrophages, including the 
translocation of bacteria-derived cyclic adenosine monophosphate (cAMP) into the 
macrophage cytoplasm (Agarwal et al. 2009) as well as masking their pathogen-
associated molecular patterns (PAMPs) with membrane lipids (Cambier et al. 2014). 
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Overall, processes promoted by virulent mycobacterial strains increase the 
intracellular replication of bacteria and the death of host cells, as well as contribute 
to bacterial spread, survival and pathogenesis. Furthermore, not only bacterial 
virulence factors and immunodeficiency can cause mycobacterial outgrowth, but also 
excessive TNF production has been demonstrated to lead to macrophage necrosis 
and to increase the spread of extracellular mycobacteria (Roca & Ramakrishnan 
2013; Tobin, David M et al. 2012), exemplifying the complexity of the host immunity 
against mycobacteria. 
2.1.3.2 Adaptive immune response 
 
Following the innate immune response, DCs present the mycobacterial antigens to 
naïve lymphocytes in the lymph nodes (Cooper 2009). In fact, already in the 1970´s 
T cells were shown to be important in the defense against TB infection (Lefford 
1975; North 1973; Orme & Collins 1983). Later, both CD8+ (Canaday et al. 1999; 
Lin & Flynn 2015) and CD4+ T cells (Lyadova & Panteleev 2015) have been 
suggested to play an indispensable role in the human M. tuberculosis infection. 
Although the function of CD8+ T cells in TB immunity can be directly mediated by 
target cell killing mechanisms through cytotoxin production (e.g. perforin and 
granulysin) also the production of cytokines such as IFNG and TNF, similarly to 
CD4+ T cells, has been suggested to play a role (Lin & Flynn 2015). However, while 
the significance of CD8+ T cells in TB is still somewhat elusive, the role of the T 
helper (Th) type 1 cell response (a subtype of the CD4+ T cells) has been 
demonstrated to be crucial for the immune response against M. tuberculosis in human 
patients (Onwubalili, Scott & Robinson 1985; Zhang et al. 1994) and in experimental 
studies using Il12 and Ifng knockout mice (Cooper et al. 1993; Cooper et al. 1997; 
Flynn et al. 1993; Flynn et al. 1995). Mechanistically, it has been suggested that the 
importance of Th1 cells stems from the important role of IFNG in the activation of 
macrophages (Weiss & Schaible 2015).  
Nevertheless, not all of the regulators of the Th1 type immune response are 
well characterized. As an example, Th1 differentiation studies using mouse and 
human T cell microarrays, identified a proprotein convertase subtilisin/kexin 
(PCSK) family member FURIN as one of the genes regulated by the IL12/STAT4 
signaling pathway (Lund et al. 2004; Pesu et al. 2006). Moreover, FURIN has been 
shown to enhance the secretion of IFNG from Th1 cells (Pesu et al. 2006), and to 
favor Th1 cell development by the inhibition of the expression of the IL-4 receptor 
alpha chain and the IL4/STAT6 signaling required for Th2 cell polarization 
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(Oksanen et al. 2014). In fact, the role of these Th1 type immunity regulators, like 
that of FURIN, in the host response to TB, requires further studies. In addition to 
Th1 cells, also other Th cell subtypes such as Th17 cells can confer protection against 
M. tuberculosis (Gallegos et al. 2011; Gopal et al. 2014; Khader et al. 2005), whereas 
regulatory T (Treg) cells can suppress the mycobacterial host response (Kursar et al. 
2007; Quinn et al. 2006; Scott-Browne et al. 2007). 
Although the induction of the adaptive immune response is similar to many 
other human pathogens, the initiation of the response is significantly delayed in a 
M. tuberculosis infection. In fact, mouse studies demonstrated that it took 9-11 days 
before T cell proliferation could be measured and a total of 15-17 days before 
effector T cells trafficked back to the lungs (Reiley et al. 2008; Wolf et al. 2008). 
Furthermore, in humans it has been reported that it can take as long as 42 days until 
a measurable T cell response against TB can be detected (Ernst 2012). Contributing 
to the delay of the adaptive response and the failure of the host to eliminate bacteria, 
M. tuberculosis has been shown to actively inhibit the expression of major 
histocompatibility complex II (MHCII) and the presentation of MHCII-mediated 
antigens to CD4+ T cells (Noss, Harding & Boom 2000), and it has been shown to 
disrupt IFNG-responses (Ting et al. 1999). It has also been suggested that the 
immune-privileged nature of the initial recognition-site of M. tuberculosis, the alveoli, 
delays the DC mediated antigen transport (Cambier, Falkow & Ramakrishnan 2014; 
Cooper 2009). Consequently, as hypothesized by Wolf et al. (2008), it is likely that 
this delayed induction of the adaptive immune response contributes to the inability 
of the host to eradicate the bacteria. 
B cell responses in a M. tuberculosis infection have not been studied as extensively 
as the immune function of T lymphocytes. Nevertheless, it has been experimentally 
demonstrated that the lack of functional B cells increases infection susceptibility in 
mice (Maglione, Xu & Chan 2007; Vordermeier et al. 1996), and that 
immunoglobulins confer protection against TB (Achkar, Chan & Casadevall 2015; 
Balu et al. 2011; Lu et al. 2016; Maglione et al. 2008). Collectively, in most 
M. tuberculosis infections both the initial innate response and the subsequent 
activation of the adaptive immunity lead to bacterial containment and to the 
development of the hallmark signs of  a mycobacterial infection - the granulomas. 
2.1.3.3 The role of the mycobacterial granulomas in the immune response 
Tuberculous granulomas are organized structures of several immune cell sub-types 
that encapsulate mycobacteria at their central core (Figure 3 and Figure 5) 
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(Ramakrishnan 2012). Studies performed in zebrafish embryos using the M. marinum 
model of TB have shown that granulomas initially form as macrophage aggregates 
in the absence of the adaptive immunity (Davis et al. 2002). However, at later stages 
of the infection also other immune cells such as NK cells, DCs and neutrophils as 
well as B and T lymphocytes are found at the granuloma site (Ramakrishnan 2012). 
Although a long-held dogma was that the granulomas benefit the host by 
restricting bacterial spread, relatively new research has shown that the granulomas 
are dynamic structures that support also the proliferation and dissemination of 
mycobacteria (Ramakrishnan 2012). A host-protective view of the granuloma is 
supported by the impaired granuloma formation and consequent increase in the 
incidence of TB in HIV-infected people (Lawn, Butera & Shinnick 2002) as well as 
by experimental studies using M. tuberculosis infected Ifng and Tnf knockout mouse 
models with disrupted tuberculous granulomas and increased infection susceptibility 
(Bean et al. 1999; Cooper et al. 1993). Conversely, using the zebrafish M. marinum 
model it has later been demonstrated that mycobacteria exploit the granuloma 
macrophages in order to multiply and spread to novel sites in the host (Davis & 
Ramakrishnan 2009), and that this is mediated by mycobacterial virulence factors 
encoded by the region of difference 1 (RD1) locus (Volkman et al. 2004). All in all, 
although the interplay between the innate and adaptive immunity enables the host 
to either eradicate or to isolate the mycobacteria inside the granulomas, the 
granuloma can also serve as a niche that benefits bacterial outgrowth. Furthermore, 
the host immune response is affected by several bacterial virulence factors but it is 
also largely dependent on the genetic composition of the host. 
2.1.4 Genetic association of infection susceptibility 
Similarly to other infectious diseases, the importance of host genetics in TB 
susceptibility is nowadays well-established. To this end, the genetic component in 
TB has been demonstrated with twin studies, by studying families with Mendelian 
susceptibility to mycobacterial diseases but also with human candidate gene and 
genome wide association studies (GWAS) (Barreiro et al. 2012; Bustamante et al. 
2014; Meyer & Thye 2014). In addition, transcriptomic studies of blood samples 
from human TB patients have identified new gene candidates with a possible 
biomarker potential and association with mycobacterial immunity (Joosten, Fletcher 
& Ottenhoff 2013; Walzl et al. 2014). 
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Table 2. Genes associated with M. tuberculosis susceptibility. 
 
While observations made in human twins gave strong general evidence for the 
genetic association to TB susceptibility (Comstock 1978), later studies have identified 
specific genes such as the aforementioned IFNG (Onwubalili, Scott & Robinson 
1985; Shimokata et al. 1982) and IL12 (Zhang et al. 1994), that are important for TB 
immunity. The list of genes associated with the immune response against TB has 
later expanded substantially (Lerner, Borel & Gutierrez 2015; Meyer & Thye 2014; 
Möller, de Wit & Hoal 2010), and a large amount of gene polymorphisms have been 
linked to host susceptibility against M. tuberculosis i.e. in TNF, TLR, complement receptor 
1 (CR1) as well as mannan-binding lectin (MBL) genes (Azad, Sadee & Schlesinger 2012; 
Meyer & Thye 2014; Möller, de Wit & Hoal 2010; Selvaraj, Narayanan & Reetha 
1999). Collectively, a thorough understanding of the host genetics in the immune 
response against mycobacteria can lead to personalized TB therapies and the 
development of new drugs and vaccines against M. tuberculosis, and it can also support 
the identification of new biomarkers for TB diagnostics. Nonetheless, experimental 
Gene name Gene symbol Reference (reviewed in)
C-C motif chemokine ligand 2 CCL2 Möller et al., 2010
C-C motif chemokine ligand 5 CCL5 (RANTES) Azad et al., 2012
CD14 molecule CD14 Azad et al., 2012
CD209 molecule CD209 Möller et al., 2010
complement C3b/C4b receptor 1 CR1 Azad et al., 2012
C-type lectin domain containing 7A CLEC7A (Dectin-1) Azad et al., 2012
C-X-C motif chemokine ligand 10 CXCL10 Azad et al., 2012
interferon gamma IFNG Möller et al., 2010
interleukin 1 beta IL1B Azad et al., 2012
interleukin 12 IL12 Azad et al., 2012
interleukin 6 IL6 Azad et al., 2012
interleukin 8 IL8 Azad et al., 2012
mannose binding lectin 2 MBL2 Möller et al., 2010
nitric oxide synthase 2 NOS2A Möller et al., 2010
nucleotide binding oligomerization domain containing 1 NOD1 Azad et al., 2012
nucleotide binding oligomerization domain containing 2 NOD2 Azad et al., 2012
purinergic receptor P2X 7 P2RX7 Azad et al., 2012
solute carrier family 11 member 1 SLC11A1 Möller et al., 2010
SP110 nuclear body protein SP110 Möller et al., 2010
surfactant protein A1 SFTPA1 (SP-A1) Azad et al., 2012
surfactant protein A2 SFTPA2 (SP-A2) Azad et al., 2012
TIR domain containing adaptor protein TIRAP Azad et al., 2012
toll like receptor 1 TLR1 Möller et al., 2010
toll like receptor 2 TLR2 Möller et al., 2010
toll like receptor 4 TLR4 Möller et al., 2010
toll like receptor 8 TLR8 Möller et al., 2010
toll like receptor 9 TLR9 Azad et al., 2012
tumor necrosis factor TNF Azad et al., 2012
vitamin D receptor VDR Möller et al., 2010
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models are invaluable in harnessing the knowledge about genetic susceptibility to the 
development of novel therapies and diagnosis methods. Table 2 lists some of the 
human genes associated with TB susceptibility. 
2.2 Experimental models for TB 
2.2.1 In vitro models 
As described earlier, mycobacteria-macrophage interactions are crucial in the initial 
stages of granuloma formation (Davis et al. 2002) as well as in the pathogenesis of a 
mycobacterial infection (Davis & Ramakrishnan 2009). Not surprisingly, several 
in vitro models used in TB research are based either on cultures of immortalized 
monocytes, such as the leukemic THP-1 cell line, or on freshly derived peripheral 
blood mononuclear cells, that can be stimulated to differentiate into macrophages 
(Fonseca et al. 2017). Additionally, as described by Fonseca et al., (2017) several 
co-culture and three-dimensional tissue models have emerged in order to recapitulate 
cell-cell interactions in a mycobacterial infection as well as to mimic tuberculous 
granulomas. In fact, the in vitro models can provide the means for cost-effective TB 
studies, but they can also decrease the use of experimental animals. Nonetheless, 
animal models are required for studying the complex host-pathogen interactions in 
a mycobacterial infection and to test new TB regimens prior to clinical trials. 
2.2.2 Animal models 
2.2.2.1 Mammalian models 
Common mammalian animal species used in modeling TB include mouse, guinea 
pig, rabbit, cattle and non-human primates (Dharmadhikari & Nardell 2008; Flynn 
2006; Myllymäki et al. 2015). Of these animal models, the non-human primates offer 
major advantages to TB research such as the anatomical and physiological similarities 
between primates and humans, comparable clinical manifestations to human TB, 
comparable disease progression and pathology as well as the possibility to use human 
TB diagnostics in evaluating the outcome of an infection (Peña & Ho 2015). 
However, ethical concerns and high costs limit the usefulness of the non-human 
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primate models (Myllymäki et al. 2015). In fact, other mammalian TB models can 
also recapitulate important aspects of the human disease with both advantages and 
limitations to the research. While the mouse model is relatively affordable and a lot 
of tools are available for its genetic manipulation, M. tuberculosis is not a natural 
mouse pathogen and for example spontaneous latency does not occur in mice 
(Cooper 2014). On the other hand, although guinea pig, rabbit and cattle models 
have proven their feasibility in TB research and for example guinea pigs and cattle 
have been highly useful in vaccine development, the high cost, size as well as the lack 
of reagents and genetic tools limits the practicality of their use (Dharmadhikari & 
Nardell 2008; Flynn 2006; Myllymäki et al. 2015). 
2.2.2.2 The zebrafish model 
Mycobacterium marinum is a natural fish pathogen that normally causes a chronic 
progressive disease in its host (Stamm & Brown 2004). Together with Mycobacterium 
ulcerans, M. marinum is the closest genetic relative of M. tuberculosis outside the 
M. tuberculosis complex (Tønjum et al. 1998). In fact, M. marinum shares most of its 
virulence determinants with M. tuberculosis (Stamm & Brown 2004; Tobin, David & 
Ramakrishnan 2008) and genetic material from M. tuberculosis has been demonstrated 
to complement the lack of corresponding genomic regions in M. marinum (Gao et al. 
2003a; Gao et al. 2003b; Gao et al. 2004). Importantly, the pathology of M. marinum 
in vitro, as well as in animal models, is similar compared to human TB. Accordingly, 
M. marinum is able to modulate the phago-lysosomal fusion of host macrophages 
(Barker et al. 1997) and to use them for its survival and replication (El-Etr, Yan & 
Cirillo 2001). In addition, human TB-like histopathological features have been 
reported in different M. marinum susceptible hosts, including frogs (Ramakrishnan et 
al. 1997), goldfish (Talaat et al. 1998) and zebrafish (Myllymäki, Bäuerlein & Rämet 
2016; Parikka et al. 2012). 
Zebrafish (Danio rerio) is a small fresh-water teleost that has been used in 
developmental biology research since the 1970´s (Sullivan & Kim 2008). Among 
other things, the applicability of the zebrafish as a model organism can be attributed 
to its small size, high fecundity, ex-utero development, the optical transparency of 
the embryos as well as to the ease of its genetic manipulation and vast genetic 
resources (Renshaw & Trede 2012; Yoder et al. 2002). Relatively recently, the 
zebrafish has also gained popularity as an immunological model organism with 
immune cell populations and humoral effectors comparable to those in humans 
(Renshaw & Trede 2012). Of the traditional human innate immune cells, at least 
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macrophages and neutrophils (Lieschke et al. 2001), DCs (Lugo-Villarino et al. 2010; 
Tanne et al. 2009), NK cells (Wei et al. 2007), mast cell-like cells (Dobson et al. 2008) 
and eosinophils (Balla et al. 2010) have been identified and characterized also in 
zebrafish. Furthermore, gamma-delta (γδ) T cells (Wan et al. 2016), T cells (Yoon et 
al. 2015) as well as B cells (Danilova & Steiner 2002) exist in the zebrafish, and more 
specifically comparable populations of Th2- and Treg cells (Dee et al. 2016; Kasheta 
et al. 2017) as well as the expression of Th subtype specific transcription factors 
(Hammaren et al. 2014; Mitra et al. 2010) have been reported. It is also noteworthy 
that effectors of the humoral immunity including complement components (Seeger, 
Mayer & Klein 1996) and immunoglobulins (Danilova et al. 2005; Lam et al. 2004) 
function in zebrafish. Moreover, anatomical similarities of the zebrafish immune 
system to that of humans include the lymphatic vasculature (Küchler et al. 2006; 
Yaniv et al. 2006) as well as the thymus (primary lymphoid organ for T cell 
development) and the spleen (secondary lymphoid organ) (Renshaw & Trede 2012). 
While many similarities of the human and zebrafish immune systems can be 
specified, some differences are also found. First of all, the zebrafish kidney serves as 
the primary lymphoid organ and the place for B cell and blood cell precursor 
development (equivalent of the mammalian bone marrow) (Renshaw & Trede 2012). 
In addition, lymph nodes have not been identified in zebrafish, and in fact it has 
been proposed that the antigenic presentation in zebrafish takes place in the spleen 
as well as in the Peyer´s patch- like structures of the intestine (Renshaw & Trede 
2012). Lastly, the absence of the lungs needs to be reckoned while studying 
pulmonary diseases in zebrafish. 
An experimental M. marinum infection can be used to model TB in both 
zebrafish embryos (Davis et al. 2002) as well as in adult fish (Prouty et al. 2003) 
(Figure 5). Since it can take as long as 4 weeks until an immunocompetent adaptive 
immunity is present in the zebrafish (Lam et al. 2004; Trede et al. 2004), the zebrafish 
embryos can be used to specifically study the innate immune response against 
mycobacteria. In fact, microinjecting M. marinum into zebrafish embryos leads to a 
progressive infection characterized by the initial engulfment of the bacteria by 
macrophages and, in collaboration with neutrophils, the formation of the early 
granulomas (Davis et al. 2002; Yang et al. 2012). Furthermore, the small size of the 
embryos and the high-throughput yolk sac infection possibilities enable the efficient 
screening of drugs against TB (Carvalho et al. 2011), whereas the transparency of the 
embryos provides numerous imaging possibilities including the use of transgenic-
reporter fish and bacteria for the real-time visualization of the host-mycobacterial 
interactions (Davis et al. 2002; Meijer, van der Vaart & Spaink 2014). In addition, 
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bacterial microinjections into different locations in the embryos, enable the 
separation of localized and systemic infections and consequently studying the 
different forms of a mycobacterial infection (Meijer 2016). Naturally, the lack of an 
adaptive immunity in the embryos means that the embryonic model cannot be used 
in studying the adaptive immune response. 
Figure 5. The zebrafish model for TB. A) Following a M. marinum infection, the embryos 
develop a progressive infection in which the early stages of granuloma formation can be studied 
in the presence of macrophages and neutrophils. B) Adult zebrafish can be used to model both 
latent and progressive mycobacterial infections as well as the reactivation of the infection. While 
a low-dose inoculate can cause well-organized granulomas and lead to bacterial containment, the 
reactivation of the latent disease and a high-dose infection cause unrestricted bacterial growth 
and a progressive disease leading to lethality. Figure is modified from Myllymäki et al., (2016), 
Frontiers in Immunology, Volume 7, Article 196, Copyright (2016), and reprinted under the terms 
of the Creative Commons Attribution license 
(https://creativecommons.org/licenses/by/4.0/legalcode). 
A 
B 
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An experimental M. marinum infection can be used to model TB in both 
zebrafish embryos (Davis et al. 2002) as well as in adult fish (Prouty et al. 2003) 
(Figure 5). Since it can take as long as 4 weeks until an immunocompetent adaptive 
immunity is present in the zebrafish (Lam et al. 2004; Trede et al. 2004), the zebrafish 
embryos can be used to specifically study the innate immune response against 
mycobacteria. In fact, microinjecting M. marinum into zebrafish embryos leads to a 
progressive infection characterized by the initial engulfment of the bacteria by 
macrophages and, in collaboration with neutrophils, the formation of the early 
granulomas (Davis et al. 2002; Yang et al. 2012). Furthermore, the small size of the 
embryos and the high-throughput yolk sac infection possibilities enable the efficient 
screening of drugs against TB (Carvalho et al. 2011), whereas the transparency of the 
embryos provides numerous imaging possibilities including the use of transgenic-
reporter fish and bacteria for the real-time visualization of the host-mycobacterial 
interactions (Davis et al. 2002; Meijer, van der Vaart & Spaink 2014). In addition, 
bacterial microinjections into different locations in the embryos, enable the 
separation of localized and systemic infections and consequently studying the 
different forms of a mycobacterial infection (Meijer 2016). Naturally, the lack of an 
adaptive immunity in the embryos means that the embryonic model cannot be used 
in studying the adaptive immune response. 
Unlike the zebrafish embryos, the adult zebrafish can be used to study the 
components of both the innate and the adaptive immune system in an infection.  
Normally an acute or a chronic progressive mycobacterial disease occurs in adult fish 
upon a M. marinum infection (van der Sar et al. 2009). However, as the final infection 
outcome depends on several host and bacterial specific factors, also a latent infection 
can be modeled by using a low-dose M. marinum inoculate of the M. marinum strain 
ATCC 927 (Parikka et al. 2012). While the acute and chronic infections can be used 
to determine differences in survival between e.g. knockout and WT fish or to study 
the transcriptomics of the host response, the latent model offers new possibilities to 
study latency/dormancy and reactivation (Myllymäki et al. 2018; Parikka et al. 2012). 
Additionally, the sequenced and assembled zebrafish genome (Howe et al. 2013) has 
not only made it possible to screen for the candidate genes of the adaptive immune 
response important for mycobacterial susceptibility, by performing transcriptomic 
analyses (e.g. Meijer et al. 2005), but it has also largely benefitted both the forward- 
(Tobin 2010) and the reverse genetic approaches (Clay, Volkman & Ramakrishnan 
2008; van der Vaart et al. 2013). Conversely, while the embryos can be grown with 
relative ease on a petri dish in an incubator, the adult fish require costly maintenance 
in specific water circulation systems with constant monitoring of the water quality 
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and temperature. In addition, the relatively large size of the adult fish reduces the 
real-time imaging possibilities compared to the embryos. 
2.3 Reverse genetics in zebrafish 
The zebrafish genome sequencing project was initiated by the Wellcome Trust 
Sanger Institute (Cambridge, UK) in 2001, and the recent 11th assembly (GRCz11) 
provides invaluable information about the zebrafish genome to scientists (Howe et 
al. 2013). According to Howe et al. (2013), approximately 70% of all human genes 
have an orthologue in the zebrafish genome. However, complicating the direct 
comparison of the human and zebrafish genes, the teleost specific genome 
duplication event has led to duplicated orthologues (ohnologues) of human genes 
(Howe et al. 2013). Nevertheless, the large number of orthologous genes between 
human and zebrafish makes it possible to study numerous human disease-related 
genes in the zebrafish (Cronan & Tobin 2014). 
2.3.1 Morpholino-mediated gene silencing 
Anti-sense oligonucleotides are nowadays widely used in modulating gene expression 
in both in vitro as well as in in vivo applications. The two main approaches for the 
oligonucleotide specific silencing include RNA interference (RNAi) mediated 
knockdown and the administration of single-stranded oligos (Watts & Corey 2012). 
RNAi is based on the endogenous mechanism in which double-stranded small 
interfering RNA molecules (siRNAs) bind to the RNA-induced silencing complex 
(RISC) and subsequently degrade or repress the translation of the complementary 
mRNA translation (Watts & Corey 2012). Although this approach is widely 
applicable as well as efficient (Li & Cha 2007), the immunogenicity of siRNAs has 
raised concerns (Marques & Williams 2005). Conversely, single-stranded anti-sense 
oligonucleotides (ASOs) bind directly to their complementary RNA (Watts & Corey 
2012). By doing so, they can block the initiation of mRNA translation, affect pre-
mRNA splicing or block microRNA (miRNA) functionality (Watts & Corey 2012). 
In addition, as described by Watts & Corey (2012), initial problems such as a high 
nuclease degradation rate, significant off-target effects and low delivery efficiency 
have later been solved with chemical modifications to the oligonucleotide backbone. 
Compared to natural single-stranded DNA and RNA molecules, the nucleic 
acid backbone in the morpholino ASOs has been modified with non-ionic 
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phosphorodiamidates that link adjacent morpholine moieties (Summerton & Weller 
1997). With these modifications Summerton & Weller (1997) described nuclease-
resistant, sequence-specific and highly efficient ASO that could be produced 
cost-efficiently compared to other DNA analogs of that time. Soon after their 
introduction, in vivo morpholino experiments were conducted in different model 
organisms including rat (Arora et al. 2000), mouse (Qin et al. 2000) and frog (Xenopus 
laevis) (Heasman, Kofron & Wylie 2000). In addition, at the same time Nascevisius 
& Ekker (2000) published the first article describing the use of morpholinos in 
zebrafish embryos by utilizing yolk sac microinjection. Not only were the 
morpholinos found to be efficient and target specific, the morphant phenotypes 
could also be recapitulated in the null-mutant embryos. Since then, morpholinos 
have been widely used in zebrafish embryos to perform gene knockdown by either 
blocking the translation or normal splicing of the mRNA (Table 3). Furthermore, 
the tissue specific use of morpholinos has been reported in adult zebrafish (Hyde, 
Godwin & Thummel 2012; Kizil et al. 2013; Thummel, Bailey & Hyde 2011). Here, 
only the embryonic use of morpholinos will be reviewed further. 
From an immunological perspective, several genes important for the innate 
immune response have been studied using morpholino-mediated gene knockdown 
in zebrafish embryo infection models. To this end, van der Sar et al. (2006) knocked 
down the Tlr adaptor protein gene myd88, and demonstrated its importance in the 
zebrafish immune response. Similarly, Clay et al. (2008) blocked TNF signaling using 
a tumor necrosis factor receptor superfamily, member 1a (tnfrsf1a) morpholino, and 
demonstrated increased susceptibility of the morphants to a M. marinum infection as 
well as abnormal granuloma formation in these embryos. In addition, morpholino 
silencing has been used for the zebrafish orthologues of also other human genes 
such as Wiskott-Aldrich syndrome (WAS) (Rounioja et al. 2012), macrophage receptor with 
collagenous structure (MARCO) (Benard et al. 2014), TNF receptor associated factor 6 
(TRAF6) (Stockhammer et al. 2010) and spi-1 proto-oncogene (SPI1) (Rhodes et al. 
2005).  
Despite the widespread use of morpholinos, a relatively recent study revealed 
poor correlation between the phenotypes of morphants and mutant zebrafish, 
suggesting an under-estimated off-target prevalence in morpholino-mediated 
knockdown (Kok et al. 2015). In fact, the proper control of morpholino experiments 
is required to ensure the efficient and specific silencing of the gene of interest 
without unwanted effects such as p53 activation mediated apoptosis (Eisen & Smith 
2008; Robu et al. 2007; Stainier et al. 2017). These control methods include the use 
of multiple morpholinos for a given target gene, rescue experiments with the target 
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mRNA, random control (RC) morpholino usage as well as the generation of a dose 
response curve for the target morpholino. However, although appropriate control is 
necessary to prevent significant off-target effects, the lack of correlation between the 
morphant and mutant phenotypes can in some cases also be caused by compensatory 
mechanisms functioning in the null-mutants but not in the knockdown embryos 
(Rossi et al. 2015). 
 
Table 3. Common gene silencing and mutagenesis methods in zebrafish. 
2.3.2 Knockout zebrafish lines 
2.3.2.1 Commercial mutants 
Initiated by the Wellcome Trust Sanger Institute, the Zebrafish mutation project 
aims to create and identify knockout alleles for all of the protein-coding genes in the 
zebrafish genome, and to make the produced mutant zebrafish lines commercially 
available (Kettleborough et al. 2013). To this end, a forward genetic screen using a 
combination of N-ethyl-N-nitrosourea (ENU) mutagenesis (Table 3) and 
high-throughput exome sequencing has been used, and currently null-mutations 
have been identified in approximately 60% of the zebrafish protein-coding genes, 
corresponding to a total of 37,624 knockout alleles  
(https://www.sanger.ac.uk/science/collaboration/zebrafish-mutation-project; 13th 
of August, 2018). Furthermore, the Zebrafish International Resource Center (ZIRC) 
as well as the European Zebrafish Resource Center (EZRC) have distributed the 
obtained mutant zebrafish lines to the research community. In fact, to date 17,882 
fish lines containing knockout alleles are available from ZIRC or EZRC (13th of 
August, 2018). However, despite the impressive amount of commercial lines, mutant 
zebrafish are not yet available for all zebrafish genes. In addition, since the ENU 
mutagenesis causes random mutations into the zebrafish genome, off-target 
mutations do occur and they can co-segregate with the knockout allele of interest. 
Method Silencing vs. Mutagenesis
Morpholino-oligonucleotides Silencing
N-ethyl-N-nitrosourea (ENU) treatment Mutagenesis
Zinc-finger nucleases (ZFNs) Mutagenesis
Transcription activator-like effector nucleases (TALENs) Mutagenesis
CRISPR/Cas9 technology Mutagenesis
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This in turn has to be controlled in the experiments, for example by using only 
siblings of the same parents or by performing exome sequencing. 
2.3.2.2 Zinc-finger nucleases (ZFNs) and Transcription activator-like effector 
nucleases (TALENs) 
Although a lot of attention has been recently given to the CRISPR/Cas9 system, 
Zinc-finger nucleases (ZFNs) and Transcription activator-like effector nucleases 
(TALENs) can be applied in the zebrafish to generate site-specific genetic 
modifications (Table 3) (Huang et al. 2012). Zinc-finger proteins were initially 
identified in Xenopus laevis oocytes and they were shown to bind DNA through their 
zinc-finger motifs (Miller, McLachlan & Klug 1985). Later, the fusion of these 
proteins to the catalytic domain of the FokI-endonuclease initiated the use of ZFNs 
in targeted and programmable genomic modifications (Kim, Cha & Chandrasegaran 
1996). Similarly to the standard CRISPR/Cas9 system, ZFN induced double-
stranded breaks (DSBs) in cellular DNA are repaired by endogenous non-
homologous end joining (NHEJ) (Bibikova et al. 2002) and homology-directed 
repair (HDR) mechanisms (Porteus & Baltimore 2003). Subsequently, the DNA 
repair systems mutate the specified genomic target site. Several in vitro and in vivo 
studies using ZFNs have since been published (e.g. Bibikova et al. 2002; Lombardo 
et al. 2007), including the study by Meng et al. (2008) in which a zebrafish gene was 
mutated for the first time using ZFNs (Meng et al. 2008; Woods & Schier 2008). 
Transcription activator-like (TAL) proteins are major virulence factors of 
pathogenic plant bacteria of the genus Xanthomonas (Bogdanove & Voytas 2011; 
Moscou & Bogdanove 2009). By localizing to the nucleus and binding to the host 
cell DNA, these proteins can alter the host´s gene expression signature for the 
benefit of the bacterium. Soon after the DNA binding strategy of the TAL proteins 
was determined, these proteins were engineered to target and modify genomic loci 
of interest in vitro in cell lines (Miller et al. 2011; Morbitzer et al. 2010). Furthermore, 
using the engineered TALs, or TALENs, described by Miller et al. (2011), in vivo 
genome modifications in the zebrafish were later reported (Sander et al. 2011). 
2.3.2.3 CRISPR/Cas9 mutagenesis 
The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-
associated (Cas) system was initially identified as a bacterial and archaeal immune 
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response against viruses and phages (Bolotin et al. 2005; Mojica et al. 2005; Pourcel, 
Salvignol & Vergnaud 2005). In fact, in nature at least three types of CRISPR/Cas 
systems exists with their main function being to recognize and cleave foreign RNA 
or DNA by target specific RNAs (CRISPR RNA, crRNA; tracer RNA, tracrRNA) 
and Cas proteins with nuclease activity (Makarova et al. 2011). While the type I and 
type III systems require multi-protein complexes for their functionality, the type II 
system uses a single protein, Cas9, to generate target specific RNAs and to cleave 
target nucleic acids (Makarova et al. 2011). Importantly, the type II system was 
relatively recently engineered for scientific use as a two-component genome editing 
system with dual-tracrRNA:crRNA (or guide RNA, gRNA) and the Cas9-protein 
(Figure 6) (Jinek et al. 2012). More specifically, the site-specific gRNA molecule 
binds to the target DNA region through its complementary nucleic acid sequence, 
and directs the Cas9 endonuclease to the same site. For the Cas9-mediated cleavage 
an adjacent protospacer adjacent motif (PAM) downstream from the target site is 
additionally required. Consequently, Cas9 creates a double-stranded break that can 
be repaired with either the NHEJ or HDR system, leading to mutations at the target 
site (Ran et al. 2013). While NHEJ leads to insertion/deletion (indel) mutations and 
can result in the knockout of a gene, for example by disrupting the reading frame, 
the use of a repair template can lead to HDR and mediate the specific addition of 
genetic material (Ran et al. 2013). In fact, the CRISPR/Cas9 system can be used to 
knockout genes as well as to mediate DNA knock-in (Albadri, Del Bene & Revenu 
2017; Hruscha et al. 2013) and gene knockdown (CRISPR interference) (Larson et 
al. 2013). 
Not surprisingly, owing to its simplicity, effectivity and low cost, an enormous 
amount of both in vitro and in vivo systems have used CRISPR/Cas9 mutagenesis to 
create targeted genomic mutations. Importantly, this system has been used in the 
zebrafish in to create both bi-allelic mutations in F0-generation fish (Jao, Wente & 
Chen 2013) as well as knockout zebrafish lines (Table 3) (e.g. Cai et al. 2018; Hruscha 
et al. 2013; Sugimoto et al. 2017; Varshney et al. 2015). Still, as a relatively recent 
mutagenesis method the off-target effects of the CRISPR/Cas9 technology have 
raised concern. However, reports suggesting that the proper design of gRNAs can 
significantly reduce the off-target frequency (Cho et al. 2014) have later mitigated 
these worries. In addition, it has been demonstrated that the chromatin accessibility 
can influence the in vivo efficiency of the CRISPR/Cas9 system making some genes 
difficult to mutate (Uusi-Mäkelä et al. 2018). 
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Figure 6. Overview of the engineered type II CRISPR/Cas9 mutagenesis. sgRNA targets 
the Cas9 protein to the target site by recognizing complementary genomic DNA. By recognizing 
the adjacent PAM sequence (NGG), Cas9 induces a double-stranded break (DSB) at the site. 
Finally, the endogenous DNA repair mechanisms repair the DSB, creating deletions or insertions 
in the corresponding genomic loci. Figure is re-printed from Peng et al., (2015), FEBS Journal, 
Volume 282, Issue 11, Pages No. 2089–2096, Copyright (2015) under the terms of the Creative 
Commons Attribution license (https://creativecommons.org/licenses/by/4.0/legalcode). 
 
Together, the ZFN, TALEN and CRISPR/Cas9 systems have provided major 
advantages to the genetic tractability of the zebrafish genome, and efficient means 
of creating both somatic as well as germ-line transmitted indel-mutations. 
Importantly, these methods have made it possible to create mutant zebrafish lines 
in-house. 
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3 AIMS OF THE STUDY 
The genetic influence on the susceptibility for TB is nowadays well-established. 
While the PCSK family member FURIN is known to regulate T cell function and 
activation, ITLNs have been shown to bind to different bacterial species in vitro. 
More precisely, human FURIN regulates the production of IFNG and the 
polarization of T helper (Th) type 1 cells, both of which are crucial for the immune 
response against TB, whereas ITLN1 can bind to carbohydrates on mycobacterial 
cell surface. However, not much is known about their in vivo role in infectious 
diseases or specifically in the host response against mycobacteria. The aims of this 
study were to set up an in-house CRISPR/Cas9 mutagenesis method in zebrafish, 
and to use furinA- and itln3 -mutant zebrafish lines together with the zebrafish 
M. marinum model of TB in order to understand the significance of these genes for 
the mycobacterial immune response. 
 
 
Specifically the aims can be divided as follows: 
 
1) To study the role of FURIN in the immune response against 
mycobacteria by using commercially available furinAtd204e/+ mutant 
zebrafish. 
 
2) To set up an in-house CRISPR/Cas9 mutagenesis system in zebrafish 
using exogenous egfp as well as endogenous ca10a and ca10b zebrafish 
gene targets. 
 
3) To identify differentially expressed genes in the zebrafish M. marinum 
infection model, and to study the highly up-regulated itln3 in the 
mycobacterial infection using self-produced itln3 knockout zebrafish. 
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4 MATERIALS AND METHODS 
4.1 Zebrafish maintenance 
4.1.1 Ethical considerations (I, II, III) 
The National Animal Experiment Board of Finland has approved the zebrafish 
housing, care and all of the experiments. In addition, experiments are in accordance 
with the EU-directive 2010/63/EU on the protection of animals used for scientific 
purposes and with the Finnish Act on Animal Experimentation (62/2006). Zebrafish 
were monitored daily and humane endpoint principles defined in the permits were 
applied. Permits: LSLH-2007-7254/Ym-23, ESAVI/10079/04.10.06/2015, 
ESAVI/6407/04.10.03/2012, ESAVI/733/04.10.07/2013, 
ESAVI/2267/04.10.03/2012, ESAVI/8125/04.10.07/2013, 
ESAVI/11133/04.10.07/2017, and ESAVI/2235/04.10.07/2015.  
4.1.2 Fish lines and housing (I, II, III) 
Zebrafish embryos were maintained in embryonic medium (E3, 5 mM NaCl, 0.17 
mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, 0.0003 g/l methylene blue) at 28.5°C 
until 7 days post fertilization. Media was changed completely at 2 dpf and half of it 
replaced at 4 dpf. From 5 dpf onwards the larvae were given SDS100 (Special Diets 
Services, Essex, UK) or GM75 (Skretting, Stavanger, Norway) food. In the 
experiments with adult zebrafish, three- to 16-month-old fish were used. Adult fish 
were maintained in a flowthrough system (Aquatic Habitats, Florida, USA or Aqua 
Schwarz, Göttingen, Germany) with an automatic cycle of 14 hours of light and 10 
hours of dark and fed with SDS400 (Special Diets Services) or GM500 (Skretting) 
fish food. Zebrafish lines used in the thesis are shown in Table 4. 
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Table 4. Zebrafish lines used in the study. 
 
4.2 Nucleic acid extraction 
4.2.1 DNA extraction using ethanol precipitation (I, II, III) 
Standard ethanol precipitation was used to isolate DNA from the adult zebrafish 
tailfins as well as from zebrafish embryos. For the tailfin isolation, the zebrafish were 
treated with 0.02% 3-amino benzoic acid ethyl ester (Sigma-Aldrich, Missouri, US) 
and a piece of their tailfin cut under anesthetic. Tissues/embryos were incubated 
overnight in 100 µl of buffer containing 10 mM Tris (pH 8.2), 10 mM 
ethylenediaminetetraacetic acid (EDTA), 200 mM NaCl, 0.5% Sodium dodecyl 
sulfate (SDS) and 200 µg/ml Proteinase K (Thermo Fischer Scientific) until 
homogenous lysate was obtained. The samples were centrifuged (16,000 g, 20 min, 
room temperature, RT) and the genomic DNA isolated using the following 
procedure. Briefly, 200 µl of 100% ethanol (twice the lysate volume) was mixed to 
the supernatant and the DNA precipitated in -20°C for at least 30 min. Precipitated 
DNA was pelleted by centrifugation (16,000 g, 10 min, RT), washed with 70% 
ethanol, centrifuged (16,000 g for 5 min, RT), air-dried and resuspended in 30µl 
(embryos) or 200 µl (tailfins) of ddH2O. 
4.2.2 Rapid isolation of PCR-ready genomic DNA (III) 
The method for PCR-ready genomic DNA isolation from zebrafish tissues 
published by Meeker et al. (2007) was used for genotyping of the adult zebrafish. 
Zebrafish were anesthetized and a piece of their tailfin cut as described above. Tailfin 
Zebrafish line ZFIN ID
Mutagenesis 
method
Used in Reference
AB ZDB-GENO-960809-7 − I, II, III −
TL ZDB-GENO-990623-2 − II, III −
furinA td204e ZDB-FISH-150901-26631 ENU I Walker et al., 2006
Tg(fli1a :egfp ) ZDB-TGCONSTRCT-070117-94 − II Lawson & Weinstein. 2012
itln3uta145 − CRISPR/Cas9 III −
itln3uta148 − CRISPR/Cas9 III −
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tissue was placed in 50 µl of 50 mM NaOH, incubated for 30 min at 98°C, cooled 
down at +4°C and neutralized with 1 M Tris-HCl (pH 8.0). Tissue debris was 
removed by centrifugation (3000 g, 10 min, RT) and the DNA containing 
supernatant used directly to PCR. 
4.2.3 RNA extractions (I, III) 
RNeasy kits (Qiagen) were used for RNA isolations from the adult fish tissues as 
well as from the embryos. Prior the RNA extractions, zebrafish were euthanized in 
0.04% 3-amino benzoic acid ethyl ester (Sigma-Aldrich, Missouri, USA) and samples 
kept in RNAlater (Qiagen) at +4°C, placed on dry ice and stored at -80°C or freshly 
suspended in RLT-lysis buffer (Qiagen). From the zebrafish embryos, simultaneous 
genomic DNA (gDNA) removal and RNA extraction were done using the RNeasy 
Mini Plus kit (Qiagen) according to the manufacturer´s instructions. RNA 
concentrations were measured using Nanodrop (ThermoFisher) and the RNA 
quality analyzed from randomly selected samples using the Fragment analyzer 
(Advanced Analytical). In order to simultaneously isolate DNA and RNA from the 
adult zebrafish organ blocks, Trireagent (Molecular research center, Ohio, USA) was 
used and the manufacturer´s instructions were followed.  
4.3 Zebrafish genotyping 
4.3.1 Sequencing (I, III) 
Sanger sequencing was used to screen for furinAtd204e, itln3uta145 and itln3uta148 
mutation carriers. To this end, genomic DNA was isolated from the zebrafish and 
the mutation site amplified by PCR. Primers used for mutation site amplification are 
shown in Table 5. 
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Table 5. Primers used for mutation site amplification by PCR. 
4.3.2 Polymerase chain reaction (PCR) (III) 
Genomic DNA was isolated from the itln3 mutant zebrafish and two different PCR 
reactions for each sample were done with both the WT and the mutant target site 
specific PCR primers: itln3uta145 mutant F: ATGCTAGGTTGAGGAGCTCG, WT 
itln3uta145 F: ATGCTAGGTTGAGGAGCATC, itln3uta148 mutant R: 
CCGAGCTGATACTTACCTAGC, WT itln3uta148 F: 
CTAGGTTGAGGAGCATCGCT and the appropriate flanking primers (Table 5). 
PCR products were analyzed on 1.5% agarose Tris-acetate-EDTA (TAE) gel. 
4.4 Reverse genetics 
4.4.1 Gene knockdown using morpholino oligonucleotides (I, III) 
All morpholino oligonucleotides were purchased from GeneTools (Oregon, USA) 
and microinjected into the yolk sac of the embryos prior to the 16-cell-stage. 
Whereas furinA and furinB morpholinos were designed to block the translation of the 
corresponding mRNAs, the itln1 morpholino disrupted splicing of its cognate 
precursor mRNA. Morpholino injections were performed using borosilicate capillary 
needles (Sutter instrument Co., California, USA), a micromanipulator (Narishige 
International, London UK) and a PV830 Pneumatic PicoPump (World Precision 
Instruments, Florida, USA). Used morpholino concentrations are described in the 
original communications. 
Gene Ensembl ID Primer sequence 5´-3´ Product size (bp) Used in
furinA ENSDARG00000062909 F: ATCAGCAGCAGTACGCAAAA
R: ATGAATTGGCTTGGCAGTTT
egfp N/A (transgene) F: CAAGGGCGAGGAGCTGTTCAC
R: TCTTCTGCTTGTCGGCCATG
ca10a ENSDARG00000052644 F: CTGCAAATCATCCCTTTGTG
R: GTTCCTCGCATCAAAACACC
ca10b ENSDARG00000009568 F: TCCACGACTCAGCCAACAG
R: GCACTGCGTTATCAGCAAAAG
itln3 ENSDARG00000003523 F: GGAGCTGTCACTCCAAAGCC
R: GTGGTTGATCAACCATTCAGCAC
III
II
II
II
I
212
531
415
470
242
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4.4.2 CRISPR/Cas9 mutagenesis (II, III) 
4.4.2.1 gRNA design and production 
Target site for egfp was obtained from Jao et al. (2013). gRNA target sites for ca10a 
and ca10b as well as itln3 were designed using both the online CRISPR design tool 
(http://crispr.mit.edu/) as well as the sgRNA excel tool (Krebs 2014). Further 
evaluation of the specificity of the suggested target sites were done with the Basic 
Local Alignment Search Tool (BLAST) analysis (Altschul et al. 1997). The synthesis 
of the gRNAs was primarily based on a protocol by Hruscha and Schmid (2015). 
Briefly, DNA-oligos (containing the reverse complementary sequence of the gRNA) 
(Sigma-Adrich) were annealed to the T7-primers and the gRNAs synthetized using 
the MEGAshortscript T7 Transcription Kit (Ambion Life Technologies, USA). The 
quality and quantity of the gRNAs were evaluated using 1% agarose TAE gel 
electrophoresis and Nanodrop, respectively. Table 6 summarizes the gRNA target 
sites for the genes of interest. 
Table 6. Genes and gRNA target sites for CRISPR/Cas9 mutagenesis. 
4.4.2.2 gRNA and Cas9 mRNA microinjections 
Prior to the microinjections, the embryos were aligned on self-made 1.2% agarose 
E3-medium plates. For target site mutagenesis, 1.5 ng phenol red (Sigma), 
270- 2000 pg gRNA and 330 pg Cas9 mRNA (Invitrogen, California, USA) were 
microinjected into one-cell-stage embryos in a 1 nl nuclease free water suspension. 
Whereas egfp was mutated from the transgenic tg(fli1a:egfp) zebrafish, both ca10a and 
ca10b as well as itln3 were mutated from AB zebrafish. Previously described 
Gene Ensembl ID Target site sequence 5´-3´ Targeted exon Used in
egfp N/A (transgene) GGGCACGGGCAGCTTGCCGG - II
ca10a ENSDARG00000052644 TCCACCCAAAATCCATGA 2 II
TACAAAGAAGTTGTTCAG 2 II
ACTGAGGCTCAACACTGG 3 II
ca10b ENSDARG00000009568 AACGAACTCCCAAACGTG 1 II
TTGGGAAGAGACAGTCGC 3 II
itln3 ENSDARG00000003523 AGGTTGAGGAGCATCGCT 2 III
TGACATGACCACAGCCGG 3 III
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microinjection equipment was used, and the injections were visualized under a 
SMZ645 microscope (Nikon, Tokio, Japan). 
4.4.2.3 Target loci analysis using the T7 endonuclease I assay 
 
The gRNA target sites were amplified by PCR using target site specific primers 
(Table 3) as well as Maxima Hot Start DNA polymerase (Thermo Scientific). 10 µl 
of the PCR product was denatured and annealed in 1x NEBuffer 2 (New England 
Biolabs, USA) and incubated with 0.5µl of T7 endonuclease I (T7EI, New England 
Biolabs) for 30 minutes at 37°C in a total reaction volume of 20 µl. Finally, the T7EI 
treated PCR products were analyzed by 2.5% agarose TAE gel electrophoresis. 
4.4.2.4 Microscopical analysis of the CRISPR/Cas9 mutants 
In report II, the phenotypes of the CRISPR/Cas9 mutated zebrafish were evaluated 
by microscopy. Enhanced green fluorescent protein (EGFP) mutagenesis was 
analyzed from 2-day-old tg(fli1a:egfp) zebrafish using fluorescence microscopy. 
Phenotypic consequences of the ca10a and ca10b mutations were assessed and 
imaged using a Lumar V12 microscope (Zeiss, Oberkochen, Germany) 1-5 dpf. 
4.5 Experimental infections 
4.5.1 Bacterial culture (I, III) 
M. marinum strain ATCC 927 was used in all of the mycobacterial infection studies. 
Mycobacteria was cultured in the dark at a constant temperature of 28°C as described 
previously (Parikka et al. 2012). Bacterial amounts for the infection experiments were 
estimated from the 7H9 liquid cultures using a spectrophotometer and the optical 
density (OD) value at 600 nm as well as with a previously determined growth curve 
(Parikka et al. 2012). 
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4.5.2 Bacterial preparation and inoculation (I,III) 
In the embryonic M. marinum infections both yolk sac method (0 dpf) and a blood 
island inoculate (2 dpf) were used. The yolk sac infection was also used in the 
M. marinum and morpholino coinjections. Whereas the general 1-2 nl injection 
suspension contained 2% polyvinylpyrrolidone (PVP) (Sigma-Aldrich) and 
0.3 mg/ml phenol red in a PBS carrier solution, 7 mg/ml rhodamine dextran tracer 
was used in the morpholino and M. marinum co-injections. 2dpf zebrafish embryos 
were anesthetized with 0.02% 3-amino benzoic acid ethyl ester (Sigma-Aldrich) prior 
to injections. For the adult zebrafish M. marinum infections, zebrafish were 
anesthetized as above and mycobacteria injected into the abdominal cavity of the 
fish using a 30 G insulin needle. PBS solution with 0.3 mg/ml phenol red was used 
in the adult infections as a mycobacterial carrier solution. Bacterial dose in all of the 
experimental M. marinum infections was verified by plating on 7H10 agar plates. 
4.6 Analyzing the outcome of the infection 
4.6.1 Flow cytometry (I, III) 
Zebrafish were first euthanized with 0.04% 3-amino benzoic acid ethyl ester, 
followed by isolation and suspension of the kidneys in a PBS solution with 0.5% 
fetal bovine serum (Sigma-Aldrich/Gibco). Before flow cytometry, the kidney cell 
suspensions were filtered using cell strainer caps with a 35 µm mesh 
(Corning/Thermo Fisher Scientific). Kidney cell samples were kept on ice prior to 
the runs. Flow cytometry was perfomed using FACSCanto II (Becton, Dickinson, 
New Jersey, USA) and the data analyzed with the FlowJo program (v7.5; Tree Star, 
Inc, Oregon, USA). Gating for the blood cell populations was based on previously 
published research articles (Langenau et al. 2004; Traver et al. 2003). Of note, steady 
state fish were analyzed by flow cytometry in report I whereas both steady state and 
M. marinum infected fish were analyzed in report III. 
4.6.2 Ziehl-Neelsen staining (I) 
Histological examination using Ziehl-Neelsen stain of tissue sections was used to 
verify mycobacterial presence in the adult furinAtd204 zebrafish. To this end, 
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euthanized zebrafish were prepared using a previously described protocol (Parikka 
et al. 2012). In brief, fish were fixed in 10% phosphate buffered formalin (pH 7.0) 
for 5 days and de-calcified in 20% EDTA-citrate (pH 7.2) for 7 days. For de-
hydration and clearing, the fish were sequentially incubated in rising ethanol series 
from 70% to 100% followed by xylene, respectively. After tissue preparations, the 
zebrafish were embedded in paraffin, cut into 5 µm longitudinal sections and placed 
on microscopy slides. A basic Ziehl-Neelsen staining procedure utilizing 
carbolfuchsin, acid alcohol and methylene blue was used. Visualization of the stained 
tissues were performed either with an Olympus BX51 microscope together with an 
Olympus ColorView IIIu camera or with an automated Objective Imaging Surveyor 
virtual slide scanner (Objective Imaging, Cambridge, United Kingdom). Scanned 
slides were digitized at a resolution of 0.4 µm per pixel using a 20x Plan 
Apochromatic microscope objective. Scanned data were converted to JPEG2000 
format as described previously (Tuominen & Isola 2009). 
4.6.3 Gene expression microarray (III) 
RNA from the zebrafish organ blocks was extracted with TRIreagent (Molecular 
Research Center, Ohio, USA) following the manufacturer’s instructions. Zebrafish 
(V3) Gene Expression Microarray, 4x44K (Agilent Technologies, California, USA) 
was conducted by the Turku Centre for Biotechnology at the Finnish Microarray 
and Sequencing Centre. 100 ng of RNA was prepared with the RNA Spike-In Kit, 
One-Color (Agilent) and Low Input Quick Amp Labeling Kit, One-Color (Agilent) 
and analyzed using the 2100 bioanalyzer RNA 6000 Nano kit (Agilent). RNA 
labelling and hybridization were performed in a Microarray Hybridization Chamber 
(Agilent) using GE Hybridization Kit (Agilent). Agilent scanner G2565CA and 
AgilentHD_GX_1Color profile were used in scanning the arrays and a Feature 
Extraction Software v. 10.7.3 (Agilent) to obtain numerical data. 
4.6.4 Quantitative PCR (I, III) 
4.6.4.1 Expression analysis 
RNA for qPCR analysis was extracted and analyzed as described above. cDNA 
synthesis was done with iScript Select cDNA synthesis kit (Bio-Rad, California, 
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USA) or SensiFAST™ cDNA synthesis kit (BioLine, London, UK). qPCR was done 
with Maxima SYBR green qPCR master mix (Fermentas, Burlington, Canada) or 
PowerUp™ SYBR® master mix (Thermo Fischer Scientific) and the CFX96™ PCR 
system (Bio-Rad Laboratories, In., California, USA). Data was obtained using 
Bio-Rad CFX Manager software. 2-deltaCt method was used to normalize the target 
gene expression to the expression of eukaryotic translation elongation factor 1 alpha 1, like 
1 (eef1a1l1 or ef1a) (Tang et al. 2007). No-template controls as well as No-RT controls 
were included in the qPCRs. Melt curve analysis and agarose TAE gel electrophoresis 
were performed in order to confirm correct size of the qPCR products. Primers used 
in the qPCR analysis are depicted in Table 7. 
4.6.4.2 M. marinum quantification 
To determine the mycobacterial burden in M. marinum infected zebrafish, the total 
DNA was isolated from the zebrafish with previously described methods. In order 
to amplify M. marinum specific DNA, a previously described protocol utilizing M. 
marinum internal transcribed spacer (MMITS) –primers; F: 
CACCACGAGAAACACTCCAA and R: ACATCCCGAAACCAACAGAG were 
used (Parikka et al. 2012). SensiFAST™ SYBR® No-ROX kit and a CFX96 qPCR 
(Bio-Rad) machine was utilized in the qPCR. The results were normalized to 
previously determined M. marinum count controls and analyzed using the Bio-Rad 
CFX Manager software (Bio-Rad). 
4.6.5 Immunosuppression by dexamethasone (III) 
A mixture of 25mg dexamethasone (Sigma-Aldrich) and gelatin (Sigma-Aldrich) was 
used to coat 10 g of SDS400 food, and a daily food dose of 4 mg (10 µg 
dexamethasone)/fish was administered for a total duration of 5 weeks. The method 
for the dexamethasone food preparation has been previously reported (Myllymäki et 
al. 2018). 
4.6.6 Statistical analysis (I, III) 
Prism v. 5.02 (GraphPad  Software, California, USA) was used in the statistical 
analyses. Whereas a log-rank (Mantel-Cox) test was used in the survival experiments, 
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the flow cytometry and qPCR results were analyzed using nonparametric one- or 
two-tailed Mann-Whitney. P values of < 0.05 were considered statistically significant. 
Table 7. Primers used in the qPCR analyses. 
Gene Primer sequence 5 -´3´ Used in
furinA F: CCAAAGAGGCTTTCCAACGC I
R: CGTACTGCTGCTGATGGACAG I
pcsk1 F CGGGAAAAGGAGTGGTCAT I
R GGTGGAGTCGTATCTGGG I
pcsk2 F CGGATCTGTATGGAAACTGC I
R GCCGGACTGTATTTTATGAAT I
furinB F CCAAGGCATCTACATCAACAC I
R ACACCTCTGTGCTGGAAA I
pcsk5a F GGAGTTTCAATGACCCCAA I
R ACCACAACTCCTTTCCCA I
pcsk5b F TGTTCCTCGACCCTTACCAC I
R ATCTCGCCATGTCAGGAAAG I
pcsk7 F AGAGTGTTGGACGGG I
R TGCCTAATGGATGCGGT I
cd247 (cd3zeta) F CATCACCGGCTTCTTTGTGC I
R CCCCAGTTTATCAATGGCCTGA I
tbx21(T-bet) F GGCCTACCAGAATGCAGACA I
R GGTGCGTACAGCGTGTCATA I
gata3 F GGATGGCACCGGTCACTATT I
R CAGCAGACAGCCTCCGTTT I
foxp3a F CAAAAGCAGAGTGCCAGTGG I
R CGCATAAGCACCGATTCTGC I
rorca F GAAGGCTGCAAGGGCTTCTT I
R TGCAGTTCCTCTGCCTTGAG I
tnfa F GGGCAATCAACAAGATGGAAG I
R GCAGCTGATGTGCAAAGACAC I
il1b F TGGACTTCGCAGCACAAAATG I
R GTTCACTTCACGCTCTTGGATG I
lta F CCACAGTTCAGCAGGACCTC I
R TTTCCTGCGTGCTCTCATGTC I
ifng1-1 F AAATGGTGCTACTCTGTGGAC I
R TTCCAACCCAATCCTTTG I
il22 (ifnphi6 ) F TCAGACGAGCACACAGATATG I
R GATGGCTGGAGTAGTCGTG I
il17a/f3 F GGCTCTCACGGGTTTTCAG I
R ACACTTCTTCACACCAGAACATC I
il10 F GCTCTGCTCACGCTTCTTC I
R TGGTTCCAAGTCATCGTTG I
tgfb1a F TCGTCTTCCAGCAAGCTCAG I
R TTGGAGACAAAGCGAGTTCC I
itln1 F GACGACTACAAGAACCCTGG III
R ATCGTTGCATGTACCTATGCC III
itln2 F TATGGGAATGGCTGCCTTTC III
R TTTCAAGCTCATGGTTGCTG III
itln2-like F ACTGTTCAAGAAATTCCCTGTG III
R ATGCCCAGTTGGTTTAGTGC III
itln3 F GTGCAACACAGGATGGCATG III
R TTCTGCACTGCCAAACGTAG III
eef1a1l1 (ef1a) F CTGGAGGCCAGCTCAAACAT I, III
R ATCAAGAAGAGTAGTACCGCTAGCATTAC I, III
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4.7 The bacterial binding assay 
4.7.1 Recombinant itln3 gene construct and protein purification (III) 
Zebrafish itln3 gene was synthetized and cloned into a Gateway donor vector; 
pDONR™221 (Thermo Scientific) by GeneArt (Invitrogen). Subsequently, itln3 was 
amplified by PCR using the following primers: F: 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGCTGCGCTGCC
TGTTTGTCTTCG and R: 
GGGGACCACTTTGTACAAGAAAGCTGGGTTTTATTAACGATAAAACA
GCAGAACTGCGCTC, and Gateway cloned into the 
pVBboostFGII+Wpre-VSV-G expression vector (Heikura et al. 2012). Freestyle 
293-F cells (Thermo Fisher Scientific) were transfected  with  10  μg  of  expression  
vector  using  FreeStyle™  MAX  Reagent  (Thermo Fisher Scientific) and the cells 
cultured for 7 days. Strep-Tactin®XT resin (IBA Lifesciences, Göttingen, Germany) 
was used for affinity chromatography together with automated ÄKTA pure protein 
purification system (GE Healthcare Life Sciences, UK), Strep-Tactin®/Strep-
Tactin®XT wash buffer (IBA Lifesciences) and Strep-Tactin®XT elution buffer 
with biotin (IBA Lifesciences). Itln3-Strep-Tag®II was detected with 2.5 µg of 
Streptactin Oyster 645 conjugate (IBA Life Sciences) in 0.05% Tween TBS for 1 h 
at RT. Imaging was done with the Odyssey® CLx (LI-COR Biosciences, Nebraska, 
USA) and analyzed with the Image Studio Lite (v.5.2; LI-COR Biosciences). 
4.7.2 Bacterial binding assay (III) 
M. marinum (ATCC927) was cultured as described above and S. pneumoniae (serotypes 
T4 and S1) as described previously (Rounioja et al. 2012). E. coli was cultured 
overnight in LB-media at 37°C with constant shaking (200 rpm). Prior the binding 
experiments bacteria were pelleted by centrifugation, washed once with 1x PBS and 
incubated for two hours with 7.5 µg of Itln3-Strep-Tag®II or GFP-Strep-tag®II 
(Iba Lifesciences) in 500 µl of buffer containing 20 mM HEPES (pH 7.4), 150 mM 
NaCl, 10 mM CaCl2, 0.1% BSA and 0.05% Tween-20 or in a similar buffer with 
10 mM EDTA instead of CaCl2 at +4°C. Subsequently, bacteria were re-pelleted and 
washed once with 1x PBS. Detection of the Strep-tagged proteins were done as 
described above. 
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5 SUMMARY OF THE RESULTS 
5.1 FurinA regulates the zebrafish host response against 
M. marinum (I) 
It is well known that both the innate and adaptive immunity are required for TB 
immunity and the containment of the bacteria in the mycobacterial granulomas. 
While aberrations in TNF signaling can lead to increased bacterial spread and 
dissemination (Roca & Ramakrishnan 2013; Tobin et al. 2012), a deficient Th1 cell 
function can reduce the efficiency of the macrophage-mediated killing of the 
mycobacteria (Lyadova & Panteleev 2015; Weiss & Schaible 2015). The proprotein 
convertase subtilisin/kexins (PCSKs) are a nine-membered enzyme family of serine 
endoproteases that function by activating immature pro-proteins through proteolytic 
cleavage (Seidah & Prat 2012). FURIN is a PCSK family member with a broad range 
of substrate proteins ranging from growth factors to bacterial toxins to 
immunological mediators (Thomas 2002). Consequently, FURIN regulates a wide 
variety of biological processes from embryogenesis to T cell function. More 
specifically, FURIN has been shown to regulate IFNG production and subsequently 
Th1 cell polarization (Pesu et al. 2006). In this study, we used the zebrafish 
M. marinum model of TB together with the commercially available furinAtd204e mutant 
zebrafish (Walker et al. 2006); Zebrafish Information Network (ZFIN) ID: ZDB-
GENO-080606-310 in order to understand the role of FURIN in the host immune 
response against a mycobacterial infection. 
5.1.1 Decreased furinA expression in furinAtd204e/+ mutant zebrafish affects 
granulocyte development as well as the expression of Th subtype 
transcription factors 
furinAtd204e mutant zebrafish carry a splice site mutation that leads to the exclusion 
of exon 9 from the mature mRNA (Walker et al. 2006). Consequently, this results in 
the loss of a catalytic asparagine-residue (Asn295) and in a non-functional FurinA 
protein (I, Suppl. Fig. 1). Moreover, the exonic exclusion in the furinAtd204e mutant 
 52 
zebrafish allows the specific quantification of the WT furinA mRNA molecules by 
qPCR. Due to the observed and published developmental lethality of homozygous 
furinA mutant zebrafish (Walker et al. 2006), the experiments were performed using 
heterozygous furinAtd204e/+ mutants as well as their WT siblings.  In order to compare 
furinA expression in both furinAtd204e/+ mutants and in WT fish, the relative levels of 
furinA mRNA were measured by qPCR in steady state and M. marinum infected 
(34 CFU, SD 10 CFU) zebrafish 4 and 9 weeks post infection (wpi) (I, Fig. 1A). In 
line with the previous in vitro studies that have demonstrated induced FURIN 
expression in the activated immune cells of both the myeloid (Meissner et al. 2013) 
and lymphoid lineages (Lund et al. 2004; Pesu et al. 2006), furinA was significantly 
up-regulated in both furinAtd204e/+ mutants and in WT zebrafish upon a 
mycobacterial infection (I, Fig. 1A). Additionally, confirming the expression of 
zebrafish furin in both the innate and adaptive immune cells, furinA was expressed in 
FACS sorted zebrafish granulocytes and lymphocytes isolated from the fish kidneys 
(I, Fig. 2A). Importantly, decreased furinA levels were observed in the heterozygous 
furinAtd204e mutants compared to WT fish, validating the feasibility of using the 
furinAtd204e/+ zebrafish in our experiments. 
Next, we characterized whether decreased furinA expression in furinAtd204e/+ 
zebrafish affects hematopoiesis. To this end, we studied the blood cell populations 
of steady state zebrafish kidneys by flow cytometry (I, Fig. 1B-C). Although blood 
cell precursor, erythrocyte and lymphocyte populations did not reveal any 
differences between furinAtd204e/+ mutants and WT fish, significantly lower 
granulocyte amounts were observed in furinAtd204e/+ zebrafish compared to the WT 
ones. 
The significance of FURIN for T cell function has been studied with 
conditional T cell FURIN knockout mice (CD4cre-furf/f). Although thymocyte 
development is unaffected in the CD4cre-furf/f mice, these animals have altered 
effector T cell populations as well as abnormalities in the production of Th subtype 
specific cytokines (e.g. IFNG, IL4)(Pesu et al. 2008). Moreover, activated Furin-
deficient T cells produce significantly less transforming growth factor beta-1 
(TGFB1) (Pesu et al. 2008), a cytokine that is crucial for the development of Treg 
cells and consequently for peripheral tolerance through inducing the expression of 
Foxp3 (Andersson et al. 2008; Chen et al. 2003). Therefore, we next quantified the 
expression of the Th cell subtype specific transcription factors T-box 21 (tbx21, Th1 
marker), gata3 (Th2 marker), forkhead box P3a (foxp3a, Treg marker), retinoic acid 
receptor-related orphan receptor C a (rorca, Th17 marker) as well as tgfb1a in furinAtd204e/+ 
mutants and in WT fish by qPCR (I, Fig. 1D). A transcriptional analysis indicated 
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significantly higher expression levels of tbx21, gata3 as well as foxp3a in furinAtd204e/+ 
fish compared to WT controls. These results are in line with the increased Foxp3-
positive T cell amounts as well as with the extensive Th1- and Th2 type cytokine 
production in CD4cre-furf/f mice (Pesu et al. 2008), indicating a conserved role for 
FURIN in T cell activation. Additionally, the up-regulation of tgfb1a mRNA 
associated with the decreased expression of furinA in furinAtd204e/+ zebrafish, a result 
possibly arising from the compensatory transcriptional mechanisms complementing 
the deficient maturation of the TGFB1 protein in the mutants. 
Since conventional PCSK family enzymes (PCSK1-7), including FURIN (also 
known as PCSK3), have an identical consensus cleavage site; (K/R)-(X)n-(K/R) (n= 
0, 2, 4 or 6 and X= any amino acid), PCSKs can have redundant functions and shared 
substrate proteins (Turpeinen, Ortutay & Pesu 2013). To study whether reduced 
furinA expression influences the transcript levels of other pcsk family members in 
furinAtd204e/+ mutant zebrafish, we quantified the relative mRNA levels of pcsk1, 
pcsk2, furinB, pcsk5a, pcsk5b and pcsk7 in steady state fish (I, Fig. 2B). Suggesting a 
possible transcriptional compensation mechanism, pcsk1 and pcsk2 expressions were 
significantly up-regulated in furinAtd204e/+ mutants compared to the WT controls. 
However, no differences were observed in the expression of furinB, pcsk5a, pcsk5b 
and pcsk7. 
5.1.2 Silencing furin in zebrafish embryos decreases their survival in a 
mycobacterial infection 
A M. marinum (ATCC-927) injection into the abdominal cavity of adult zebrafish 
(Parikka et al. 2012) as well as a yolk sac microinjection into the embryos (Carvalho 
et al. 2011) can be used to model TB pathogenesis. In order to study the immune 
defense against M. marinum in our furinA mutant fish, we first infected adult 
furinAtd204e/+ and WT zebrafish with a high-dose of M. marinum (8300 CFU, SD 1800 
CFU) and followed the survival of these fish until 11 wpi (I, Fig. 3A) as well as 
performed Ziehl-Neelsen staining to verify the presence of mycobacteria (I, Fig. 3B). 
Although our histological analysis confirmed the presence of both mycobacteria and 
well-organized mycobacterial granulomas in the infected zebrafish at 3 and 11 wpi, 
respectively, we could not detect statistically significant differences in the infection-
induced mortality between the adult furinAtd204e/+ mutants (ca. 80% mortality) and 
the WT controls (ca.70% mortality) during the 11-week follow-up. 
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While the adult zebrafish possess the components of the innate and adaptive 
immune system, the zebrafish embryos can be used to specifically study the innate 
immunity alone (Renshaw & Trede 2012; Sullivan & Kim 2008). To this end, we 
silenced furinA and furinB with morpholinos and simultaneously infected the same 
embryos with M. marinum (131 CFU, SD 125 CFU). After following their survival 
until 7 dpf (I, Fig. 3C), a significant difference was observed between the 
furinA/furinB morphants and the RC-morpholino injected control embryos with 
end-point mortalities of 100% and 93%, respectively. 
5.1.3 Zebrafish furinAtd204e/+ mutants have an enhanced expression of 
proinflammatory cytokine genes and a decreased mycobacterial 
burden in a mycobacterial infection 
To better understand the furinA-mediated modulation of the innate immune 
response in our experimental TB model, we infected adult furinAtd204e/+ mutants and 
WT zebrafish with a high-dose of M. marinum (10,300 CFU, SD 3,300 CFU) and 
quantified the expression of both proinflammatory (tnfa, il1b, lta, ifng1-1, il22, 
il17a/f3) as well as anti-inflammatory cytokine genes (il10, tgfb1a) between 1 and 12 
dpi (I, Fig. 4A-I). In WT zebrafish, the early innate response at 1 and 6 dpi was 
characterized by an increase in the expression levels of tnfa, lta, ifng1-1 and il17a/f3 
(I, Fig. 4A). Furthermore, while the expression levels of tnfa, lta, ifng1-1 and il17a/f3 
had already decreased at 12 dpi, the expression of anti-inflammatory cytokine genes 
(il10 and tgfb1a) were at their highest at 12 dpi. Interestingly, a comparison of the 
cytokine gene expression levels between furinAtd204e/+ mutants and WT controls 
revealed that the decrease in furinA expression was associated with the up-regulation 
of the proinflammatory cytokine genes tnfa, lta and il17a/f3 at 1 dpi (I, Fig. 4B-I). 
While a high-dose M. marinum infection leads to an acute, progressive disease 
with high mortality, a low-dose mycobacterial inoculate results in a different immune 
response and can lead to latency (Parikka et al. 2012). In order to see how the 
reduction in furinA mRNA levels affects the host response against a low-dose 
infection, we injected a low M. marinum dose (46 CFU, SD 8 CFU) into the 
abdominal cavity of furinAtd204e/+ zebrafish and their WT siblings and followed their 
survival for 9 weeks (I, Fig. 6A). Similarly to the high-dose infection (See I, Fig. 3A), 
we did not see a significant difference in the survival of the infected furinAtd204e/+ 
and WT zebrafish with end-point mortalities of ~75% and ~80%, respectively. Since 
the host immunity against an infectious agent is dependent on both tolerance as well 
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as host resistance, we next quantified the mycobacterial burden at 4 and 9 wpi 
(34 CFU, SD 10 CFU) (I, Fig. 6B). Interestingly, a M. marinum qPCR revealed a 
significantly reduced mycobacterial burden in furinAtd204e/+ mutants compared to the 
WT fish at 9 wpi, whereas the expression of Th subtype specific markers (tbx21 gata3, 
foxp3a, rorca) was unaltered at 4 and 9 wpi (I, Fig. 6C). 
Collectively, our results imply that furinA regulates the development of zebrafish 
granulocytes in steady state, and that FURIN has an evolutionarily conserved 
function in regulating the differentiation of T cell subtypes. Moreover, in the context 
of a mycobacterial infection, furinA down-regulation can result in the enhanced 
expression of proinflammatory cytokine genes, which is associated with a lower 
mycobacterial burden in a chronic infection. 
5.2 CRISPR/Cas9 mutagenesis can be used to efficiently 
mutate target loci in the zebrafish embryos (II) 
Ever since the off-target effects of morpholins were reported (Kok et al. 2015; Robu 
et al. 2007), concerns about the use of morpholino-mediated gene silencing in 
zebrafish embryos have risen. Silencing carbonic anhydrase 10 a (ca10a) and ca10b in 
zebrafish embryos using morpholinos results in a dose-dependent mortality of the 
morphants characterized by severe phenotypic defects, including a curved body, 
small head and extensive neural apoptosis (II, Fig. 7A-C). In order to validate the 
phenotypic consequences seen in the ca10a and ca10b morphants, we established an 
in-house CRISPR/Cas9 mutagenesis system using egfp producing transgenic 
tg(fli1a:egfp) fish and subsequently knocked out both ca10a and ca10b in zebrafish 
embryos. 
5.2.1 Inactivation of egfp in the transgenic tg(fli1a:egfp) zebrafish 
Previously, Hruscha & Schmid (2015) reported a simple CRISPR/Cas9 mutagenesis 
method utilizing in vitro transcribed gRNA and Cas9 mRNA and the subsequent one-
cell-stage embryo microinjection of the synthetized RNAs (Hruscha & Schmid 
2015). Using this report as a method template, we tested if we could silence the 
enhanced green fluorescent protein gene (egfp) in our transgenic tg(fli1a:egfp) zebrafish line 
(ZFIN ID: ZDB-ALT-011017-8) (Lawson & Weinstein 2002). Since the tg(fli1a:egfp) 
zebrafish express egfp under a blood vessel marker fli1 promoter site (Lawson & 
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Weinstein 2002), the fluorescence intensity in the vasculature of the embryos can be 
used to directly visualize the success of mutagenesis. As a proof of concept, injection 
of a previously described egfp gRNA (Jao, Wente & Chen 2013) and Cas9 mRNA 
into the zebrafish embryos, could reduce the Egfp fluorescence compared to the 
uninjected and gRNA injected controls at  2 dpf (II, Suppl. Fig. 2A). 
As described previously, targeted mutagenesis in the CRISPR/Cas9-system is 
based on the endogenous NHEJ pathway that repairs the experimentally induced 
cuts at the target loci and creates random indel mutations at this site (Ran et al. 2013). 
In order to quantify the mutagenesis efficiency at the egfp target site, we used the 
T7EI assay (Krebs 2014). In the egfp gRNA and Cas9 mRNA injected tg(fli1a:egfp) 
embryos, the expected PCR cleavage products of ~150bp and ~320bp were 
observed after the T7EI treatment, whereas only a single 470bp WT PCR product 
was detected in the control embryos (II, Suppl. Fig. 2B). Furthermore, an average of 
a 50% cleavage rate of the WT egfp PCR was observed with the comparison of the 
band intensities using the Image Lab™ Software (Bio-Rad). Taken together, our in-
house CRISPR/Cas9 mutagenesis method can efficiently create mutations at the 
gRNA specified target loci in the zebrafish embryos. 
5.2.2 ca10a and ca10b mutagenesis in zebrafish embryos leads to high 
mortality and developmental defects 
The zebrafish CRISPR/Cas9 system can be used to create null-like phenotypes 
already in the parental F0-generation embryos (Figure 7) (Jao, Wente & Chen 2013). 
To this end, we initially designed and produced three gRNAs for ca10a as well as two 
for ca10b (II, Fig. 7B-C), and tested their in vivo functionality. Of these gRNAs, we 
found gRNAs for both ca10a and ca10b with as high as 86% and 97% PCR product 
cleavage rates corresponding to a 63% and 83% mutagenesis efficiency, respectively 
(II, Fig. 7F) (Ran et al. 2013). In line with the morpholino knockdown results of 
zebrafish ca10a, the mutagenesis of ca10a resulted in a high mortality of the embryos 
already at 1 dpf. Moreover, comparable phenotypes including a curved body and 
pericardial effusion were seen in both the ca10a morphants and the F0-generation 
ca10a mutant embryos (II, Fig. 8A-H). In addition, similarly to the ca10b morphants, 
all of the ca10b mutants died after the first few days of development with severe 
phenotypic defects (II, Fig. 8A-H). In comparison, gRNA injected control embryos 
did not show signs of developmental defects up to 5 dpf, indicating that the injected 
RNA amounts were not toxic for the developing embryos. 
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Figure 7. CRISPR/Cas9 mutagenesis in phenocopying null mutations in F0-generation 
zebrafish embryos. Possible target sites for mutagenesis are identified with a gRNA design tool. 
gRNAs are in vitro transcribed using a DNA template and microinjected into the oocyte with the 
Cas9 mRNA. Mutagenesis efficiency is analyzed for all of the tested gRNAs (e.g. with T7EI assay) 
and the most efficient gRNA is chosen for the determination of the mutant phenotype in the 
embryos. 
Altogether, our in-house CRISPR/Cas9 mutagenesis in zebrafish was proven 
efficient in modifying the target loci of both transgenic egfp as well as the endogenous 
ca10a and ca10b genes. Furthermore, similarly to Jao et al. (2013) this method could 
be used for creating null-like phenotypes in F0-generation mosaic embryos. 
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5.3 Intelectin 3 is not required for a protective immune response 
against mycobacteria in the zebrafish (III) 
In order to screen for novel candidate genes important for mycobacterial immunity, 
we used the zebrafish M. marinum model together with a gene expression microarray 
analysis, and identified a lectin gene member itln3 as one of the most highly up-
regulated genes in a mycobacterial infection. To understand the function of ITLNs 
in the host defense against mycobacteria, we studied the in vivo significance of itln3 
in the zebrafish M. marinum infection model by creating two homozygous itln3 
mutant zebrafish lines using CRISPR/Cas9 mutagenesis, and tested the bacterial 
binding ability of recombinant Itln3.   
5.3.1 Genome-wide expression analysis of genes induced by M. marinum 
in zebrafish 
A limited number of genome-wide gene expression studies have been conducted in 
the zebrafish M. marinum TB model (Benard et al. 2016b; Hegedus et al. 2009; 
Kenyon et al. 2017; Meijer et al. 2005; Rougeot et al. 2014; van der Sar et al. 2009; 
van der Vaart, Spaink & Meijer 2012). To identify novel candidate genes in the 
mycobacterial host response, we infected adult zebrafish with a low-dose of M. 
marinum (20 CFU, SD 6 CFU) and studied their gene expression status using a 
microarray platform. While a large number of the induced genes such as parvalbumin 
1 (pvalb1), tropomyosin (tpma) and troponin I, skeletal, fast 2b, tandem duplicate 2 (tnni2b.2) 
were related to muscle specific functions, also immunological genes e.g. arachidonate 
5-lipoxygenase b, tandem duplicate 3 (alox5b.3) and CD59 molecule (cd59) were up-regulated 
(log2 fold change >│3│) compared to the PBS injected controls (III, Fig. 1A). In 
contrast, some immunological genes, including CD58 molecule (cd58), myeloid-specific 
peroxidase (mpx) and complement factor b-like (cfbl), were down-regulated (III, Fig. 1A). 
Previous studies in zebrafish (Lin et al. 2009), channel catfish (Peatman et al. 
2007; Takano et al. 2008) and in Wuchang bream (Ding et al. 2017) have shown itln 
up-regulation upon a bacterial infection. In line with this, zebrafish itln3 was induced 
(3.3-fold, log2 change) in our microarray data following a M. marinum infection (III, 
Fig. 1A). Conversely, the itln2 and itln2-like genes were down-regulated (-3.5 and -3.2 
-fold, respectively, log2 change) compared to the PBS-injected controls. Additional 
gene expression analyses of itln1, itln2, itln2-like and itln3 in M. marinum infected 
(39 CFU; SD 47 CFU) adult zebrafish by qPCR confirmed the up-regulation of itln3 
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and the reduced itln2 expression upon infection (III, Fig.1B-E). Interestingly, the 
expression of all of the studied four itln genes (itln1, itln2, itln2-like, itln3) in zebrafish 
embryos were significantly induced in a mycobacterial infection (III, Fig. 1F-I). 
While the expression of itln1 and itln3 was higher in the infected embryos already at 
2 dpi, itln2-like and itln2 were up-regulated later upon infection at 4 dpi and 7 dpi, 
respectively. 
5.3.2 itln3 mutant zebrafish in studying the host resistance against 
mycobacteria 
Knowledge about the in vivo immune function of ITLNs in infectious diseases is 
scarce. While Pemberton et al. (2004) used the C57BL/10 mouse strain, in which 
the Itln2 gene is naturally missing, and infected the mice with Trichinella spiralis, 
Voehringer et al. (2007) studied Itln1 and Itln2 over-expression in the mouse lungs 
against Nippostrongylus brasiliensis and M. tuberculosis. In these studies, the lack of Itln2 
was associated with a higher susceptibility against T. spiralis, whereas no differences 
were seen in the resistance against N. brasiliensis or mycobacteria in the Itln transgenic 
mice. However, since Pemberton et al. (2004) did not perform further functional 
studies on the immunoprotective role of Itln2, they could only speculate that the 
increased susceptibility against the parasite was related to the dysfunctional innate 
immune response caused by the lack of Itln2. 
In order to better understand the function of the infection-inducible zebrafish 
itln3, we used CRISPR/Cas9 mutagenesis to create itln3 null mutant zebrafish. To 
this end, we tested three different gRNAs together with the Cas9 mRNA and found 
one gRNA with an approximately 40% mutagenesis efficiency in the gRNA/Cas9 
mRNA injected F0-generation embryos (III, Fig. 3A-B). The target site for this 
gRNA was situated in the second exon of the itln3 gene, leading to mutations early 
in the encoded regions of itln3. Following outcrosses of the adult F0-generation 
mutants with WT zebrafish, we identified two prominent out-of-frame and germ-
line transmitted itln3 mutations in the F1-generation fish (III, Fig. 3C), and annotated 
the mutation carrying zebrafish lines as itln3uta145 and itln3uta148. In order to obtain 
F2-generation zebrafish for our experiments, we incrossed heterozygous F1-fish 
from both of the lines (itln3uta145/+ and itln3uta148/+) and used either the embryos or 
adult fish obtained from the spawnings. 
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5.3.2.1 Both itln3 and itln1 are dispensable for mycobacterial immunity in zebrafish 
embryos 
Since both our observations of itln3 up-regulation in a mycobacterial infection and 
the previous reports about the bacterial binding capability of ITLNs (Chen et al. 
2016; Ding et al. 2017; Nagata 2018; Tsuji et al. 2009; Wesener et al. 2015) suggest a 
role for Itln3 in zebrafish immunity, we first tested if itln3 mutant embryos are more 
susceptible than WT embryos to a M. marinum infection. In order to exclude possible 
variation in the immune response caused by the site of the mycobacterial 
microinjection (Meijer 2016), we infected M. marinum both into the yolk sac (40 CFU; 
SD 30 CFU) as well as into the blood circulation valley (46 CFU; SD 31 CFU) of 
zebrafish embryos at 0 dpf and 2 dpf, respectively. A survival analysis of the yolk sac 
injected itln3uta145 and itln3uta148 background embryos revealed average mortalities of 
47 % and 48 %, respectively, but it did not reveal any statistically significant 
differences in the mortality of itln3uta145/uta145 and itln3uta148/uta148 mutants and their 
sibling controls prior to 7 dpi (III, Fig. 4A-B). In addition, the M. marinum burdens 
between the genotypes were comparable with the following bacterial copy number 
medians (log10) in 100ng of zebrafish DNA; 4.18 (WT itln3uta145), 4.15 (WT 
itln3uta148), 4.02 (itln3uta145/+), 4.22 (itln3uta148/+), 3.53 (itln3uta145/uta145) and 4.25 
(itln3uta148/uta148) (III, Fig. 4C). In line with the injection site dependable infection 
outcome, the blood circulation valley M. marinum inoculate did not cause any 
mortality of the embryos before 5 dpi, although our qPCR analysis confirmed the 
presence of bacteria in these fish with bacterial burdens ranging from 3.61 to 3.83 
(copy number medians (log10) in 100ng of zebrafish DNA) (III, Fig. 4D). However, 
no significant differences in the M. marinum burden were seen between the 
genotypes, suggesting that the injection site does not affect the itln3 –dependent 
immune response against mycobacteria. 
Genetic compensation is an evolutionarily important process that can restore 
an organism´s functionality in the case of a loss-of-function mutation (Tautz 1992). 
This can occur through additional mutations to the genome or by the increased 
expression of other complementing genes. As already mentioned, our gene 
expression analyses of M. marinum infected zebrafish embryos and PBS injected 
controls revealed induction of all of the studied itln gene family members (itln1, itln2, 
itln2-like, itln3) upon infection (III, Fig. 1F-I). However, only itln1 and itln3 had 
similar induction kinetics, suggesting a possible functional redundancy of these genes 
in the innate immune response. To see if itln1 could compensate for the loss of itln3, 
we silenced itln1 with a splice blocking (SB) morpholino in our mutant zebrafish 
lines itln3uta145 and itln3uta148 and simultaneously infected them with M. marinum 
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(20 CFU; SD 19 CFU). In our initial experiments, we could observe that the 
morpholino causes the exclusion of exon 2 from the final transcript, and we could 
measure the loss of WT itln1 mRNA by qPCR. In fact, 82.9%, 78.2% and 66.1% 
reductions in the relative itln1 mRNA amounts were observed in the SB morphants 
at 4 dpi, 5 dpi and 6 dpi, respectively (III, Fig. 5B). In the morpholino and M. marinum 
co-injections, we observed high genotype-independent mortality with both the RC 
and SB morpholinos ranging between 77.8% and 100% at 7 dpi (III, Fig. 5C-E). 
Nevertheless, we did not see any statistically significant differences between the 
M. marinum infected RC and SB morpholino injected groups (III, Fig. 5C) nor 
between the WT or itln3 mutant zebrafish (III, Fig. 5D-E), suggesting that neither 
itln1 nor itln3 are required for the mycobacterial immune response in the embryos. 
5.3.2.2 Survival and mycobacterial burden of adult itln3uta145 and itln3uta148 mutant 
zebrafish are similar to their WT siblings 
A previous report in zebrafish showed that a low-dose M. marinum infection 
recapitulates a latent disease with well-defined granuloma structures and a constant 
bacterial burden (Parikka et al. 2012). Consequently, we infected adult itln3uta145 and 
itln3uta148 zebrafish with a similar dose of M. marinum (48 CFU; SD 5 CFU) and 
followed their survival for 24 weeks (III, Fig. 6A-B). At the end of this experiment, 
the following survival percentages were observed; 74% (WT itln3uta145), 73% 
(itln3uta145/+), 59% (itln3uta145/uta145), 78% (WT itln3uta145), 82% (itln3uta148/+) and 84% 
(itln3uta148/uta148). However, although a slight difference in the average end-point 
mortalities was observed between the itln3uta145 and itln3uta148 fish lines (30% and 
20%, respectively), no statistically significant differences were detected between the 
different genotypes. In line with this, the mycobacterial burdens in M. marinum 
infected (422 CFU; SD 221 CFU) adult zebrafish were comparable between the WT 
fish and itln3 mutants at 2 and 4 wpi (III, Fig. 6C-D). 
Previously Myllymäki et al. (2018), introduced a dexamethasone mediated 
immunosuppression model in zebrafish in studying the reactivation of a 
mycobacterial infection. In this model, dexamethasone-containing feed could 
decrease the total lymphocyte amounts by 36% but it could also reduce the 
expression of the Th1 cell marker tbx21 upon infection. For report III, we modified 
this model slightly by starting an immunosuppressive treatment one week prior to 
the infections, continued to the infections with M. marinum (47 CFU; SD 4 CFU) 
and followed the fish for another four weeks with daily dexamethasone 
administration (III, Fig. 7A). At 2 and 4 wpi, some of the fish were withdrawn from 
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the experiment and their blood cell composition and M. marinum burden were 
analyzed. In line with the study of Myllymäki et al. (2018), we observed a 
dexamethasone-mediated decrease in the lymphocyte populations of our itln3uta145 
and itln3uta148 zebrafish lines (reduction between 23.7% and 40.5%, P<0.01 in all 
comparisons) (III, Fig. 7B-D), whereas the myeloid cell population was unaffected 
(III, Suppl. Fig. 6). In addition, homozygous itln3 mutants (itln3uta145/uta145 and 
itln3uta148/uta148) and WT controls did not show any statistically significant differences 
in their cell amounts, suggesting that the decrease is independent of the itln3 
mutation. Nonetheless, no differences were seen in the M. marinum burden of 
itln3uta145/uta145 fish and WT (itln3uta145) controls or itln3uta148/uta148 and WT (itln3uta148) 
fish at 2 and 4 wpi (III, Fig. 7E-F). Here, the mycobacterial copy number medians 
of 2.60 and 2.65 in WT itln3uta145, 2.55 and 3.10 in itln3uta145/145, 2.87 and 2.43 in WT 
itln3uta148 and 2.25 and 2.91 in itln3uta148/148 zebrafish were observed at 2 and 4 wpi, 
respectively (log10, in 100ng of zebrafish DNA). 
Overall, our results demonstrated that itln3 expression is highly up-regulated in 
a M. marinum infection in both adult zebrafish and zebrafish embryos. However, the 
lack of differences in our survival assays between itln3 knockout fish and their WT 
siblings led us to conclude that itln3 is dispensable for the zebrafish immune response 
against mycobacteria in our model. This conclusion was also supported by our 
mycobacterial binding experiment using recombinant Itln3 (III, Suppl. Fig. 7), in 
which we did not detect binding of Itln3 to the surface of M. marinum. 
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6 DISCUSSION 
6.1 Furin, an important regulator of T cell function, as a 
candidate gene in TB immunity (I) 
The activation of naïve T cells is largely dependent on the antigenic stimulation 
mediated by interactions between the T cell receptor (TCR) and the antigen-MHC 
complexes on antigen presenting cells (APCs) (Luckheeram et al. 2012). Eventually, 
the final differentiation into distinct CD4+ T helper cell subtypes (e.g. Th1, Th2, 
Th17 and Treg) is dependent on the additional interaction of a CD4 co-receptor with 
the MHC receptor (specifically MHC type II receptor) and on the present cytokine 
environment (Luckheeram et al. 2012). In fact, the central cytokines required for the 
differentiation of these subtypes are well known, and the cytokines produced by the 
differentiated Th cells can create positive feedback loops amplifying further 
polarization into the corresponding Th cell subtype and to suppress that of the other 
subtypes (Luckheeram et al. 2012). For example, the IL12-mediated production of 
IFNG can polarize naïve T cells into Th1 type cells by signaling via STAT4 and by 
inducing the expression of the T-box transcription factor (T-bet). T-bet can in turn induce 
the additional production of IFNG and thereby amplify its own expression via 
STAT1 and the additional differentiation of Th1 cells (Djuretic et al. 2007). 
Conversely, T-bet can inhibit the function of the GATA3 transcription factor and 
the consequent expression of IL4, a key cytokine in Th2 cell polarization (Djuretic 
et al. 2007). Interestingly, a conditional knockout of Furin (CD4cre-furf/f) in mouse 
T cells, leads to altered effector T cell populations as well as to abnormal production 
of Th subtype specific cytokines such as IFNG and IL4 (Pesu et al. 2008). In fact, it 
has also been demonstrated that Furin expression enhances secretion of IFNG, and 
that FURIN consequently controls the differentiation of Th1 cells (Pesu et al. 2006). 
Overall, FURIN is directly linked to the immunological function of T cells. 
Since its discovery in the mid 1980´s (Roebroek et al. 1986), FURIN has been 
associated with a number of diseases (Thomas 2002; Turpeinen, Ortutay & Pesu 
2013). While defective FURIN mediated pro-protein processing can lead to diseases 
such as X-linked hydrohidrotic ectodermal dysplasia and Alzheimer´s disease 
(Thomas 2002), FURIN overexpression has been associated with different types of 
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cancers (Thomas 2002), autoimmune diseases (Ranta et al. 2018; Valli et al. 2018) as 
well as atherosclerosis (Turpeinen et al. 2011). In addition, single nucleotide 
polymorphisms in the FURIN gene and its promoter site have been associated with 
the regulation of blood pressure and hypertension (Ganesh et al. 2013; Li et al. 2010; 
Turpeinen et al. 2015) as well as with HBV infections (Lei et al. 2009). Nevertheless, 
FURIN polymorphisms have not been linked to a susceptibility for bacterial 
infections. Moreover, complicating experimental research, a Furin knockout in 
mouse germline cells, leads to embryonic lethality between 10 and 12 days into 
development (Roebroek et al. 1998).  
Zebrafish have two FURIN paralogs; furinA and furinB (Walker et al. 2006) with 
approximately 70% sequence similarity. However, of these PCSKs only FurinA is 
able to cleave zebrafish pro-Tgfb1a in vitro and to promote the translocation of 
mature Tgfb1a out of the cells into the cell culture supernatant (Turpeinen et al. 
2013), which suggests that furinA is the true zebrafish ortholog of human FURIN. 
Consequently in report I, we used a commercially available furinAtd204e mutant 
zebrafish line (ZDB-FISH-150901-26631) to study the systemic role of FURIN in 
mycobacterial immunity in vivo. Previously, Walker et al. (2006) demonstrated the 
substantial lethality (more than 98%) of zebrafish lines carrying different 
homozygous non-sense furinA mutations. Corresponding with this observation as 
well as with the embryonic lethality of Furin null mice (Roebroek et al. 1998), we 
could not obtain adult homozygous furinA mutant (furinAtd204e/td204e) zebrafish. 
Nonetheless, since the heterozygous furinAtd204e/+ mutants were phenotypically 
normal and fertile and showed a measurable decrease in furinA expression, they could 
be used in our experiments.  
The total numbers of splenocytes is reduced in myeloid cell specific Furin 
knockout mice (LysMCre-furf/f) compared to the corresponding WT controls, 
suggesting that FURIN affects the development of immune cells in vivo (Cordova et 
al. 2016). In line with this observation as well as with the normal thymocyte counts 
in CD4cre-furf/f mice described by Pesu et al. (2008), the granulocyte amount was 
significantly lower in steady state furinAtd204e/+zebrafish, whereas the cell numbers in 
the lymphocyte gate were comparable between furinAtd204e/+ mutants and the WT 
controls. In order to provide a mechanistic explanation for the FurinA-mediated 
regulation of granulopoiesis, extensive proteomic analyses followed by functional 
studies would be required. Additionally, it can be speculated whether a more 
pronounced effect on granulopoiesis would have been seen with a complete furinA 
knock-out model. 
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CD4+ T cells, and more specifically the Th1 type immune response, are 
indispensable in a M. tuberculosis infection (Cooper et al. 1993; Cooper et al. 1997; 
Flynn et al. 1993; Flynn et al. 1995; Onwubalili, Scott & Robinson 1985; Zhang et 
al. 1994). To determine if also zebrafish furinA could regulate Th cell differentiation 
similarly to its mammalian counterparts, we analyzed the expression of different Th 
cell transcription factors in both furinAtd204e/+ fish and WT controls, and found 
increased levels of tbx21, gata3 as well as foxp3a mRNAs in the furinAtd204e/+ mutants. 
Although the up-regulation of these transcription factors is likely to reflect the furinA 
mediated changes in the differentiation of Th cells in zebrafish, the quantification of 
the exact Th subtype cell amounts by e.g. a FACS analysis or semi-quantitative 
western blot would be required to confirm this. However, because of the shortage 
of commercial antibodies raised specifically against zebrafish proteins, the use of 
cross-reactive antibodies raised against other species, as in the study of Hammaren 
et al. (2014), would be required to study Th cell polarization in detail. Collectively, 
the mycobacteria dependent regulation of FURIN expression, association of FURIN 
polymorphisms and expression levels with a number of diseases as well as the direct 
effects of FURIN on the function of myeloid cells and T cells, make this PCSK 
family member an interesting candidate gene for studying the host response against 
a mycobacterial infection. 
6.2 furinA regulates the zebrafish host response against 
mycobacteria (I) 
The zebrafish M. marinum model can mimic several aspects of the pathogenesis of 
M. tuberculosis, such as the replication of bacteria in macrophages and the formation 
of granulomas, in a safe and cost-efficient manner. However, since the adult 
zebrafish M. marinum infection was introduced as a model for TB by Prouty et al. 
(2003), only a few articles have depicted the kinetics of the host cytokine response 
in adult zebrafish. Although genome-wide transcriptomic approaches have 
collectively studied several different timepoints post infection (Hegedus et al. 2009; 
Meijer et al. 2005; van der Sar et al. 2009; van der Vaart, Spaink & Meijer 2012), 
different mycobacterial strains used in these studies make the interpretation of the 
response kinetics from these studies demanding. In addition, while some qPCR-
based expression data for genes such as tnfa, il1b, il6, il12, nos2b and ifng1-2 in a M. 
marinum infection had been published prior to the publication of report I (Parikka et 
al. 2012), the information about the early cytokine response in this model was 
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incomplete. In order to fill this knowledge gap, we chose three different timepoints 
of 1, 6 and 12 dpi and a panel of eight common cytokine genes (tnfa, il1b, lta, ifng1-1, 
il22, il17a/f3, il10 and tgfb1a) for our study. In line with observations from Parikka 
et al. (2012) and van der Vaart, Spaink & Meijer (2012), our M. marinum infection 
experiments could confirm the infection-inducible nature of genes such as tnfa, il1b 
and il10. Moreover, we were able to determine the timing for the resolution of their 
up-regulation. Most importantly, this data can benefit future research in the field of 
M. marinum infections in adult zebrafish by providing cytokine expression parameters 
for studying the innate response. 
Previously, the lack of T cell expressed Furin in CD4cre-furf/f mice was 
associated with an increase in the concentration of proinflammatory cytokine IL6 in 
the serum (Pesu et al. 2008), whereas the exogenous administration of Furin into 
mice with collagen-induced arthritis was shown to be able to reduce inflammation 
in mouse joints (Lin et al. 2012). To study the role of furinA in the early cytokine 
response and in inflammation upon infection, we used the previously described set 
of genes and time points and infected furinAtd204e/+ mutant zebrafish with 
M. marinum. Supporting the previously published data that indicated excess 
inflammation in CD4cre-furf/f mice, the expression of the proinflammatory 
cytokines tnfa, lta and il17a/f3 was increased in furinAtd204e/+ mutants in a 
mycobacterial infection. In addition, since this difference could only be seen at 1 dpi, 
it suggests a T cell independent role for furinA in regulating inflammation and the 
immune response against an infection. In fact, an immunogenic challenge in 
LysMcre-furf/f mice, which have deficient Furin production in their myeloid cells, 
resulted in an increase in the levels of circulating proinflammatory cytokines such as 
Tnfa, suggesting that furinA deficient macrophages play a role in mediating the 
proinflammatory phenotype in zebrafish (Cordova et al. 2016). An outcross of 
furinAtd204e/+ mutants with transgenic Tg(tnfa:eGFP-F) zebrafish expressing eGFP 
under the tnfa promoter (Nguyen-Chi et al. 2015), could provide additional insights 
into the proinflammatory phenotype caused by FURIN deficiency both in steady 
state conditions and during an infection. Furthermore, it would be of great interest 
to determine, whether this phenotype is a consequence of the deficient FurinA-
mediated cleavage of Tgfb1a and the resulting lack of peripheral immune tolerance 
(Pesu et al. 2008), or a result of abnormal proteolytic processing of other FURIN 
substrates. 
The wide range of PCSK substrates functioning in different physiological 
processes offers a great deal of possibilities for developing PCSK-based drugs 
against different diseases (Artenstein & Opal 2011; Seidah & Prat 2012). 
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Consequently, while the exogenous administration of FURIN can reduce arthritis 
(Lin et al. 2012), FURIN inhibitors are considered potential drugs against infectious 
diseases. In fact, the inhibition of FURIN activity has been shown to prevent the 
activation of HIV (Hallenberger et al. 1992) and influenza viruses as well as bacterial 
toxins (Becker et al. 2012). Furthermore, FURIN inhibitors have been suggested as 
possible drug candidates also in cancer and atherosclerosis (Artenstein & Opal 2011; 
Seidah & Prat 2012; Turpeinen et al. 2011). Accordingly, our findings, which showed 
that furinA deficiency in furinAtd204e/+ mutant zebrafish can lead to a reduced 
mycobacterial burden in an infection, imply the possibility of using FURIN 
inhibitors also as anti-TB drugs by boosting the anti-mycobacterial host responses. 
However, the systemic administration of FURIN inhibitors could lead to severe side 
effects considering the role of FURIN in controlling inflammation (Cordova et al. 
2016) and in maintaining peripheral tolerance (Pesu et al. 2008). Whether the 
inhibition of FURIN activity specifically in the lungs by, for example, the inhalation 
of small molecule inhibitors would prove safe and efficient in treating pulmonary 
TB remains to be studied. For this purpose, a conditional lung-specific Furin 
knockout mouse, together with the mouse TB models, could be useful. 
As described previously, the most common diagnostic tests for latent TB, the 
TST and IGRA, can lead to false negative as well as false positive results. In fact, 
since both of these tests rely on the memory T cell response, genes or proteins 
chronically up-regulated in the presence of bacteria can provide additional diagnostic 
measures to diagnose the latent disease and to prevent false positive diagnoses. In 
report I, we found that the zebrafish furinA was up-regulated in a chronic 
mycobacterial infection at 4 and 9 wpi, making FURIN a possible biomarker 
candidate for latent TB. Although a comparable infection dose was shown to lead to 
a latent M. marinum infection (Parikka et al. 2012), further studies, such as the 
quantification of mycobacterial dormancy markers and the verification of the static 
bacterial burdens would be required to confirm latency-related furinA up-regulation. 
6.3 CRISPR/Cas9 mutagenesis in studying gene-function 
relationships (II, III) 
Commercial mutant lines have been invaluable in studying gene-function 
relationships in the zebrafish. Accordingly, since the beginning of the zebrafish 
mutation project, several zebrafish carrying knockout alleles have been identified, 
and subsequently made available at the zebrafish stock centers (EZRC and ZIRC). 
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Nevertheless, mutant lines are not yet commercially available for all protein coding 
zebrafish genes, and the off-target effects of ENU mutagenesis can potentially 
confound scientific findings. Relatively recent genome modification tools such as the 
ZFNs and TALENs, and most importantly the CRISPR/Cas9 system provide the 
means for the in-house production of mutant zebrafish by targeted mutagenesis 
(Hruscha et al. 2013; Jao, Wente & Chen 2013). As already described, targeting in 
the CRISPR/Cas9 method is mediated through the sequence specific binding of 
gRNA molecules and a so called PAM sequence (NGG) immediately downstream 
of the target site (Jinek et al. 2012; Ran et al. 2013). Since PAM sites are found 
frequently in DNA, it can be speculated that any gene of interest could be mutated 
by CRISPR/Cas9 mutagenesis. The dense array of PAM sequences also makes it 
possible to target the beginning of gene sequences, which in turn can lead to the 
early disruption of the reading frame upon translation and/or to the nonsense-
mediated decay of transcribed mutant mRNAs (Nickless, Bailis & You 2017). 
Although the in vivo efficiency of the CRISPR/Cas9 system can be affected by 
the chromatin accessibility or the nucleotide composition of the gRNA target site 
(Uusi-Mäkelä et al. 2018), several reports have published evidence for the relatively 
simple and highly efficient use of the CRISPR/Cas9-mediated mutagenesis in the 
zebrafish (e.g. Hruscha et al. 2013; Jao, Wente & Chen 2013). However, while even 
a low mutagenesis efficiency can result in the transmission of mutations to the germ-
line cells of F0-generation fish (Hwang et al. 2013; Varshney et al. 2015), a 
substantially higher efficiency is required to study phenotypic effects already in the 
parental (F0-generation) mosaic fish (Jao, Wente & Chen 2013). Accordingly, 
approximately 20% rates for somatic mutation have been reported to function in 
creating mutant zebrafish lines (Hwang et al. 2013; Varshney et al. 2015), whereas 
Jao et al. (2013) concluded that with 75-99% mutagenesis rates most of the cells in 
the F0-embryos carried bi-allelic mutations. In this study, we were able to mutate 
both ca10a and ca10b with an average mutagenesis efficiency of 73% (II). In addition, 
suggesting that the functionality of these genes was lost already in the mosaic F0-
embryos, CRISPR/Cas9 mutagenesis could phenocopy the severe developmental 
effects of the morpholino silencing. Conversely, in order to create itln3 mutant 
zebrafish lines, an itln3 mutagenesis efficiency of 40% was observed in the F0-
generation embryos (III). Although the efficiency was substantially lower compared 
to the ca10 mutagenesis, a significant proportion of the germ-line cells had a 
mutation in itln3. In fact, approximately 40% of the F1-generation fish (39/96) 
carried a mutant form of the itln3 gene, and a total of three different indel-mutations 
were detected (Unpublished data) (Figure 8). Moreover, from a total of eight gRNAs 
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tested in reports II and III, a maximum of three were required to mutate the gene of 
interest in the F0-generation embryos. Overall, in line with previous literature, our 
experience with the CRISPR/Cas9 system in zebrafish supports the high 
mutagenesis rate as well as ease of mutagenesis. 
 
Figure 8. Alignment of the itln3 mutation site sequence from F1-generation 
CRISPR/Cas9 mutants. After an outcross of F0-mutants with WT fish, the itln3 target site loci 
was amplified by PCR, screened for mutations from 96 fish and sequenced from a total of 48 
F1-mutant zebrafish. From these individuals, 39 zebrafish carried a mutant itln3 allele with either 
an insertion or a deletion. 
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As with other mutagenesis or knockdown approaches, the off-target effects of 
CRISPR/Cas9 have raised concern regarding the use of the system for scientific 
research. While some of the early reports on using the CRIPSR/Cas9 method in 
human cells described a high frequency of off-target cleavage (Fu et al. 2013), it was 
later stated that the off-target cleavage properties of Cas9 are more limited compared 
to for example ZFNs and TALENs (Duan et al. 2014), and that he off-target activity 
can be abolished by the proper design of the gRNA target region (Cho et al. 2014). 
In fact, already at the gRNA design step, the design tools can recognize off-target 
binding sites and calculate the possibility for a given gRNA to mediate incorrect 
binding. Consequently, this information can be used in choosing a gRNA with a 
minimum off-target affinity but it can also later be used to assess whether off-target 
mutations have occurred after mutagenesis. In reports II and III, both the gRNA 
design tool from CRISPR.mit.edu as well as the sgRNA excel tool (Krebs 2014), 
were used to identify target-loci-specific gRNAs with minimal off-target site 
recognition. In addition, for further confirmation of the specificity of the gRNAs, a 
BLAST analysis was also utilized (Altschul et al. 1997). Since the comparable 
phenotypes of the ca10a and ca10b morphants and the CRISPR/Cas9 mutated 
embryos (II) as well as the unchanged resistance upon infection in two different itln3 
mutant zebrafish lines compared to the WT fish (III), off-target analyzes were not 
conducted in reports II or III.  
6.4 Genome-wide gene expression analysis as a starting point 
for reverse genetics (III) 
Since virulent M. tuberculosis strains are able to modify the host immune response 
upon infection to their own benefit, the immunity against TB is largely dependent 
on both the host as well as the bacterium. In order to better understand the complex 
host-pathogen interactions in mycobacterial infections, comprehensive analyses of 
this interplay are required. To this end, a large amount of studies have focused on 
studying blood samples from M. tuberculosis infected patients with genome-wide 
epigenetic, proteomic and transcriptomic approaches (Esterhuyse et al. 2015; Lee et 
al. 2016; Roe et al. 2016; Walzl et al. 2014; Zhang et al. 2014). In fact, based on these 
studies, several potential diagnostic biomarkers for TB have been identified for both 
the active and latent stages of the infection. Nevertheless, the blood samples derived 
form M. tuberculosis infected patients are inadequate for unraveling the mediators of 
the immediate systemic immune response upon infection or the spatio-temporal 
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expression of host response genes. For this purpose, proper animal models are 
required. 
A few genome-wide transcriptomic studies have been so far published in the 
zebrafish M. marinum model (Benard et al. 2016b; Hegedus et al. 2009; Kenyon et al. 
2017; Meijer et al. 2005; Rougeot et al. 2014; van der Sar et al. 2009; van der Vaart, 
Spaink & Meijer 2012). Moreover, since both zebrafish embryos as well as adult fish 
have been used in these studies, it has been possible to describe both the early and 
chronic stages of the infection in the context of the innate immunity (embryos) alone 
or with both innate and adaptive immune components (adult fish), respectively. 
However, since it is well-known that the virulence properties of different 
mycobacterial strains can also affect the immune response, we infected adult 
zebrafish with the M. marinum strain ATCC 927 that has been used previously in our 
experiments, and conducted a separate microarray gene expression analysis at 14 dpi 
(III). By using a low mycobacterial infection dose (20 CFU, SD 6 CFU), we found 
several muscle associated genes as well as immune function related transcripts such 
as si:busm1-194e12.11 (mhc2 family gene) and CD59 molecule (cd59) to be up-regulated 
compared to PBS controls. While the si:busm1-194e12.11 induction could indicate the 
increased Mhc2-mediated antigen presentation from the APC´s and the initiation 
phase of the adaptive immune response, the increased cd59 (membrane attack 
complex component gene) mRNA levels suggest the functionality of the 
complement system in the mycobacterial response. Overall, some of the 
differentially expressed immunological genes e.g. myeloid specific peroxidase (mpx) and 
immunoresponsive gene 1, like (irg1l) have previously also been described in the 
M. marinum infection of zebrafish (Benard et al. 2016a; Meijer et al. 2005; van der Sar 
et al. 2009; van der Vaart, Spaink & Meijer 2012). Importantly, we also detected one 
member of the itln gene family, itln3, whose expression was highly induced in an 
infection. In fact, although itln genes have been shown to be induced in parasite 
(Voehringer et al. 2007) and bacterial infections (Lin et al. 2009; Peatman et al. 2007; 
Takano et al. 2008; Ding et al. 2017), their infection-inducible expression has not 
previously been reported in a mycobacterial infection. Whether itln expression is of 
diagnostic relevance for TB, remains to be established. Overall, the previous 
transcriptomic studies as well as our microarray analysis demonstrate the feasibility 
of genome-wide gene expression studies in zebrafish in identifying novel candidate 
genes in the mycobacterial immune response. 
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6.5 itln3 is not required for the zebrafish host response against 
M. marinum (III) 
Taken together, the inducibility of itln3 in a mycobacterial infection as well as 
previous in vitro findings about the bacterial binding ability of ITLNs, make itln3 an 
interesting candidate gene for a role in the immunity against mycobacteria. Because 
there were no previous reports that would have addressed the role of itln3 in the 
zebrafish immune response against mycobacteria, we used CRISPR/Cas9 
mutagenesis to create two itln3 knockout zebrafish lines and infected the fish with 
M. marinum in both the zebrafish embryos and the adult fish. All of our bacterial 
quantifications and survival analyses suggested that itln3 is dispensable for 
mycobacterial resistance. Furthermore, our in vitro bacterial binding assays with 
recombinant zebrafish Itln3 proposed that Itln3 does not directly bind M. marinum. 
Although the dispensable role for Itln3 in the immunity can be directly explained by 
the lack of Itln3-mediated mycobacterial recognition in zebrafish, also other 
explanations can be hypothesized. In fact, perhaps the most striking difference 
between parasite and mycobacterial infections is the cellular localization of these 
pathogens. While e.g. T. spiralis is a large extracellular worm, M. marinum (like 
M. tuberculosis) is an intracellular bacterial species that exploits the host´s innate 
immune cells to replicate. In fact, the lack of itln3 could hypothetically be beneficial 
to the host by restricting mycobacterial uptake by the myeloid cells. Conversely, to 
determine if Itln3 is important for the immunity against extracellular pathogens, we 
also infected itln3uta145 and itln3uta148 mutant embryos with two different S. pneumoniae 
serotypes and followed their survival up to 7 dpf (III, Suppl. Fig. 1B-E). 
Interestingly, comparably to the M. marinum infection, no differences were observed 
between the itln3 mutant and the WT genotypes. The lack of observed survival 
differences with both intra- and extracellular bacteria also argues that zebrafish Itln3 
may not act as an important receptor for other microbial recognition proteins such 
as lactoferrin either (Suzuki, Shin & Lönnerdal 2001). 
Reactivation of latent TB is a significant contributor to the persistence of the 
TB epidemic (Rangaka et al. 2015). In humans, reactivation can occur because of 
environmental factors such as silica dust or as a result of immunosuppression e.g. in 
a HIV infection or upon immunosuppressive medication (Ai et al. 2016). Relatively 
recently, the zebrafish M. marinum infection model was engineered for studying the 
reactivation of a latent mycobacterial infection (Parikka et al. 2012; Myllymäki et al. 
2018). While Parikka et al. (2012) used gamma irradiation for immunosuppression, 
Myllymäki et al. (2018) induced immunodeficiency through dexamethasone 
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administration. More specifically in Myllymäki et al. (2018), dexamethasone coated 
food was able to specifically decrease the zebrafish lymphocyte population, which 
consequently led to the reactivation of the latent infection. Although the initial 
purpose of the dexamethasone model was to reactivate an existing latent infection, 
we hypothesized that this model could also be re-purposed to highlight the 
importance of the innate mycobacterial immunity in our itln3 mutation carrying 
zebrafish line. In fact, previously a somewhat similar approach for studying the 
innate immunity with homozygous rag mutant zebrafish has been suggested 
(Tokunaga et al. 2017). Consequently in report III, we used dexamethasone to reduce 
the lymphocyte pool prior to infecting homozygous itn3 mutants (itln3uta145/uta145 and 
itln3uta148/uta148) as well as the corresponding WT zebrafish with M. marinum. Despite 
the similar bacterial burden in itn3 mutant and WT zebrafish 2 and 4 wpi, future 
innate immunity studies in adult zebrafish are likely to benefit from the practicality 
of the described dexamethasone-mediated immunosuppression system. In addition, 
while some of the differentially expressed genes identified in our microarray analysis 
of M. marinum infected zebrafish can directly provide new candidate genes for 
upcoming research, it would also be of interest to study the broader role of the 
muscle tissue in a mycobacterial infection. 
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7 SUMMARY AND CONCLUSIONS 
Tuberculosis (TB) is an infectious disease caused by the intracellular mycobacterial 
species M. tuberculosis. Although antibiotics against the drug-sensitive M. tuberculosis 
strains are available, the worldwide occurrence of the disease and the enormous 
amount of the latently infected M. tuberculosis carriers make the efforts to fight the 
disease difficult. Moreover, the increased fraction of antibiotic-resistant 
M. tuberculosis infections demands the development of new anti-tuberculous 
regimens. TB is a multifactorial disease with a strong genetic influence on its 
pathogenesis. In order to screen for novel genes affecting TB susceptibility and to 
understand their functional significance, genetically tractable animal models are 
required. Accordingly, the zebrafish M. marinum infection can be used as a safe TB 
model to provide new insights into the host-pathogen interactions in a mycobacterial 
infection. 
The T helper (Th) type 1 immune response is of crucial importance in TB 
immunity. FURIN is an important regulator of T lymphocyte and macrophage 
function and it has been shown to control e.g. Th1 cell polarization. Our gene 
expression analysis of steady state heterozygous furinAtd204e/+ mutant zebrafish 
revealed an increase in the expression of Th-specific transcription factors tbx21 (Th1 
marker), gata3 (Th2 marker) and foxp3a (Treg marker) in comparison to WT fish, 
suggesting a similar function for FurinA in T cell differentiation as its mammalian 
counterparts. Our findings also showed, for the first time, that furinA, the zebrafish 
ortholog of human FURIN, is upregulated in a mycobacterial infection. 
Furthermore, the decreased furinA mRNA levels in the furinAtd204e/+ mutants 
associated with a proinflammatory phenotype upon M. marinum infection, which was 
characterized by higher levels of tnfa, lta and il17a/f3 expression, and with a decreased 
M. marinum burden in a chronic infection. Future studies using for example the 
zebrafish latency model would be required to assess whether FURIN expression or 
protein levels could be used as a diagnostic marker in latent TB. On the other hand, 
a conditional lung-specific deletion of Furin in a mouse TB model could help in 
evaluating the potential of inhaled FURIN-inhibitors as anti-TB drugs. 
The relatively recently engineered CRISPR/Cas9 mutagenesis system has been 
demonstrated as an effective tool for creating genomic modifications also in model 
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organisms such as the zebrafish. To set up an in-house zebrafish CRISPR/Cas9 
mutagenesis method an egfp transgene in the tg(fli1a:egfp) fish line as well as 
endogenous ca10a and ca10b genes in WT fish were targeted. Phenotypic and 
molecular analyses of the CRISPR/Cas9 mutated fish demonstrated both the 
applicability as well as the efficiency of our system in creating targeted genomic indel 
mutations in vivo. The described zebrafish CRISPR/Cas9 system can also be easily 
expanded to create knock-in animals as well as to knockdown genes of interest with 
the CRISPR interference approach. 
In order to screen for novel candidate genes associated with a mycobacterial 
infection, a genome-wide gene expression microarray analysis of M. marinum infected 
zebrafish was conducted. Here, we found itln3 to be one of the genes most induced 
during an infection. Consequently, the CRISPR/Cas9 system was used to create itln3 
mutant zebrafish lines, and to study ITLNs in vivo in the mycobacterial host response. 
However, despite our studies with both the M. marinum model of zebrafish embryos 
as well as the adult fish, we did not detect any differences in the survival or the 
mycobacterial burden of the itln3 mutants compared to the WT controls. 
Understanding why Itln3 is dispensable for a M. marinum infection requires further 
studies, although, as suggested by our bacterial binding studies, the inability of Itln3 
to bind to M. marinum provides one explanation for this. Collectively, our findings 
indicate that the zebrafish M. marinum infection model together with the genome-
wide transcriptomic approaches enables screening for novel TB candidate genes, and 
that together with the mutant zebrafish they provide a powerful combination when 
studying the influence of the host´s genetics in a mycobacterial infection. 
Importantly, these studies can elucidate the detailed molecular mechanisms involved 
in the host response against mycobacteria, which is prerequisite for finding new 
diagnostic possibilities and therapeutic agents.
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The Proprotein Convertase Subtilisin/Kexin FurinA Regulates
Zebraﬁsh Host Response against Mycobacterium marinum
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BioMediTech, University of Tampere, Tampere, Finlanda; Department of Pediatrics, Tampere University Hospital, Tampere, Finlandb; Department of Children and
Adolescents, Oulu University Hospital, Oulu, Finlandc; Department of Pediatrics, Medical Research Center Oulu, University of Oulu, Oulu, Finlandd; Department of
Dermatology, Tampere University Hospital, Tampere, Finlande; Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finlandf
Tuberculosis is a chronic bacterial disease with a complex pathogenesis. An effective immunity against Mycobacterium tubercu-
losis requires both the innate and adaptive immune responses, including proper T helper (Th) type 1 cell function. FURIN is a
proprotein convertase subtilisin/kexin (PCSK) enzyme, which is highly expressed in Th1 type cells. FURIN expression in T cells
is essential for maintaining peripheral immune tolerance, but its role in the innate immunity and infections has remained elu-
sive. Here, we utilized Mycobacterium marinum infection models in zebraﬁsh (Danio rerio) to investigate how furin regulates
host responses against mycobacteria. In steady-state furinAtd204e/ ﬁsh reduced furinA mRNA levels associated with low granu-
locyte counts and elevated Th cell transcription factor expressions. Silencing furin genes reduced the survival of M. marinum-
infected zebraﬁsh embryos. A mycobacterial infection upregulated furinA in adult zebraﬁsh, and infected furinAtd204e/mutants
exhibited a proinﬂammatory phenotype characterized by elevated tumor necrosis factor a (tnfa), lymphotoxin alpha (lta) and
interleukin 17a/f3 (il17a/f3) expression levels. The enhanced innate immune response in the furinAtd204e/mutants correlated
with a signiﬁcantly decreased bacterial burden in a chronic M. marinum infection model. Our data show that upregulated fu-
rinA expression can serve as a marker for mycobacterial disease, since it inhibits early host responses and consequently pro-
motes bacterial growth in a chronic infection.
Tuberculosis (TB) is an epidemic infectious disease caused bythe mycobacterial species Mycobacterium tuberculosis (1, 2).
Circa 13% of the individuals with active TB were simultaneous
carriers of the human immunodeﬁciency virus (HIV), and almost
one-third of TB-associated deaths occurred among HIV pa-
tients, demonstrating the critical role of cluster of differentiation 4
(CD4) T lymphocyte-mediated immunity in the control of M.
tuberculosis infection (3, 4). More speciﬁcally, the adaptive immu-
nity against TB is primarily mediated by T helper (Th) type 1 cells,
as is suggested by the gene expression proﬁle upon infection (5), as
well as the infection-induced mortality of gamma interferon-de-
ﬁcient (6, 7) and interleukin-12 (IL-12)-deﬁcient (8) mice.
The proprotein convertase subtilisin/kexin (PCSK) enzymes
are a family of serine endoproteases with nine members in hu-
mans: PCSK1 and -2, FURIN, PCSK4 to -7, membrane-bound
transcription factor peptidase site 1 (MBTPS1), and PCSK9 (9).
Typically, PCSKs convert precursor proteins (proproteins) into
their biologically active forms by cleaving them at speciﬁc target
motifs made up of the basic amino acids lysine and arginine (9,
10). FURIN was the ﬁrst identiﬁed mammalian PCSK and is pres-
ent in vertebrates and many invertebrates (11, 12). A series of in
vitro experiments have suggested a central role for FURIN in host
defense because it proteolytically activates several immunoregula-
tory proproteins, such as membrane-inserted matrix metallopep-
tidase 14 (13) and integrins (9), as well as tumor necrosis factor
(TNF) and transforming growth factor beta (TGFB) family cyto-
kines (e.g., the TNF superfamily, member 13b, and TGFB1) (12).
In addition, infectious agents, including bacterial toxins (anthrax)
and viral proteins (HIV gp160), are processed by FURIN (12).
Previously, we and others have shown that FURIN is predom-
inantly expressed in Th1 cells and that FURIN expression is in-
duced in activated CD4 T lymphocytes and myeloid cells
(14–17). Our functional analyses using mice with a tissue-speciﬁc
deletion of Furin in T cells (CD4cre-furﬂ/ﬂ) further demonstrated
that FURIN is essential for the adequate maturation of pro-
TGFB1 and for T regulatory (Treg) cell-mediated immune sup-
pression in vivo (18). The breakage of peripheral immune toler-
ance in CD4cre-furﬂ/ﬂ mice resulted in an age-related progression
of a systemic autoimmune disease characterized by excessive
numbers of overtly activated CD4 and CD8 T cells and an
increase in proinﬂammatory cytokine production. In line with the
critical role of FURIN in immune suppression, the administration
of exogenous recombinant FURIN can alleviate autoimmunity in
an experimental arthritismodel (19).Notably, as a germ line Furin
gene knockout (KO) in mice is lethal during embryonic develop-
ment (20), the systemic role of FURIN in immune regulation and
infections is still poorly understood.
Zebraﬁsh (Danio rerio) is a small nonmammalian vertebrate
model organism, with humoral and cellular components of the
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innate and adaptive immune systems similar to those of humans
(21–24). Mycobacterium marinum, a close relative of M. tubercu-
losis, is a natural zebraﬁsh pathogen and causes a mycobacterial
disease, which shares the main pathological and histological fea-
tures of human TB (25, 26). Consequently, an M. marinum infec-
tion in ﬁsh is considered a relevant, cost-effective and ethical tool
for studying the human mycobacterial disease. Both embryo and
adult zebraﬁsh infection models are now well established; while
embryos can be used to speciﬁcally investigate innate immune
responses (27, 28), the adult model enables the study of a chronic
progressive mycobacterial infection, as well as spontaneous la-
tency (25, 29).
Genetic variation affects TB susceptibility in humans. To study
mutant phenotypes of selected host genes, a large collection of
mutant zebraﬁsh strains is available (Zebraﬁsh Mutation Project,
Wellcome Trust Sanger Institute, Cambridge, United Kingdom).
Zebraﬁsh has two FURIN orthologs: furinA and furinB. furinA,
like the mammalian FURIN gene, has a critical, nonredundant
role in organism development (30). Here, we have silenced the
expression of furin genes in developing ﬁsh and used a
furinAtd204e/ mutant zebraﬁsh strain to study how FurinA regu-
lates the development of adult zebraﬁsh immune cells and the host
response against mycobacteria.
MATERIALS AND METHODS
Zebraﬁsh lines and maintenance. Nine- to 16-month-old zebraﬁsh were
used in the adult experiments. furinAtd204e mutation-bearing zebraﬁsh in
an AB genetic background (Zebraﬁsh Information Network [ZFIN] ID:
ZDB-GENO-080606-310) were purchased from the Zebraﬁsh Interna-
tional Resource Center (Oregon). The genotypes of the furinAtd204e/
mutant zebraﬁsh and their wild-type (WT) siblings were conﬁrmed by
sequencing (30). The ﬁsh were kept in a standardized ﬂowthrough system
(Aquatic Habitats, Florida, USA) with a light/dark cycle of 14 h and 10 h
and fedwith SDS 400 food twice a day. Until 7 days postfertilization (dpf),
embryos were grown according to standard protocols in embryo medium
(E3) at 28.5°C. The zebraﬁsh housing, care, and all experiments have been
approved by the National Animal Experiment Board of Finland (permits
LSLH-2007-7254/Ym-23, ESAVI/6407/04.10.03/2012, ESAVI/733/04.10.07/
2013, ESAVI/2267/04.10.03/2012, and ESAVI/8125/04.10.07/2013).
Flow cytometry. Zebraﬁsh were euthanized in a 0.04% 3-aminoben-
zoic acid ethyl ester anesthetic (pH 7.0; Sigma-Aldrich, Missouri, USA),
and kidneys were isolated and homogenized into a single-cell suspension
of phosphate-buffered saline with 0.5% fetal bovine serum (Gibco/Invit-
rogen, California, USA). Relative amounts of blood cell precursors, eryth-
rocytes, granulocytes, and lymphocytes were determined by ﬂow cytom-
etry in steady-state (uninfected) furinAtd204e/mutants and WT controls
by using a FACSCanto II (Becton Dickinson, New Jersey, USA). The data
were analyzed with the FlowJo program (v7.5; Tree Star, Inc., Oregon,
USA). Hematopoietic cell types were identiﬁed based on granularity (side
scatter [SSC]) and particle size (forward scatter [FSC]) (31). Granulocytes
and lymphocytes for furinA expression analyses were puriﬁed from WT
AB zebraﬁsh kidneys by using ﬂow cytometric sorting with a FACSAria I
apparatus (Becton Dickinson).
Experimental infections in adult zebraﬁsh. M. marinum (ATCC 927
strain) was cultured and the inoculation performed as described previ-
ously (25). In brief, the zebraﬁsh were anesthetized with 0.02% 3-amino-
benzoic acid ethyl ester and various amounts of M. marinum, together
with 0.3 mg/ml phenol red (Sigma-Aldrich), were injected intraperitone-
ally (i.p.) using an Omnican 100 (30-gauge) insulin needle (Braun, Mel-
sungen, Germany). The M. marinum CFU used in the infections were
veriﬁed by plating serial dilutions on 7H10 agar plates. Infected ﬁsh were
tracked daily, and humane endpoint criteria of the national ethical board
were monitored.
MO and M. marinum coinjections. Oligonucleotide sequences for
furinA and furinB gene silencing morpholinos (MOs) and the injection
protocol have been previously described (32). The injection volume was
set to 2 nl, and 0.25 pmol of both furinA and furinBMOsor 0.5 pmol of RC
MO was used. M. marinum was simultaneously coinjected into the yolk
sac, and 2% polyvinylpyrrolidone was used as a carrier solution in the
suspension (27, 33). Survival was analyzed daily with a visual inspection
with an Olympus IX71 microscope.
Histology. The presence of M. marinum in infected adult zebraﬁsh
was veriﬁed with a histological analysis and Ziehl-Neelsen staining (25,
34). Uninfected controls were included to exclude background mycobac-
terial infection. Sections were visualized with an Olympus BX51 micro-
scope and Olympus ColorView IIIu camera using a 100 magniﬁcation
or with a fully automated Objective Imaging Surveyor virtual slide scan-
ner (Objective Imaging, Cambridge, United Kingdom). Digitization of
scanned sample sectionswas done at a resolution of 0.4mper pixel using
a 20 Plan Apochromatic microscope objective, and image data were
converted to JPEG2000 format as described previously (35).
qRT-PCR.RNA and/orDNAwas isolated fromkidneys, lymphocytes,
granulocytes, and the tissue homogenates of organs in the abdominal
cavity using an RNeasy RNA puriﬁcation kit (Qiagen, Hilden, Germany)
or with an RNA-DNA coextraction method for TRIreagent (Molecular
Research Center, Ohio, USA). The relative mRNA levels of target genes
were quantiﬁed from cDNA with quantitative real-time PCR (qRT-PCR).
The reverse transcription was done with an iScript Select cDNA synthesis
kit (Bio-Rad, California, USA). Maxima SYBR green qPCR master mix
(Fermentas, Burlington, Canada) and a CFX96 qPCR machine (Bio-Rad)
were used. Primer sequences and ZFIN identiﬁcation codes for the qRT-
PCR-analyzed genes are listed in Table S1 in the supplemental material.
The expression of target geneswas normalized to the expression of eukary-
otic translation elongation factor 1 alpha 1, like 1 (eef1a1l1 or ef1a) (36).
Whenever the RNA-DNA coextraction method was used, the total DNA
was isolated simultaneously with the RNA to quantify the M. marinum
load in the ﬁsh with qRT-PCR (25). The results were analyzed with the
Bio-Rad CFX Manager software v1.6 (Bio-Rad). No template control
samples (H2O) were included in all experiments to monitor contamina-
tion. Melting curve analyses, followed by 1.5% agarose (Bioline, London,
United Kingdom) gel electrophoresis, were done to validate the qRT-PCR
products of the target genes.
Statistical analysis. Statistical analyses were performedwith the Prism
v5.02 program (GraphPad Software, Inc., California, USA). A log-rank
(Mantel-Cox) test was used in the survival experiments and a nonpara-
metric Mann-Whitney analysis in the ﬂow cytometry and qRT-PCR ex-
periments. P values of0.05 were considered signiﬁcant.
RESULTS
furinA is upregulated in a mycobacterial infection and it con-
trols granulopoiesis andTh cell transcription factor expression.
In the furinAtd204e mutant ﬁsh, a speciﬁc thymidine (T)-to-aden-
osine (A) splice site mutation results in a skipped exon 9 during
the transcription of the furinA gene (see Fig. S1 in the supplemen-
tal material) (30). This leads to a loss-of-function FurinA mutant
protein and enables the design of qRT-PCR primers, which can be
used to speciﬁcally quantify native furinA mRNA molecules. In
accordancewith the developmental lethality of other homozygous
furinA zebraﬁsh mutants (98% lethality of furinAtg419/tg419 mu-
tant) (30), no homozygous furinAtd204e/td204e mutant ﬁsh could be
obtained in our ﬁsh crosses (up to450 genotyped ﬁsh), suggest-
ing that in homozygous form this allele is also lethal. In contrast,
the heterozygous furinAtd204e/ mutants were born in normal
Mendelian ratios and did not show signs of developmental defects
or spontaneous autoimmunity. First, to determine the effect of a
heterozygous furinAtd204e mutation on mRNA levels, furinA ex-
pression in uninfected and M.marinum-infected adult ﬁsh (4 and
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9 weeks postinfection [wpi], low dose; 34 10 CFU) was quanti-
ﬁed with qRT-PCR (Fig. 1A). Previously, in vitro analyses have
shown that FURIN expression is upregulated as a result of CD4T
cell activation and in lipopolysaccharide (LPS)-stimulatedCD14
myeloid cells (14, 15). In accordance with this, the M. marinum
infection caused an induction in furinAmRNA expression in both
furinAtd204e/ (1.6-fold at 4 wpi, P 	 0.02, and 4.9-fold at 9 wpi,
P  0.001) and WT zebraﬁsh (1.7-fold at 4 wpi, not signiﬁcant
[NS], P	 0.11; 3.4-fold at 9 wpi, P 0.001) demonstrating that
immune activation in vivo upregulates this convertase. Further-
more, in the infected groups, furinAtd204e/ ﬁsh had on average
39% (P	 0.01) and 43% less (P	 0.003) furinAmRNAcompared
to WT controls at 4 and 9 wpi, respectively. A similar trend was
also observed in uninfected zebraﬁsh with a 44% decrease in fu-
rinA expression (NS, P 	 0.08). Put together, the data indicate
that furinA is upregulated in response to a mycobacterial infection,
and that the furinAtd204e/ zebraﬁsh can be used to explore the func-
tional role of this PCSK in a mycobacterial infection in vivo.
The development of hematopoietic cells in zebraﬁsh is highly
similar to that in humans (31, 37). To assess the effect of the
reduced furinA expression on hematopoiesis in the furinAtd204e/
ﬁsh, we studied their blood cell composition with ﬂow cytometry
(Fig. 1B and C) (31). The ﬂow cytometric analysis revealed no
marked differences in blood cell precursor, erythrocyte or lym-
phocyte populations in furinAtd204e/ zebraﬁsh compared to WT
controls. However, the amount of granulocytes in furinAtd204e/
ﬁsh was signiﬁcantly decreased, by an average of 15.4% (P 	
0.008), compared to controls, indicating a role for FurinA in gran-
ulopoiesis.
Previously, we showed that FURIN is critical for normal mam-
malian Th polarization and CD4 Treg cell function; CD4cre-
furﬂ/ﬂ mice have abnormally large effector CD4 and Treg cell
populations accompanied with an excessive production of Th1
and Th2 cytokines (15, 18). To address whether FurinA regulates
the generation of Th subsets in zebraﬁsh, we assessed the expres-
sion of different T cell markers (CD247 antigen; cd247, T-box 21;
FIG 1 furinA expression is reduced in furinAtd204e/ zebraﬁsh and associates with decreased granulocyte counts, as well as altered T helper cell subtype
transcription factor expression. (A) Relative furinA expression was measured in uninfected (n	 10) and M.marinum-infected (at 4 and 9 wpi, low-dose, n	 13
to 21) furinAtd204e/ mutant adult zebraﬁsh and WT controls with qRT-PCR. Samples were run as technical duplicates. (B and C) The relative percentages of
blood cell precursors, erythrocytes, granulocytes, and lymphocytes were determined in the kidneys of steady-state (uninfected) furinAtd204e/mutants and WT
zebraﬁsh (n	 5 in both groups) with ﬂow cytometry, based on granularity (SSC) and cell size (FSC). Representative ﬂow cytometry plots are shown in panel B.
Gated populations are outlined, and the cell counts inside the gates are given as the percentages of the total viable cell population. The average relative percentages
of different hematopoietic cell populations in mutants and controls are plotted in panel C (error bars indicate the standard deviations). (D) Relative expressions
of different Th cell-associated genes (cd247, tbx21, gata3, foxp3a, and rorca), as well as tgfb1a, were quantiﬁed in furinAtd204e/mutants and WT controls (n	 10
in both groups) with qRT-PCR. Gene expressions in panels A and D were normalized to eef1a1l1 expression and represented as a scatter dot plot and median. In
panel A, a one-tailed Mann-Whitney test was used in the statistical comparison of differences between furinAtd204e/ zebraﬁsh and WT controls, and a two-tailed
Mann-Whitney test was used in panels C and D, as well as in the comparisons between uninfected and infected experimental groups in panel A.
Furin Controls Zebraﬁsh Immunity against Mycobacteria
April 2015 Volume 83 Number 4 iai.asm.org 1433Infection and Immunity
 on M
arch 17, 2015 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
tbx21, gata3, forkhead box P3a; foxp3a, retinoic acid receptor-re-
lated orphan receptor C a; rorca) in furinAtd204e/mutants and WT
controls (Fig. 1D). As in T cell-speciﬁc FURIN conditional KO
(cKO)mice, themRNA levels of Th1, Th2, and the Treg cellmark-
ers tbx21 (T-bet, P	 0.003), gata3 (P	 0.004), and foxp3a (P
0.001) were elevated in furinAtd204e/ zebraﬁsh. In contrast, there
was no signiﬁcant difference in the expression of the Th17 cell
marker rorca between furinAtd204e/ andWT zebraﬁsh, which is in
line with the normal IL-17 production previously observed in
CD4cre-furﬂ/ﬂ mice (18).
TGFB1 directly induces Furin expression in rodents, which is a
prerequisite for its functional maturation and anti-inﬂammatory
function (18, 38). Consequently, the autoimmune phenotype of
CD4cre-furﬂ/ﬂ mice can be chieﬂy attributed to a lack of bioavail-
able, T cell-produced TGFB1. In our present study, zebraﬁsh Fu-
rinA was found to regulate tgfb1a expression in vivo (Fig. 1D),
which could result from an attempt to compensate for the defec-
tive maturation of the Tgfb1a cytokine by increasing the efﬁciency
of tgfb1a transcription.
The quantiﬁcation of the furinA mRNA expression in WT ze-
braﬁsh demonstrated that it is expressed in both innate and adap-
tive immune cells (Fig. 2A), which is in line with the previously
reported ubiquitous expression pattern of FURIN orthologues in
vertebrates (9, 32). In mammals, the ﬁrst seven PCSK enzymes
have been demonstrated to exhibit a signiﬁcant functional redun-
dancy and shared substrate molecules, which interferes with the
interpretation of a PCSK speciﬁc phenotype (39). Therefore, we
next addressed the expression of the zebraﬁsh pcsk genes (pcsk1,
pcsk2, furinB, pcsk5a, pcsk5b, and pcsk7) in furinAtd204e/mutants
and WT controls (Fig. 2B). The pcsk genes furinB, pcsk5a, pcsk5b,
and pcsk7 showed comparable expression levels between
furinAtd204e/ and WT zebraﬁsh, whereas pcsk1 and pcsk2 were
signiﬁcantly upregulated in the furinAtd204e/ ﬁsh (P 	 0.01 and
P	 0.006, respectively), which theoretically could partially com-
pensate for the effect of reduced furinA expression.
Furin regulates the survival of M. marinum-infected ze-
braﬁsh embryos. Whereas upregulated T cell gene expression in
furinAtd204e/ zebraﬁsh indicates enhanced immune responses,
granulopenia can result in immunodeﬁciency. To study the net
effect of FurinA on mycobacterial host defense in adult zebraﬁsh,
we infected furinAtd204e/ and WT zebraﬁsh with a high-dose of
M. marinum (8,300 1,800 CFU) and followed their survival for
11weeks (Fig. 3A).WTﬁsh exhibited ca. 60%mortality during the
ﬁrst 5 weeks and about one-third of them were alive at the study
endpoint (Fig. 3A). furinAtd204e/ mutants showed similar lethal-
ity, and no statistical difference in gross survival between mutant
and WT ﬁsh could be detected. In addition, a histopathological
examination revealed that the two ﬁsh groups had similarly orga-
nized granulomas at both 3 and 11wpi, and there were no obvious
differences in the numbers of granulomas (Fig. 3B). Uninfected
WT and furinAtd204e/ zebraﬁsh controls did not show back-
ground mycobacteriosis in a Ziehl-Neelsen staining (data not
shown).
Morpholino (MO)-based expression silencing in developing
zebraﬁsh embryos can be used to study a gene’s function speciﬁ-
cally in innate immune responses (22, 40). Since furinA regulated
the granulopoiesis, we addressed its role in innate immunity by
inhibiting the expressions of furinA and furinB in the embryonic
M. marinum infection model (27, 32, 33). Infecting either control
(random control MO injected [RC]) or the double furin gene
knockdown embryos withM.marinum (131 125 CFU) resulted
in substantial lethality by 7 days postinfection (dpi; 93 and 100%,
respectively, Fig. 3C). The survival of infected furinAB mor-
phants was, however, signiﬁcantly reduced compared to controls
(furinAB versus RC, P  0.01). Notably, as FurinA is essential
for zebraﬁsh development the increased lethality of M. marinum-
infected furinmorphant embryos could result from general devel-
opmental defects.
FurinA inhibits the early expression of proinﬂammatory cy-
tokine genes in a mycobacterial infection. The containment of a
mycobacterial disease is critically dependent on adaptive Th1 type
responses but also on adequate innate immune responses. The
signiﬁcance of the innate immunity is perhaps best illustrated by
an increased susceptibility to TB in patients receiving anti-TNF
FIG 2 Expression of zebraﬁsh pcsk genes in furinAtd204e/mutants and WT controls. (A) Relative furinA expression was measured with qRT-PCR in the tissue
homogenates of organs in the abdominal cavity (n	 10) and kidney (n	 10) as well as in puriﬁed granulocytes (n	 5) and lymphocytes (n	 5) isolated from
steady-state WT AB zebraﬁsh. Samples were run as technical duplicates. (B) The relative expressions of zebraﬁsh pcsk genes (pcsk1, pcsk2, furinB, pcsk5a, pcsk5b,
and pcsk7) were quantiﬁed in the tissue homogenates of organs in the abdominal cavities of steady-state adult furinAtd204e/mutant (n	 10) and WT (n	 8 to
10) zebraﬁsh by using qRT-PCR. Gene expressions were normalized to eef1a1l1 expression and are represented as a scatter dot plot and median. A two-tailed
Mann-Whitney test was used in the statistical comparison of differences.
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neutralizing antibodies and an association of human Toll-like re-
ceptor polymorphisms with an increased disease risk (4, 41, 42).
FURIN can process target molecules that are important in innate
immunity in vitro (e.g., TNF converting enzyme and Toll-like re-
ceptor 7) (43, 44), but whether it also regulates innate immune
responses in infections in vivo has not been addressed. We next
analyzed the early immune response against M.marinum by mea-
suring the cytokine gene expression in furinAtd204e/ ﬁsh and WT
controls. Both furinAtd204e/ andWTadult zebraﬁshwere infected
with a high dose of M. marinum (10,300  3,300 CFU) and a
qRT-PCR expression analysis of both proinﬂammatory (tnfa,
il1b, lta, ifng1-1, il22, and il17a/f3) and anti-inﬂammatory (il10
and tgfb1a) cytokine genes was performed at 1, 6, and 12 dpi
(Fig. 4).
An analysis of the kinetics of the cytokine gene induction in
WT ﬁsh (Fig. 4A) demonstrated that the expression levels of tnfa,
lta, and ifng1-1 were signiﬁcantly upregulated upon M. marinum
infection already at 1 dpi (15.1-, 5.5-, and 396.4-fold, respec-
tively), with rising kinetics until 6 dpi (161.4-, 13.1-, and 478.8-
fold, respectively). At 12 dpi, the induction of tnfa had declined to
110.3-fold, whereas lta and ifng1-1 expressions had returned to
their baseline levels. il17a/f3was also signiﬁcantly induced at 1 dpi
(18.0-fold), but its expression decreased during the following days
(6 dpi, 7.7-fold; 12 dpi, baseline expression). In contrast, both il1b
and il22 showed a delayed expression pattern by peaking at 12 dpi
(il1b, 2.3-fold; il22, 10.8-fold). The induction of the anti-inﬂam-
matory cytokine genes il10 and tgfb1awas evident already by day 6
postinfection (il10, 2.4-fold; tgfb1a, 10.7-fold), and the expression
of both genes was even more pronounced at 12 dpi (4.4- and
19.0-fold, respectively). In conclusion, an M. marinum infection
in zebraﬁsh results in an enhancement in the levels of various
macrophage, natural killer cell, 
 T cell, and lymphoid tissue
inducer cell-associated cytokines already during the ﬁrst 12 days
after infection, indicating an efﬁcient activation of pro- and anti-
inﬂammatory processes.
To determine how FurinA contributes to the early cytokine
levels induced byM.marinum, we compared the expression of the
aforementioned cytokine genes in infected furinAtd204e/ and WT
zebraﬁsh (Fig. 4B to I). furinAtd204e/ mutants showed a signiﬁ-
cantly higher relative expression of the proinﬂammatory cytokine
genes tnfa (P	 0.007), lta (P	 0.03), and il17a/f3 (P	 0.002) at
1 dpi compared to WT ﬁsh. Interestingly, the inherent relative
upregulation of tgfb1a in furinAtd204e/ mutants was completely
abolished by the 12th postinfective day, and this was accompanied
by a relative reduction in il10 gene expression. The low furinA
expression also associated with a sustained upregulation of the
il17a/f3 cytokine gene. Collectively, these results could indicate
that inﬂammation-accelerating innate cytokine responses domi-
nate in M. marinum-infected furinAtd204e/mutant ﬁsh. To dem-
onstrate that FURIN attenuates proinﬂammatory responses spe-
ciﬁcally in innate immune cells, we used cultured macrophages
from WT and LysMcre-furﬂ/ﬂ mice (Fig. 5) (45, 46). In these ex-
periments we saw that in activated macrophages reduced Furin
mRNA levels (77% decrease, P 	 0.004) are associated with sig-
niﬁcantly upregulated transcription of the proinﬂammatory cyto-
kine gene Tnf (P	 0.03).
furinAtd204e/mutants have decreased bacterial burden and
cd247 expression in a chronicM. marinum infectionmodel. We
have recently established a model for studying a latent mycobac-
terial infection in adult zebraﬁsh (25). A low-dose i.p. M. mari-
FIG 3 Role of furin in zebraﬁsh survival during M. marinum infection. (A)
The survival of adult furinAtd204e/ (n 	 39) and WT (n 	 14) zebraﬁsh was
monitored for 11 weeks after an experimental high-dose M. marinum inocu-
late. The data were collected from a single experiment. (B) M. marinum gran-
ulomas in adult WT and furinAtd204e/ zebraﬁsh infected with a high-dose
bacterial inoculate were identiﬁed with Ziehl-Neelsen staining at 3 wpi
(17,300  6,900 CFU) and 11 wpi (8,300  1,800 CFU). Representative im-
ages from 4 to 10 individuals per group are shown. Typical granulomas are
indicated with arrows. (C) Zebraﬁsh embryos were microinjected before the
four-cell stage with RC (n	 71) or both furinA and furinB MOs (n	 82) and
M. marinum (131  125 CFU). At 1 dpf, embryos were screened to identify
successfully injected embryos, and survival was monitored up until 7 dpf.
Collated data from two separate experiments with 30 and 41 embryos in the
RCMOgroups and 27 and 55 embryos in the furinA and furinBMOgroups are
shown. In panels A and C, a log-rank (Mantel-Cox) test was used for the
statistical comparison of differences.
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num inoculate (35 CFU) results in static bacterial burdens, a
constant number of granulomas, and low mortality. We thus uti-
lized this model to investigate how FurinA contributes to the
adaptive mycobacterial immunity and the development of myco-
bacterial latency. When furinAtd204e/ mutant and WT control
ﬁsh were infected with small amounts of M. marinum (46  8
CFU) and survival was monitored for 9 weeks, statistically signif-
icant difference between the groups could not be observed (Fig.
6A). However, mycobacterial quantiﬁcation revealed a trend of
smaller bacterial amount in the furinAtd204e/ mutants at 4 wpi
(34 10 CFU, NS) (Fig. 6B), but signiﬁcantly reduced M. mari-
num copy numbers from the internal organ isolates of infected
furinAtd204e/ zebraﬁsh compared to WT ﬁsh at 9 wpi (1.9-fold
reduction, P	 0.04) (Fig. 6B). On average, bacterial copy number
medians at 9 wpi were 11,000 (13 copies in 100 ng of zebraﬁsh
DNA) in furinAtd204e/mutants and 21,000 (50 copies in 100 ng of
zebraﬁsh DNA) in WT zebraﬁsh, which suggests that furinA in-
hibits host responses in chronic mycobacterial infection.
The reduced mycobacterial load in latency could be a result of
the upregulation of proinﬂammatory cytokines upon the M. ma-
rinum infection in furinAtd204e/ mutant ﬁsh (Fig. 4B to G) but
also a consequence of inherently accelerated T cell responses
(Fig. 1D). To evaluate theT cell responses in latency, we quantiﬁed
the relative expression of a general T cell marker cd247 (cd3zeta)
and Th cell subtype-associated transcription factors (tbx21, gata3,
foxp3a, and rorca) in furinAtd204e/ mutant and control ﬁsh at
both 4 and 9 wpi (see Fig. S2 in the supplemental material and Fig.
6C). As expected, an infection-induced upregulation of these
genes was seen in both WT and mutant zebraﬁsh (at 4 wpi, 2.9- to
23.9-fold and 1.5- to 8.1-fold, respectively, and at 9 wpi, 4.2- to
19.0-fold and 2.5- to 8-fold, respectively), suggesting T cell acti-
vation. Interestingly, at 9 wpi, cd247 expression was signiﬁcantly
lower in infected furinAtd204e/mutants compared toWTcontrols
(P 	 0.03), whereas the expression of the Th subset-associated
transcription factors tbx21, gata3, foxp3a, and rorca did not differ
between infected furinAtd204e/ ﬁsh and controls. In addition, the
expression levels of innate immunity cytokine genes (tnfa, il1b,
il10, tgfb1a, lta, ifng1-1, and il17a/f3) were found to be similar
between furinAtd204e/ and WT ﬁsh (see Fig. S2 and S3 in the
supplemental material), indicating that innate immune cell activ-
ity during a chronicM.marinum infection is FurinA independent.
Together, the reduced relative expression of cd247 at 9 wpi and
loss of upregulation of tbx21, gata3, and foxp3a in furinAtd204e/
zebraﬁsh compared toWT controls indicate that FurinA enhances
T cell responses in a mycobacterial infection. However,
furinAtd204e/ mutants had lower M. marinum copy numbers,
FIG 4 FurinA attenuates the early expression of proinﬂammatory cytokine genes in an experimental high-dose mycobacterial infection. The relative expression
of proinﬂammatory cytokine genes (tnfa, il1b, lta, ifng1-1, il22, and il17a/f3) and anti-inﬂammatory cytokine genes (il10 and tgfb1a) was determined in adult
furinAtd204e/ (n 	 7 to 12) and WT (n 	 7 to 15) zebraﬁsh with qRT-PCR after a high dose of an M. marinum inoculate at 1, 6, and 12 dpi. (A) Fold gene
expression induction median shown for all of the aforementioned genes in infected WT zebraﬁsh. The fold induction was normalized to the gene expression
median in uninfected zebraﬁsh. *, P 0.05; **, P 0.01. (B to I) Relative gene expression in furinAtd204e/ and WT zebraﬁsh represented as a scatter dot plot and
median. Note the different scales of the y axes and the divided y axis in panels B and E. Gene expressions were normalized to eef1a1l1 expression. At 1 and 6 dpi,
samples were run as technical duplicates and uninfected, as well as 12-dpi, samples once. A two-tailed Mann-Whitney test was used in the statistical comparison
of differences.
FIG 5 Reduced Furin expression is associated with an upregulated expression of Tnf in activated mouse macrophages. Bone marrow-derived macrophages were
cultured from Furin KO (LysMcre-furﬂ/ﬂ) and WT littermate mice (n 	 4 to 5) as described previously (46). The relative expressions of Furin (Ensembl ID
ENSMUSG00000030530) (A) and Tnf (Ensembl ID ENSMUSG00000024401) (B) were determined in unstimulated and LPS-stimulated (4 h) samples with
qRT-PCR. Gene expressions were normalized to ribosomal protein S18 (Rps18, Ensembl ID ENSMUSG00000008668) expression and are represented as a scatter
dot plot andmedian. A two-tailedMann-Whitney test was used in the statistical comparison of differences. The qRT-PCRprimers used for themouse genes were
as follows: Furin, 5=-CAGAAGCATGGCTTCCACAAC-3= and 5=-TGTCACTGCTCTGTGCCAGAA-3=; Tnf, 5=-CTTCTGTCTACTGAACTTCGGG-3= and
5=-CAGGCTTGTCACTCGAATTTTG-3=; and Rps18, 5=-GTGATCCCTGAGAAGTTCCAG-3= and 5=-TCGATGTCTGCTTTCCTCAAC-3=.
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which suggests that FurinA also inhibits antimycobacterial host
responses.
DISCUSSION
Despite intensive studies, our understanding of the pathogenesis
and host immunity of TB is still incomplete. We found that furinA
expression is upregulated upon M. marinum infection and that
inhibiting furin genes in developing zebraﬁsh reduces the survival
of infected embryos. An analysis of furinAtd204e/ mutant adult
zebraﬁsh demonstrated that FurinA regulates the development of
granulocytes and the expression of Th subset-associated genes in
steady-state ﬁsh. When furinAtd204e/ mutant ﬁsh were infected
with a high dose of M. marinum, reduced furinA mRNA levels
were found to correlate with an enhanced expression of the pro-
inﬂammatory cytokine genes tnfa, lta, and il17a/f3. In contrast,
experiments using a latent mycobacterial infection model showed
that infected furinAtd204e/ mutants have lowered expression lev-
els of the T cellmarker gene cd247 (cd3zeta) compared to controls.
The net effect of the reduced furinA expression in adult zebraﬁsh
was a signiﬁcant decrease in M. marinum copy numbers in a low-
dose infection model, suggesting that FurinA attenuates protec-
tive host responses against mycobacteria.
Through catalyzing the endoproteolytic cleavage of targetmol-
ecules, PCSK enzymes regulate the maturation of host defense
factors, as well as the activity of invading pathogens (9, 10). In vitro
analyses have demonstrated that PCSK enzymes have signiﬁcantly
overlapping biochemical functions in substrate processing, and
therefore genetic inactivation of PCSKs is instrumental for decod-
ing their speciﬁc biological roles (9, 10, 47). We have previously
characterized the expression of seven pcsk genes in developing
embryos and multiple adult zebraﬁsh tissues (32). Two ortholo-
gous genes of mammalian FURIN, furinA and furinB (30), were
found to be ubiquitously expressed, and biochemical analyses
FIG 6 Downregulation of furinA expression decreases the M. marinum burden and the T cell marker cd247 mRNA level in an experimental low-dose
mycobacterial infection. A latent mycobacterial infection was induced with a low-dose M. marinum inoculate. (A) Survival of adult furinAtd204e/ (n	 29) and
WT (n	 22) zebraﬁsh was monitored for 9 weeks. A log-rank (Mantel-Cox) test was used for the statistical comparison of differences. The data were collected
from a single experiment. (B) The M. marinum burden of furinAtd204e/ mutants (n 	 17 to 20) and WT controls (n 	 13 to 18) was quantiﬁed with DNA
qRT-PCR at 4 and 9wpi. Bacterial load is represented as themedian of total bacterial copies (log10).M.marinum quantiﬁcations were run as technical duplicates.
(C) The relative expression of Th cell markers (cd247, tbx21, gata3, foxp3a, and rorca) was quantiﬁed with qRT-PCR in furinAtd204e/mutants (n	 18 to 21) and
WT controls (n	 18) at 9 wpi. Gene expressions were normalized to eef1a1l1 expression and represented as a scatter dot plot and median. Expression analyses
were run as technical duplicates. In panels B and C, a two-tailed Mann-Whitney test was used in the statistical comparison of differences.
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showed that FurinA, but not FurinB, is able to proteolytically pro-
cess pro-Tgfb1a, suggesting that FurinA is the corresponding bi-
ological equivalent for human FURIN (32). Germ line Furin KO
mice die on day 11 of embryogenesis due to severe developmental
defects in ventral closure, as well as in heart tube fusion and loop-
ing (20). Accordingly, we could not identify any homozygous
adult furinAtd204e/td204e ﬁsh, indicating that FurinA has a speciﬁc,
nonredundant function also during zebraﬁsh development.
Importantly, however, in its heterozygous form, the adult
furinAtd204e allele did not interfere with normal development but
reduced the levels of furinAmRNA. This in turn allowed the use of
adult furinAtd204e/ mutants in the experiments to assess how
furinA expression regulates host responses. Interestingly, furinA
downregulation in furinAtd204e/ mutant zebraﬁsh upregulated
pcsk1 and pcsk2 expression, which implies an attempt to compen-
sate for the reduced FurinA activity. In mammals, PCSK1 and
PCSK2 have restricted gene expression patterns, function chieﬂy
in neuroendocrine tissues, and are not able to compensate for
FURIN during development (9, 10). However, the lack of PCSK1
was recently found to associate with a proinﬂammatory pheno-
type and increased lethality in LPS-induced septic shock in mice
(48). Consequently, the elevated pcsk1 expression in zebraﬁsh
could theoretically also attenuate inﬂammation in zebraﬁsh and
thus partially mask the speciﬁc immunoregulatory function of
FurinA.
It is well established that protective immunity against TB is
mediated by both innate and adaptive immune responses. As in
mammals, the cells of the zebraﬁsh immune system include lym-
phocytes, neutrophils, and macrophages (49), as well as dendritic
cells (50), eosinophils (51, 52), human mast cell-like cells (53),
and natural killer cells (54). Our ﬂow cytometric analyses of
furinAtd204e/mutant ﬁsh kidneys (the primary site of hematopoi-
esis in ﬁsh) showed normal numbers of lymphocytes, blood cell
precursors, and erythrocytes, but low granulocyte counts, indicat-
ing that FurinA promotes granulopoiesis. Granulocyte matura-
tion is regulated through a complex network of protein mediators
(55), some of which are known substrates for PCSKs (12). For
example, granulocyte development is disrupted in mice deﬁcient
in integrin alpha 9 (56). Also, functional NOTCH signaling pro-
motes entry into granulopoiesis (57), whereas conditional inacti-
vation of TNF converting enzyme increases granulopoiesis (58).
Deciphering the detailed molecular mechanisms by which FurinA
regulates granulocyte development, however, would require the
spatiotemporal identiﬁcation of its speciﬁc substrates using pro-
teomics analyses, followed by characterizing the function of the
substrates in zebraﬁsh.
Although theTh1 type cell immune response is crucial in adap-
tive immunity against TB (5–8), other Th lymphocyte subsets,
including Th2, Th17, and Treg cells, also regulate the magnitude
of the host defense and survival (59–62). We have previously
shown that FURIN is dispensable for T cell development in mice
but that it plays a role in CD4 T cell activation and polarization
(15, 18). When we characterized the expression of Th cell subtype
transcription factors in steady-state zebraﬁsh, we found that de-
creased furinA expression associated with the upregulation of
tbx21 (a Th1 cell marker), gata3 (a Th2 cell marker), and foxp3a (a
Treg cell marker) expression, suggesting an increase in Th1, Th2,
and Treg cell counts in the furinAtd204e/mutants. These ﬁndings
are in line with the previously reported hyperproduction of both
Th1 and Th2 hallmark cytokines and increased Treg cell numbers
in FURIN T cell cKO mice (18) but also indicate that reduced
FURIN expression (and not only the lack of it) can accelerate Th1
and Th2 responses. In contrast, aging furinAtd204e/ mutants did
not develop overt autoimmunity, which demonstrates that the
residual furinA expression, accompanied with elevated tgfb1a
mRNA levels, is sufﬁcient for maintaining adequate peripheral
immune tolerance in steady state.
To assess how granulopenia and altered Th subtype gene ex-
pressions in furinAtd204e/ mutants might contribute to the host
defense against mycobacteria, adult zebraﬁsh were infected i.p.
with M. marinum inoculates. furinAtd204e/ mutants exhibited
similar gross survival, and statistically signiﬁcant differences could
not be observed. In contrast, inhibiting furin genes during devel-
opment associated with signiﬁcantly reduced survival of M. mari-
num-infected embryos. Albeit these ﬁndings could be indicative of
either immunodeﬁciency or an unnecessarily strong host re-
sponse in the lack of Furin, they need to be interpreted cautiously.
The expression of furinA is critical for zebraﬁsh development, and
survival differences in furinAB morphant ﬁsh could simply re-
sult from “failure to thrive.” Therefore, we chose to use adult
furinAtd204e/ ﬁsh to address how furinA regulates the innate im-
mune responses in M. marinum infection (30). After a high-dose
mycobacterial infection, lower furinAmRNA expression levels re-
sulted in a proinﬂammatory phenotype characterized by en-
hanced early expression of tnfa, lta, and il17a/f3 but declining
expression levels of the anti-inﬂammatory cytokine genes il10 and
tgfb1a. Previously, TNF and IL-17 have been linked to a protective,
innate immunity against TB (61, 63), and an LTA polymorphism
has been associatedwith susceptibility to the disease (64). The role
of Tnfa appears, however, complicated; Roca and Ramakrishnan
recently showed that either deﬁcient or excess production of this
cytokine accelerates TB pathogenesis through reduced microbici-
dal activity of macrophages or programmed necrosis of macro-
phages, respectively (65). Since furinA downregulation causes a
proinﬂammatory phenotype, FurinA deﬁciency could be beneﬁ-
cial for protection by increasing the early microbicidal activity of
innate cells through upregulated Tnfa levels. In addition, both
furinAtd204e/mutants and controls showed well-organized gran-
ulomas and no free bacteria in Ziehl-Neelsen staining, which sug-
gests relatively normal macrophage function also in controlling
the high bacterial loads in the chronic phase.
We have previously shown that infecting zebraﬁsh with a low
M. marinum dose (35 CFU) results in a nonprogressive myco-
bacterial disease that can be reactivated by gamma irradiation
(25). In this model, the host survival and the latent state of infec-
tion both depend on functional adaptive immune responses and
normal lymphocyte numbers. The determination of themycobac-
terial burden in latency revealed that reduced furinA expression
associated with signiﬁcantly decreased M. marinum copy num-
bers, and this could not be explained by elevated T cell responses.
Speciﬁcally, we noticed that furinAtd204e/ mutant ﬁsh actually
expressed lower levels of the general T cell marker gene cd247
(cd3zeta) and that the overexpression of Th1/2, as well as Treg
marker genes in steady-statemutants, was completely abolished in
the chronically infected furinAtd204e/ zebraﬁsh. How furinA
downregulation affects these responses is not clear but would re-
quire a careful kinetic analysis of marker gene expression levels. In
summary, we can conclude that a reduction in systemic furinA
expression associates with enhanced host responses to mycobac-
teria in zebraﬁsh.
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A challenge in TB diagnostics is to speciﬁcally identify the ac-
tivation of latent infection. The present means, such as the tuber-
culin skin test, the interferon gamma release assay (IGRA), and a
chest X-ray, can only reveal the presence of TB-associated mem-
ory cells and tissue damage, but there are no markers available for
the detection ofmycobacterial growth in the host in the clinic.Our
data show that furinA/FURIN expression is upregulated in the
host in response to a mycobacterial infection and the Th1 hall-
mark cytokine IL-12 (15). FURIN is also secreted from macro-
phages in response to LPS activation (14), and it can be measured
from serum (66). Therefore, in the future it will be interesting to
assess whether serum FURIN levels can be used as an infection
biomarker to mirror mycobacterial growth and the activation of
Th1 type immune responses. Furthermore, PCSK inhibitors have
relatively recently been suggested as drugs for cancer and infec-
tious diseases (9, 10, 67). Blocking FURIN also associates with
accelerated immune responses, as shown by the spontaneous de-
velopment of autoimmunity in T cell-speciﬁc FURIN cKO mice
andby the prevention of experimental arthritis upon recombinant
FURINadministration (18, 19).Our results here demonstrate that
diminished furinA expression reduces mycobacterial loads in a
latent infection model, which suggests that PCSK inhibitors could
potentially be used to harness also TB. Adverse effects, such as
autoimmunity and developmental defects in stem cells, may pose
a signiﬁcant clinical problem. Investigating the molecular mech-
anisms by which FURIN regulates mycobacterial immunity fur-
ther may help us ﬁnd speciﬁc target molecules for future drug
development.
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Supplemental Table 1. Primers used in the qRT-PCR analyses. 
F  CCAAAGAGGCTTTCCAACGC
R  CGTACTGCTGCTGATGGACAG
F  CGGGAAAAGGAGTGGTCAT
R  GGTGGAGTCGTATCTGGG
F  CGGATCTGTATGGAAACTGC
R  GCCGGACTGTATTTTATGAAT
F  CCAAGGCATCTACATCAACAC
R  ACACCTCTGTGCTGGAAA
F  GGAGTTTCAATGACCCCAA
R  ACCACAACTCCTTTCCCA
F  TGTTCCTCGACCCTTACCAC
R  ATCTCGCCATGTCAGGAAAG
F  AGAGTGTTGGACGGG
R  TGCCTAATGGATGCGGT
F  CATCACCGGCTTCTTTGTGC
R  CCCCAGTTTATCAATGGCCTGA
F  GGCCTACCAGAATGCAGACA
R  GGTGCGTACAGCGTGTCATA
F  GGATGGCACCGGTCACTATT
R  CAGCAGACAGCCTCCGTTT
F  CAAAAGCAGAGTGCCAGTGG
R  CGCATAAGCACCGATTCTGC
F  GAAGGCTGCAAGGGCTTCTT
R  TGCAGTTCCTCTGCCTTGAG
F  GGGCAATCAACAAGATGGAAG
R  GCAGCTGATGTGCAAAGACAC
F  TGGACTTCGCAGCACAAAATG
R  GTTCACTTCACGCTCTTGGATG
F  CCACAGTTCAGCAGGACCTC
R  TTTCCTGCGTGCTCTCATGTC
F  AAATGGTGCTACTCTGTGGAC
R  TTCCAACCCAATCCTTTG
F  TCAGACGAGCACACAGATATG
R  GATGGCTGGAGTAGTCGTG
F  GGCTCTCACGGGTTTTCAG
R  ACACTTCTTCACACCAGAACATC
F  GCTCTGCTCACGCTTCTTC
R  TGGTTCCAAGTCATCGTTG
F  TCGTCTTCCAGCAAGCTCAG
R  TTGGAGACAAAGCGAGTTCC
F  CTGGAGGCCAGCTCAAACAT
R  ATCAAGAAGAGTAGTACCGCTAGCATTAC
F  CACCACGAGAAACACTCCAA
R  ACATCCCGAAACCAACAGAG
Zebrafish gene names and qRT-PCR primer sequences are listed accompanied with the ZFIN identification codes and the names of the 
orthologous genes in humans. HGNC, HUGO Gene Nomenclature Committee.
Human gene 
ortholog (HGNC)
Sequence 5´-3´ ReferenceGene ZFIN ID
pcsk2 ZDB-GENE-090608-1
furinA ZDB-GENE-040901-1
tbx21 (T-bet) ZDB-GENE-080104-3
rorca ZDB-GENE-990415-250
lta ZDB-GENE-050601-3
pcsk5b ZDB-GENE-070822-7
GATA3
Hammarén et al. 2014
foxp3a ZDB-GENE-061116-2 FOXP3
Hammarén et al. 2014
FURIN
-
cd247 (cd3zeta) ZDB-GENE-061130-4 CD247
Hammarén et al. 2014
PCSK2
Turpeinen et al. 2013
furinB ZDB-GENE-040901-2 FURIN
Turpeinen et al. 2013
LTA
-
ifng1-1 ZDB-GENE-060210-1 IFNG
Oksanen et al. 2013
pcsk5a ZDB-GENE-060531-130 PCSK5
Turpeinen et al. 2013
RORC
-
tnfa ZDB-GENE-050317-1 TNF
Parikka et al. 2012
il1b ZDB-GENE-040702-2 IL1B
Parikka et al. 2012
TBX21
Hammarén et al. 2014
gata3 ZDB-GENE-990415-82
ZDB-GENE-041001-192 IL17A and IL17F
-
il10 ZDB-GENE-051111-1 IL10
-
tgfb1a ZDB-GENE-030618-1 TGFB1
-
-
eef1a1l1  (ef1a)
pcsk1
Turpeinen et al. 2013
Tang et al. 2007
PCSK1
EEF1A1
ZDB-GENE-071009-1
ZDB-GENE-990415-52
PCSK5
Turpeinen et al. 2013
pcsk7 ZDB-GENE-030131-7293 PCSK7
Turpeinen et al. 2013
mmits -
Parikka et al. 2012
il22 (ifnphi6 ) ZDB-GENE-060209-3 IL22
-
il17a/f3
F8/R9 F8/R10 F8/R9
500 bp
400 bp
250 bp
300 bp
WT furinAtd204e/+
100 bp
50 bp
155 bp
200 bp
150 bp
277 bp
64 bp
(Exon9 missing)
B
F8/R10
A
Supplemental Figure 1. furinAtd204e mutation disrupts the transcription of exon 9.
(A) A schematic presentation of the FURIN/FurinA domain structure and the catalytic amino acid 
residues (Asp153, His194, Asn295 and Ser 368), as well as the location of exon 9. (B) cDNA from both 
WT and  furinAtd204e/+ mutant zebrafish was used as a template in a standard PCR reaction with different 
primer pairs (F8=Forward primer in exon 8, R9=Reverse primer in exon 9, R10=Reverse primer in exon 
10). PCR products were analyzed with agarose gel electrophoresis, which demonstrates the presence of 
a 64 bp band only in reactions containing cDNA from furinAtd204e/+ mutants. The bands were excised and 
further verified by DNA sequencing (Data not shown).
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Supplemental Figure 2. Comparison of the T cell marker gene expression and the innate cytokine 
response in furinAtd204e/+ mutants and WT controls in an experimental low-dose mycobacterial 
infection at 4 wpi.  
A latent mycobacterial infection was induced with a low-dose M. marinum inoculate. Relative expression 
of (A) Th  cell  marker  genes  (cd247, tbx21, gata3, foxp3a, rorca)  as  well  as  (B) pro-inflammatory 
cytokine genes (tnfa, il1b, lta, ifng1-1, il17a/f3) and anti-inflammatory cytokine genes (il10, tgfb1a) was 
determined in furinAtd204e/+ (n=13-14) and WT (n=16-18) zebrafish with qRT-PCR at 4 wpi. Gene 
expressions were normalized to eef1a1l1 expression and represented as a scatter dot plot and median. A 
two-tailed Mann-Whitney was used in the statistical comparison of differences.
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Supplemental Figure 3. Comparison of the innate cytokine response in furinAtd204e/+ mutants and 
WT controls in an experimental low-dose mycobacterial infection at 9 wpi.  
A latent mycobacterial infection was induced with a low-dose M. marinum inoculate. Relative expression 
of pro-inflammatory cytokine genes (tnfa, il1b, lta, ifng1-1, il17a/f3) and anti-inflammatory cytokine 
genes (il10, tgfb1a) was determined in furinAtd204e/+ (n=18-21) and WT (n=16-18) zebrafish with qRT-
PCR at 9 wpi. Gene expressions were normalized to eef1a1l1 expression and represented as a scatter dot 
plot and median. A two-tailed Mann-Whitney was used in the statistical comparison of differences. 
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Abstract
Carbonic anhydrase related proteins (CARPs) X and XI are highly conserved across spe-
cies and are predominantly expressed in neural tissues. The biological role of these pro-
teins is still an enigma. Ray-finned fish have lost the CA11 gene, but instead possess two
co-orthologs of CA10. We analyzed the expression pattern of zebrafish ca10a and ca10b
genes during embryonic development and in different adult tissues, and studied 61 CARP
X/XI-like sequences to evaluate their phylogenetic relationship. Sequence analysis of zeb-
rafish ca10a and ca10b reveals strongly predicted signal peptides, N-glycosylation sites,
and a potential disulfide, all of which are conserved, suggesting that all of CARP X and XI
are secretory proteins and potentially dimeric. RT-qPCR showed that zebrafish ca10a and
ca10b genes are expressed in the brain and several other tissues throughout the develop-
ment of zebrafish. Antisense morpholino mediated knockdown of ca10a and ca10b showed
developmental delay with a high rate of mortality in larvae. Zebrafish morphants showed
curved body, pericardial edema, and abnormalities in the head and eye, and there was
increased apoptotic cell death in the brain region. Swim pattern showed abnormal move-
ment in morphant zebrafish larvae compared to the wild type larvae. The developmental
phenotypes of the ca10a and ca10bmorphants were confirmed by inactivating these genes
with the CRISPR/Cas9 system. In conclusion, we introduce a novel zebrafish model to
investigate the mechanisms of CARP Xa and CARP Xb functions. Our data indicate that
CARP Xa and CARP Xb have important roles in zebrafish development and suppression of
ca10a and ca10b expression in zebrafish larvae leads to a movement disorder.
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Introduction
The α-carbonic anhydrases (α-CA) are zinc-containing metalloenzymes that catalyze the
reversible hydration of carbon dioxide (CO2 + H2O$HCO3- + H+) [1–3]. In vertebrates
there are 17 members in the α-CA gene family (CA1-17) which includes 14 catalytically active
(CA I, II, III, IV, V, VI, VII, IX, XII, XIII, XIV, XV, XVI, XVII) and 3 inactive (CARP VIII, X,
XI) forms [4]. The catalytic inactivity of CARP VIII, X, and XI is due to the lack of one, or
more, of the three zinc atom binding histidine residues, which are essential for the classical cat-
alytic activity of CAs [5]. Genes, which code for enzymatically inactive α-CAs, are found in
seemingly all metazoan genomes, often in multiple copies. In previous studies of invertebrate
CAs, two CA10-like genes have been detected in insect genomes [6–8], exemplified by
CG32698 and CG1402 in Drosophila melanogaster, and two of the six α-CAs in the Caenorhab-
ditis elegans genome (cah-1 and cah-2) code for CARP X-like proteins. The CA10-like genes in
invertebrates are more similar to their vertebrate homologs than are any enzymatically active
CA genes compared to their vertebrate homologs [7,8].
The expression of CA10 and CA11genes and their protein products has been analyzed in
fetal and adult brain in humans, in developing mouse embryos, and in adult mouse tissues [9–
12]. In humans the expression of CA10 and CA11 has been seen ubiquitously in the central ner-
vous system (CNS), while weak, but significant, signals of the expression were seen in the fetal
brain [9]. Similarly, expression studies at the mRNA and protein level showed that the proteins
are expressed in all parts of the brain in the adult mouse [6,11]. Developmental expression pro-
filing of Ca10 and Ca11 in the brain of mouse embryos showed that Ca10mRNA appeared in
the middle phase of the gestation, whereas Ca11mRNA was seen during early gestational
period [11]. In addition, recent studies show that CA10 is highly expressed in the pineal gland
during the nighttime, compared with the daytime, suggesting its involvement in sleep-wake
patterns of humans [13].
Previous studies have shown that CARP X and CARP XI play a role in several human dis-
eases such as certain tumors and neurological conditions. For example, human CA10 sequence
contains seven CCG repeats in the 5’-untranslated region followed by two CCG repeats 16 bp
downstream of the sequence. The expansion of these trinucleotide repeats lead to various neu-
ropsychiatric diseases in humans [14]. In addition, CARP XI is overexpressed in the gastroin-
testinal stromal tumors (GISTs), promoting their proliferation and invasion [15]. Finally, three
recent expression analyses of CA11 in transgenic mice with Machado-Joseph disease (MJD), a
human patient with Spinocerebellar ataxia type 3 (SCA3), and in cultured neuronal cells pro-
ducing mutant Ataxin 3 showed an upregulation of CARP XI, suggesting a role for the CA11
gene in the development of ataxia in humans and mice [16].
The zebrafish has recently emerged as an attractive model organism for studying vertebrate
development, as it uniquely combines the advantages of genetic tractability with biologic rele-
vance [17]. Our previous studies showed that there is no CA11 ortholog in ray-finned fish spe-
cies, however the CA10 gene has been duplicated, resulting in genes ca10a and ca10b [6].
Recently, we have developed an ataxic zebrafish model lacking the ca8 gene product [18]. The
phenotype of these zebrafish resembles that which is observed in human patients with a muta-
tion in the CA8 gene [18–20]. Our ultimate aim is to find the mechanisms of action and precise
physiological roles of CA10-like genes, and their protein products, in the brain, especially dur-
ing embryonic development.
The physiological roles of CARP X and CARP XI have been largely unknown. Furthermore,
there have been no systematic studies on the expression pattern of CA10 and CA11 genes dur-
ing embryonic development. Similarly, genetically modified model organisms have not been
available to evaluate the function of CA10 and CA11 genes. To extend our understanding on
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the function of the CARP family, we investigated the expression pattern of ca10a and ca10b
genes during embryonic development in zebrafish. In addition, we studied the developmental
roles of CARP X and CARP XI by silencing the ca10a and ca10b genes in zebrafish larvae.
Materials and Methods
Sequence analysis
Using an automated pipeline, a total of 83 CA10 and 54 CA11 protein sequences, and their cor-
responding coding regions, were retrieved from vertebrate genomes in the Ensembl database v.
74 and analyzed for completeness. Of these sequences, 46 were identified as complete and cor-
rect, and predictions using the Exonerate software package [21] were performed for the
remaining incomplete sequences. As a result a total of 16 sequences were manually improved
to completeness using the exonerate program. For each analysis, homologous sequences were
used as queries to model the gene intron/exon boundaries with full genomes as the search
space. Because no bird sequences for CA11 were found, we performed full-genome scans with
Exonerate on all available bird genomes in Ensembl v. 74 (Ficedula albicollis, Gallus gallus,
Meleagris gallopavo, and Taeniopygia guttata) and one preliminary, unannotated Ensembl
genome (Anas platyrhynchos). After seeing that the genome of the lamprey in Ensembl (Petro-
myzon marinus) only yielded short sequence fragments of CA10, we retrieved the genome of
Japanese lamprey (Lethenteron japonicum) from the Institute of Molecular and Cell Biology at
ASTAR, Singapore (http://jlampreygenome.imcb.a-star.edu.sg/) and performed a full-genome
scan to find complete CA10-like genes of a jawless vertebrate. Because of the unique position of
the jawless vertebrates in evolution, the two nearly complete L. japonicum CA10-like sequences
were also included in further analyses, even though they lack initiation ATG/Met and are
slightly shorter than the other sequences. Hence, a total of 57 vertebrate sequences were
retrieved for analyses. For comparison purposes, we used two D.melanogaster CARPs and the
cah-2 of C. elegans directly from the Ensembl and NCBI databases (CARP-A, CG1402:
Ensembl FBGN0029962; CARP-B, CG32698: Ensembl FBGN0052698; cah-2: RefSeq
NP_495567.3), whereas the existing predicted gene model coding for cah-1 of C. elegans was
revised with the help of Exonerate and support from a fragment sequence FM247165. The full
list of sequence names, as they appear in the phylogenetic tree, and their database codes are
presented in S1 Table. All multiple sequence alignments were performed with Clustal Omega
[22]. To calculate amino acid identity percentages, the number of conserved amino acid resi-
dues in each aligned sequence pair was divided by the length of the shorter sequence.
SignalP 4.1 [23] and TargetP 1.1. [24] were used to predict N-terminal secretion signal pep-
tides in the protein sequences (http://www.cbs.dtu.dk/services/). The default cutoff values were
used in SignalP (chosen to optimize performance), and predefined cutoffs for specificity>0.95
were used in TargetP. C-terminal glycosylphoshpatidylinositol anchor attachment sites were
predicted in the Pred-GPI server [25] (http://gpcr.biocomp.unibo.it/predgpi/) with the general
model and taking “Highly probable” and “Probable” predictions (99.5% specificity cutoff) as
positive. Potential N-glycosylation sites were identified by the sequence motif (N—not P—S/T
—not P).
Phylogenetics
For phylogenetic analysis, the 57 vertebrate CARP X/XI and Drosophila CARP-B (CG32698)
protein sequences were aligned with Clustal Omega. The protein alignment was used as guide in
generation of a codon-based coding DNA sequence (CDS) alignment with the Pal2Nal web
server [26], with the remove gaps/internal stop codons option. MrBayes [27] was run first to esti-
mate a reliable set of model parameters. To produce our final tree, MrBayes was run for 50,000
Abnormal Movement in Morphant Zebrafish
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generations utilizing the GTR+I (+G) model, with all other parameters as optimized byMrBayes.
A 50%majority rule consensus tree was created, rooted by Archaeopteryx [28], with the Dro-
sophila sequence as an outgroup. Final trees were drawn aided by the R package Ape [29].
Protein model
Preliminary protein models of human CARP X were constructed using the I-TASSER server
[30,31] at http://zhanglab.ccmb.med.umich.edu/I-TASSER/ by submitting the sequence of resi-
dues 22–328. UCSF Chimera 1.8.1 [32] was used for creating model visualizations.
Zebrafish maintenance and ethics statement
Wild-type zebrafish of the AB and TL strain were maintained at 28.5°C as described previously
[33]. The larvae were grown at +28.5°C in embryonic medium (5 mMNaCl, 0.17 mM KCl,
0.33 mM CaCl2, 0.33 mMMgSO4, and 10–15%Methylene Blue (Sigma-Aldrich)). All the
experiments using zebrafish were performed according to the Provincial Government of West-
ern Finland, Province Social and Health Department Tampere Regional Service Unit protocol
# LSLH-2007-7254/Ym-23. The care was taken to ameliorate suffering by euthanizing the zeb-
rafish by prolonged immersion in a petridish containing 0.04% tricaine (Sigma-Aldrich).
Isolation of total RNA and synthesis of cDNA
Total RNA was isolated from whole larvae at different stages of development during 0–168 hpf
(0–7 dpf) and from specific organs of the adult zebrafish using the RNeasy mini RNA extrac-
tion kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The concen-
tration and purity of total RNA were determined using a NanoDrop Spectrophotometer
(NanoDrop 2000, Thermo Scientific). cDNA synthesis was performed using 0.1–5 μg of total
RNA and the First Strand cDNA Synthesis kit (Applied Biosystems, Foster City, CA) with ran-
dom primers and M-MuLV reverse transcriptase according to the protocol recommended by
the manufacturer.
Cloning and sequencing of ca10a and ca10b genes
ca10a and ca10b cDNAs were amplified using the primers P1 and P2 (Table 1). The primer P2
adds restriction sites for BamHI and XhoI to the amplification products. The resulting PCR
products and pcDNA 3.1 vector were then digested with BamHI and XhoI and ligated with T4
DNA ligase (Promega). The ca10a and ca10b constructs were then transformed into One Shot
TOP10 competent cells (Invitrogen, Espoo, Finland), and the cells were spread on LB plates
containing ampicillin (2500μg/ml). The overnight colonies were screened by colony PCR for
the presence of the ca10a or ca10b insert. The pcDNA3.1 plasmid was isolated from the 3-ml
overnight culture using Plasmid Maxi Kit (QIAGEN), and sequencing of ca10a and ca10b was
carried out using P2 from the plasmid DNA. The sequences were aligned with ClustalW and
compared with cDNA obtained from Ensembl database (Transcript IDs ca10a and ca10b are
ENSDART00000074540 and, ENSDART00000055264 respectively).
Quantitative analysis of ca10a and ca10b genes
Real time quantitative PCR (RT-qPCR) primers were designed based on the complete cDNA
sequences taken from Ensembl (Transcript IDs as above: using the program Primer Express
Software v2.0 (Applied Biosystems)) (Table 1). The RT-qPCR was performed using a SYBR
Green PCRMaster Mix Kit in an ABI PRISM 7000 Detection System according to the manu-
facturer's instructions (Applied Biosystems). The PCR conditions consisted of an initial
Abnormal Movement in Morphant Zebrafish
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denaturation step at 95°C for 10 min followed by 40 cycles at 95°C for 15 sec (denaturation)
and 60°C for 1 min (elongation). The data was analyzed using the ABI PRISM 7000 SDS soft-
ware (Applied Biosystems). Each PCR reaction was performed in a total reaction volume of
15 μl containing 20ng of cDNA, 1 × Power SYBR green PCR Master Mix (Applied Biosystems,
Foster City, CA, USA), and 0.5 μM of each primer. The relative expression of the genes between
the studied samples, and internal control gene β-actin were calculated according to Pfaffl's
equation [34].
Knockdown of ca10a and ca10b genes in zebrafish larvae using
antisense morpholino oligonucleotides
To check for the possible polymorphism in genomes at the morpholino target site, we ampli-
fied the genomic target region of six adult zebrafish (Table 1) and sequenced the PCR products.
The sequenced genomic regions were analyzed for the presence of polymorphism before
designing the antisense morpholinos (MOs). Two independent MOs, translation-blocking and
splice junction blocking, were designed for the ca10a gene, while two splice site blocking MOs,
each one targeting a different exon, were designed for the ca10b gene. The MOs were designed
by Gene Tools (GeneTools LLC, Philomath, OR, USA). As a control, random control (RC)
MOs, which did not correspond to any gene in the zebrafish, and p53-MOs, which suppress
the expression of p53mRNA, were used. The control MOs were also obtained from the Gene
Tools (Table 2). 1–2 nl of antisense MOs in 0.2 M KCl, 10% phenol red and 10% Rhodamine B
(Sigma-Aldrich) was injected into the yolks of one to two-cell stage larvae.
Phenotypic analysis of morphant and control larvae
The phenotype of the morphant and control embryos (0-5dpf) was analyzed under a light
microscope. Approximately 10 to 15 ca10a and ca10bmorphant larvae were screened per set of
experiments, with a similar number of control larvae. For the imaging, the larvae were anesthe-
tized using 0.02% Tricaine in embryonic medium and embedded in 17% high molecular weight
methylcellulose in 15x30 mm transparent polypropylene Petri dish. The images were taken
using a Lumar V1.12 fluorescence stereomicroscope attached to a camera with a 1.5X lens
(Carl Zeiss MicroImaging GmbH, Göttingen, Germany). The images were analyzed with Axio-
Vision software versions 4.7 and 4.8.
Rescue of ca10a and ca10bmorphant zebrafish with mRNA injections
Capped mRNAs encoding full-length sequences of human CA10 and CA11 were used for the
rescue of ca10a and ca10bmorphant embryos. The human CA10 and CA11 clones (CA10:
IMAGE Id 5276935, CA11: IMAGE Id 3613247) were purchased from the mammalian gene
collection (MGC Geneservice Ltd, Cambridge, UK). The coding regions of CA10 and CA11
Table 2. Morpholino sequences used for knockdown of ca10a and ca10b genes.
Gene Name Name of Morpholinos Morpholino oligonucleotide sequence
ca10a MO1-Translation blocking 5’TGTCTTCATTCCAAGTCCATTGCGC3’
MO2-Splice site blocking 5’CATCTGTAAGGACAAGCAGAGGTTT3’
ca10b MO1-Splice site blocking 5’ACTGACCTGAAAAACACACCCAAAC3’
MO2-Splice site blocking 5’GACTGCATCTATGGAAATTCATTAT3’
Radom control (RC) Control MO 5’CCTCTTACCTCAGTTACAATTTATA3’
p53 p53 MO 5’ GCGCCATTGCTTTGCAAGAATTG 3’
doi:10.1371/journal.pone.0134263.t002
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were PCR amplified using the same primers and protocol described previously (Table 1). The
restriction sites were added into the PCR product using P2 primers (Table 1) and cloned into a
pcDNA3.1 (+) vector. The vector containing the inserts was linearized using KpnI and the
capped CA10 and CA11mRNA was transcribed using the mMESSAGE mMACHINE T7 Kit
(Ambion), according to the manufacturer’s instructions. For the rescue experiments, two
groups of embryos were injected with 300 μM of CA10/CA11MOs, 300 μM antisense MOs,
and 80 pg/embryo of CA10/CA11 capped mRNA.
Design and production of guide RNAs (gRNAs) for CRISPR/Cas9
mediated genome editing
Target sequences for the ca10a and the ca10b gRNAs were identified with the online based
CRISPR design tool (http://crispr.mit.edu/) and validated with the sgRNA tool of the Casellas
laboratory [35], (Retrieved 07:16, May 19, 2015 (GMT)) and BLAST analysis [36]. Initially,
three target sequences for ca10a and two for ca10b were tested (Table 3). The target sequence
for egfp gRNA was adopted from Jao et al. [37] and gRNAs were produced mostly as described
previously [38]. In brief, gRNA oligo (Sigma-Aldrich) and T7 promoter site oligo (Sigma-
Aldrich) were annealed and transcribed in vitro using the MEGAshortscript T7 Transcription
Kit (Ambion Life Technologies, CA, USA). The integrity and size of the produced gRNAs was
checked with a 1% agarose Tris-acetate-EDTA (TAE) gel electrophoresis. However, the gRNA
design template was slightly modified with two additional guanine nucleotides in the 3´ end of
the T7-promoter site (S1 Fig).
gRNA and cas9mRNAmicroinjection and genomic DNA extraction
The gRNAs and the cas9mRNA (Invitrogen, Life Technologies) were co-injected into one-cell
stage zebrafish embryos with a micro injector (PV830 Pneumatic PicoPump, World Precision
Instruments) under a Nikon microscope (SMZ645). The embryos were aligned on 1.2% aga-
rose embryonic medium plates prior to the injection. For genome editing, injection solution of
1 nl contained 270 pg gRNA and 330 pg cas9 mRNA in nuclease-free water. 1.5 ng of phenol
red tracer was added to the solution for visualization of the injections. The injection experi-
ments were controlled with un-injected, and gRNA-injected (a mixture of different gRNAs for
ca10a and ca10b, 1280 pg in an injection) embryos. Between 1 and 5 days post fertilization
(dpf), zebrafish embryos were visually inspected and imaged with a Lumar V12 microscope
(Zeiss, Germany). At 2 and 5 dpf, selected embryos were lysed and genomic DNA isolated
from either a single or a pool of embryos (5–10 individuals).
Table 3. Gene targets and primers for CRISPR/Cas9 mediated knockout studies.
Gene Targeted exon Targeted sequence Primer sequences
ca10a 2 TCCACCCAAAATCCATGA F GAAGCTGTTTGCCAGAAATC
R ATCCAACACCATCAAAGAAGTC
2 TACAAAGAAGTTGTTCAG F GAAGCTGTTTGCCAGAAATC
R ATCCAACACCATCAAAGAAGTC
3 ACTGAGGCTCAACACTGG F CTGCAAATCATCCCTTTGTG
R GTTCCTCGCATCAAAACACC
ca10b 1 AACGAACTCCCAAACGTG F TCCACGACTCAGCCAACAG
R GCACTGCGTTATCAGCAAAAG
3 TTGGGAAGAGACAGTCGC F CCGCTCTTCCAAACAGATC
R GTGGATGATTGACAGGGCTC
doi:10.1371/journal.pone.0134263.t003
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T7 Endonuclease mutation detection assay
Targeted loci were amplified from genomic zebrafish DNA by PCR using Maxima Hot Start
DNA polymerase (Thermo Scientific) according to manufacturer’s instructions. PCR primers
(Table 3) were designed to anneal upstream and downstream of the expected cutting site. A
previously described T7 endonuclease assay protocol with minor changes was used [35]: 1.5μg
of PCR product was annealed in a 20μl reaction of 1x NEBuffer 2 (New England Biolabs, MA,
USA) and the annealed sample was incubated with 0.5μl (6 units) of T7 endonuclease I (New
England Biolabs) for 30 minutes at 37°C. Obtained products were separated with a 2.5% aga-
rose TAE gel and the band sizes were compared to control samples.
Histochemical analysis and TUNEL assay
To study the tissue morphology of 5 dpf ca10a and ca10bmorphant larvae a histochemical
analysis was performed. Prior to the analysis the larvae were washed with PBS and fixed in 4%
paraformaldehyde (PFA) in PBS for 3 hours at room temperature and the fixed larvae were
transferred to 70% ethanol and stored at 4°C before being embedded in paraffin. The paraffin
embedded samples were sectioned into 5 μm slices for the histochemical staining.
The fixed sections were deparaffinized in xylene, rehydrated in an alcohol series and histo-
logically stained with Mayer's Hematoxylin and Eosin Y (both from Sigma-Aldrich). After
dehydration, the slides were mounted with Entellan Neu (Merck; Darmstadt, Germany), exam-
ined and photographed using a Nikon Microphot microscope (Nikon Microphot-FXA, Japan).
To detect apoptotic cell death in the ca10a and ca10bmorphants and the control larvae, a
TdT-UTP nick end labeling (TUNEL) assay was performed for the prepared slides using the
QIA39 FragEL DNA Fragmentation Detection Kit (Merck Chemicals Ltd., Nottingham United
Kingdom). Briefly, the deparaffinized sections of the larvae were incubated with the TdT
enzyme followed by incubation with anti-digoxigenin. Fluorescence staining was detected and
photographed using a Nikon Microphot microscope (Nikon Microphot-FXA, Japan).
Swim pattern analysis
In order to analyze the minute body movements of the ca10a and ca10bmorphant larvae the
swimming pattern of the morphants, uninjected, and the RCMO injected larvae were observed
under a microscope. For the analysis, 5 dpf larvae were placed on a Petri dish (5 larvae/dish)
containing embryonic medium. The larvae were allowed to settle in the dish for 2 min. The
video recording of the swim pattern was done using a Lumar V1.12 fluorescence stereomicro-
scope (Carl Zeiss MicroImaging GmbH) and AxioVision software versions 4.7 and 4.8. The
swimming pattern study of the larvae was repeated a minimum of three times. In addition to
these videos, a total of 457 5dpf zebrafish larvae from four groups (ca10amorphants, n = 127;
ca10bmorphants, n = 145; RC, n = 101; and uninjected, n = 80) were analyzed for their dis-
placement pattern and distance travelled. In this analysis, the larvae were placed on 90 mm
Petri dishes filled with embryonic medium, in groups of 13 to 22, and recorded for 2 minutes.
The movements of all the larvae were analyzed using the MtrackJ plugin [39] within the ImageJ
program [40]. Distances traveled (cm/1 min) were calculated for each fish.
Results
Zebrafish CARP Xa and CARP Xb proteins are similar to human CARP X
As a result of our revised gene prediction analysis within the CARP X/XI family, a total of 881
amino acid positions were improved, and six sequences were improved to completeness
(Table 4). The File S1 data includes all novel sequences based on our improved gene models.
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Table 4. Sequences of CARP X/XI family.
Focus sequences
Description Complete
protein
Ensembl Protein ID Ensembl Transcript ID
Homo sapiens CARP
X
x ENSP00000405388 ENST00000451037
Homo sapiens CARP
XI
x ENSP00000084798 ENST00000084798
Danio rerio CARP Xa x ENSDARP00000069028 ENSDART00000074540
Danio rerio CARP Xb x ENSDARP00000055263 ENSDART00000055264
Novel and improved sequences
Description Complete
protein
Previous Ensembl Changes
Anas platyrhynchos
CARP X
x ENSAPLP00000003254 Added 75 amino acids in the ﬁrst 3
exons.
Astyanax mexicanus
CARP Xa
x ENSAMXP00000005715 Replaced 8 amino acids in the 9th
exon.
Astyanax mexicanus
CARP Xb
x ENSAMXP00000001335 Added 31 amino acids in the 5th
exon.
Choloepus hoffmanni
CARP X
x ENSCHOP00000007972 Added 14 amino acids in the 5th
exon.
Dasypus
novemcinctus CARP
XI
x ENSDNOP00000030322 Replaced 64 amino acids in 1st and
2nd exons.
Dipodomys ordii
CARP X
x ENSDORP00000010999 Added 22 residues in the 1st exon.
Dipodomys ordii
CARP XI
x ENSDORP00000009964 Replaced 68 amino acids in 6th and
7th exons.
Ficedula albicollis
CARP X
x ENSFALP00000002897 Replaced 15 amino acids in the 4th
exon.
Gadus morhua CARP
Xb
x ENSGMOP00000009825 Replaced 25 amino acids in the 6th
exon.
Lethenteron
japonicum CARP-A
x Novel Our novel gene model.
Lethenteron
japonicum CARP-B
x Novel Our novel gene model.
Loxodonta africana
CARP X
x ENSLAFP00000013325 Added 7 amino acids in the 9th exon.
Macropus eugenii
CARP X
x ENSMEUP00000011719 Added 1 amino acid in the 1st exon.
Microcebus murinus
CARP X
x ENSMICP00000008888 Replaced 2 amino acids in the 6th
exon.
Otolemur garnettii
CARP X
x ENSOGAP00000004458 Replaced 25 amino acids in the 1st
exon.
Pteropus vampyrus
CARP X
x ENSPVAP00000013111 Replaced 25 amino acids in the 1st
exon.
Sarcophilus harrisii
CARP X
x ENSSHAP00000012943 Added 105 amino acids in the 4th,
5th, and 6th exons.
Tursiops truncatus
CARP X
x ENSTTRP00000001587 Replaced 26 amino acids in the 1st
exon.
doi:10.1371/journal.pone.0134263.t004
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Zebrafish and other ray-finned fishes have two CA10 orthologs, ca10a and ca10b, as
reported earlier [6]. ca10a is highly similar to mammalian CA10 (90% identity to human
CARP X at protein level), whereas ca10b is slightly more diverged, yet highly similar (75%
identity between human CARP X and zebrafish CARP Xb) (Table 5). In addition, the phyloge-
netic branching pattern (Fig 1) and the appearance of the alignment (Fig 2) clearly support the
notion that fish CARP Xa and Xb are closer to tetrapod CARP X than to CARP XI. The posi-
tion of the two CARPs of lamprey (Lethenteron) indicates that they have duplicated from a sin-
gle ancestor in the cyclostome lineage, and that the duplication to CARP X and CARP XI took
place only in the jawed vertebrates.
It is notable that most vertebrates and even many insects and nematodes have two genes
that code for CARP X-like acatalytic proteins, resulting from lineage-specific duplications.
However, in case of birds, we could not detect even fragments of genes like CA11 or ca10b, not
in database searches nor in Exonerate scans of five bird genomes. In addition to CA8, the only
gene coding for CARPs in birds is CA10, present as one copy per genome.
CARP X-like proteins have features of secretory proteins conserved
from primitive invertebrates
A signal peptide is predicted to be present in 60 of 61 CARP X-like protein sequences by Tar-
getP or in 59 of 61 sequences by SignalP. If we exclude the two lamprey sequences, which lack
initial methionine and part of the first exon, we get predicted secretion in all sequences, with
reliability classes from 1 to 3 (1 = best, 5 = worst) by TargetP and by SignalP. All tetrapod
CARP X sequences, and most fish CARP Xa/Xb sequences, show signal peptide predictions
with reliability class 1. The predicted signal peptide cleavage sites in human CARP X and XI,
and in zebrafish CARP Xa and CARP Xb coincide with the end of the sequence coded by the
first exon in each gene. No glycosyl-phosphatidylinositol anchor attachment sites were pre-
dicted for any of the sequences.
All 61 CARP protein sequences in our study possess three conserved cysteines, correspond-
ing to the positions 60, 244, and 310 in human CARP X. In addition, there is a fourth cysteine
residue (296 in human CARP X) which is conserved in CARP X in tetrapods, coelacanth (Lati-
meria), the CARPs in lamprey, and CARP Xa and Xb. However, the fourth cysteine residue is
not found in CARP XI or in the invertebrate CARP X-like proteins. In addition, there are sev-
eral non-conserved cysteines in the predicted signal peptide regions. The conserved cysteines
C60 and C223 are predicted to be within the CA domain. Their positions in the sequence align-
ment, and preliminary protein model correspond approximately to the position of the con-
served disulfide seen in the structures of CA IV, VI, IX, XII, and XIV, and in sequence
alignments of CA XV and XVII [4], but which is absent from other, intracellular CA isoforms
(Fig 3) A disulfide with a reasonable geometry could be formed easily, even though the model
displaces the first cysteine by one turn of a helix relative to the position seen in other CAs.
Table 5. Comparisons of CARP X-like proteins as identity percentages between aligned protein
sequences.
Human CARP X Human CARP XI Zebraﬁsh CARP Xa Zebraﬁsh CARP Xb
Human CARP X 100 50 90 75
Human CARP XI 100 51 47
Zebraﬁsh CARP Xa 100 76
Zebraﬁsh CARP Xb 100
doi:10.1371/journal.pone.0134263.t005
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The third conserved cysteine (C310) occurs in the C-terminal region, which is unique to
CARP X-like proteins, and for which no reliable structural template is available. The additional
semi-conserved cysteine (C296), seen in CARP X/Xa/Xb but not in CARP XI, would be located
near the C terminus of the CA domain. Again, it is noteworthy that the three conserved cyste-
ines are present even in the CARP sequences of nematodes and insects (Fig 4).
Two conserved N-glycosylation motifs are seen in CARP X-like proteins, at N116 and N168
(human CARP X numbering). These positions correspond to non-conserved surface residues,
which are not a part of a glycosylation motif (N—not P—S/T—not P) in any other human or
zebrafish CA, except for CARP X/XI/Xa/Xb. Likewise, the positions that correspond to the
adjacent S/T residues (118 and 170 in human CARP X) are conserved only in CARP X-like
proteins. There is a third glycosylation site which is unique to CARP XI sequences, and another
one which is unique to CARP X/Xa/Xb.
Fig 4 shows a sequence alignment of CARP X-like proteins of a diverse selection of verte-
brates and invertebrates, highlighting the presence of signal peptides, three conserved cysteines,
and two conserved glycosylation motifs.
Zebrafish ca10a and ca10b genes are strongly expressed in the nervous
system and in developing embryos
We used RT-qPCR to study the expression of ca10a and ca10b in adult zebrafish. Expression
analysis showed the presence of ca10a in most of the studied tissues (Fig 5A). The expression
Fig 1. Bayesian phylogenetic tree of CARP sequences. Numbers at the nodes indicate posterior
probabilities, and branch lengths are proportional to distances. A table of full details of the sequences is given
as S1 Table.
doi:10.1371/journal.pone.0134263.g001
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of ca10a was highest in the heart, eye, and brain. In addition, ca10a was expressed in fins, testis,
kidney, gills, intestine, ovary, spleen, skin, muscle, and swim bladder. Interestingly, no ca10a
expression was detected in the liver (Fig 5A).
The tissue specific expression pattern of the ca10b gene showed differences compared to
that of ca10a (Fig 5B). The highest expression of ca10b was found in the ovary, brain, and
Fig 2. Multiple sequence alignment of selected CARP X-like protein sequences.Groups of three
asterisks (***) above the sequences indicate conserved N-glycosylation motifs in all CARP X-like proteins,
and letters ‘xxx’ above the sequences indicate N-glycosylation motifs which are only found in either CARP X
or CARP XI sequences (NFS and NIT, respectively).
doi:10.1371/journal.pone.0134263.g002
Fig 3. Preliminary model of human CARP X. The model showing a disulfide bridge between conserved
cysteines C60 and C223 (marked in red).
doi:10.1371/journal.pone.0134263.g003
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swim bladder. Expression was also observed in the fins, testis, kidney, gills, intestine, spleen,
skin, heart, and eye whereas no signal for ca10b was found in the liver or muscle.
In addition, we used RT-qPCR to investigate the expression of ca10a and ca10b during the
development of 0–168 hpf (0–7 dpf) zebrafish larvae (Fig 6). Expression of both ca10a and
ca10b were highest at 96 hpf (4 hpf) and remained high thereafter. Low levels of ca10a and
ca10b expression was seen at earlier time points. The expression pattern suggests that the
ca10a gene product is required throughout embryonic development, especially after 72 hpf (3
dpf). Interestingly, ca10b mRNA was present at a very high level at 0 hpf, suggesting maternal
origin (Fig 6B) and this is also supported by the high expression in the ovary of the adult fish
(Fig 5B). The expression pattern of the ca10b gene suggests that this gene plays a role at the
beginning of development and is required throughout embryonic development in zebrafish.
Knockdown of ca10a and ca10b genes causes developmental
abnormalities in zebrafish larvae
Evolutionary conservation of CA10-like genes, their ubiquitous expression pattern in different
tissues, and high mRNA levels during embryonic development suggest a crucial role for CARP
X-like proteins in vertebrates [41]. To shed light to the biological significance of CARP X-like
proteins in embryogenesis, we silenced zebrafish ca10a and ca10b genes with MOs (Fig 7A, 7B
and 7C).
The translation-blocking antisense MO for ca10a (ca10a-MO1) targeted a sequence that
includes the ATG start codon (from -15 to +10 nucleotides, relative to ATG) and inhibits
translation of mRNA. MO2 (ca10a-MO2) targeted exon 8, resulting in expression of shorter
length ca10amRNA (Fig 7D). Both antisense MOs for the ca10b gene (ca10b-MO1 and ca10b-
MO2) resulted in truncated ca10bmRNAs as shown in Fig 7E.
The 1 dpf zebrafish larvae injected with 200 μM ca10a-MO1 showed defects in the head,
abnormal body structure, and small eyes with a delayed hatching from the chorion (Fig 8B). As
the development progressed, the abnormalities became more prominent; the larvae had long
tapering curved tails, curved body structure, pericardial edema, absence of swim bladder,
and otolith vesicles (Fig 8B). The embryos injected with ca10a-MO2 showed a less severe
phenotype compared with the ca10a-MO1 injected larvae (Fig 8D). Injection of a higher
Fig 4. Sequence alignment of human, zebrafish,C. elegans, andD.melanogaster CARP X-like
proteins.Dashed, broad boxes indicate conserved N-glycosylation sites, and solid, narrow boxes indicate
conserved cysteines. Underlining in the N-terminal regions indicates predicted signal peptides.
doi:10.1371/journal.pone.0134263.g004
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concentration (300 μM) of ca10a-MO led to a more severe phenotype compared to the lower
dose with higher mortality in the morphant larvae after 24 hpf (Fig 9 and Table 6). Further
increase in the MO concentration (above 300 μM) had lethal effect on the larvae.
The specificities of the MOs were confirmed by analyzing the lengths of ca10a and ca10b
mRNAs from the morphant embryos injected with the splice site blocking morpholinos. Anal-
ysis of ca10amRNA from 5 dpf morphant fish injected with ca10a-MO2 (designed to knock
down one exon in ca10amRNA) showed two bands on the agarose gel, one corresponding to
the wild type length mRNA and the other band corresponding to the ca10amorphant mRNA
(Fig 7D). The analysis of mRNA from 5 dpf morphant zebrafish injected with ca10b-MO1 and
ca10b-MO2 (both targeting different exons in ca10bmRNA) showed two short bands in addi-
tion to the normal length bands compared with mRNA from wild type fish (Fig 7E). The result
Fig 5. Expression levels of ca10a and ca10b genes in adult zebrafish tissues. A quantitative analysis of
ca10a and ca10b genes was made for 14 adult zebrafish tissues using RT-qPCR. A, expression of ca10a in
zebrafish tissues; B, expression of ca10b in zebrafish tissues. The values were normalized to the beta actin
control according to the Pfaffl´s equation [34]. The expression of the ca10a gene in brain and ca10b in the
ovary assigned a relative value of 1.
doi:10.1371/journal.pone.0134263.g005
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of mRNA analysis from the morphant zebrafish confirmed that the defective phenotypes
observed in the ca10a and ca10bmorphant fish were due to specific knock down effects of
these genes by antisense MOs.
The larvae injected with 200 μM of ca10b-MO1 showed severe phenotypic defects as early
as 12 hpf (data not shown). The ca10b-MO1 morphants at 1 dpf were short and the shape of
the body was abnormal. The morphant larvae were very fragile and had a high mortality rate
(Figs 8C and 9 and Table 6). They could not survive beyond 3 dpf nor did they hatch properly
from the chorion. Injection of ca10b-MO2 produced a milder phenotype compared with the
larvae injected with ca10b-MO1. The ca10b-MO2 morphant larvae showed abnormal body
structure, smaller head and eye structure, mild pericardial edema, absence of otolith sacs,
unutilized yolk sac, and curved tail (Fig 8E).
There was no significant difference between the phenotype defects and mortality rates of
larvae injected with CA-MOs alone or in combination with p53-MOs (Table 6). In addition,
the uninjected embryos and embryos injected with RC-MOs showed normal phenotypes and
Fig 6. Expression analysis of ca10a and ca10bmRNAs during embryonic development. The
expression levels of ca10a and ca10b were measured from the total mRNA isolated from the developing
larvae of 0–168 hpf. A) Expression values of ca10amRNA.B) Expression values of ca10bmRNA. The
expression values were normalized to the beta actin control according to the equation of Pfaffl [34]. The
expression of ca10a gene at 0 hpf and ca10b at 96 hpf assigned a relative value of 1.
doi:10.1371/journal.pone.0134263.g006
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similar survival rates (Fig 9 and Table 6). These results suggest that the phenotypic defects seen
in morphant embryos injected with ca10a and ca10bMOs were most likely due to knockdown
of these genes and not p53-dependent off-target effects of antisense MOs, which normally
occur in 10–20% of the MO knockdown studies [42].
We validated our results of the ca10a and ca10bMO knockdown by silencing the respective
genes with the CRISPR/Cas9 genome editing method [37,38]. To establish this method, we
first targeted egfp in a transgenic zebrafish line (fli1a:egfp) using a previously described gRNA
[37], and confirmed mutations in the target region with a T7EI assay (S2 Fig). To silence ca10a
and ca10b, we initially, we designed 3 gRNAs for the ca10a gene and 2 gRNAs for the ca10b
gene, each of which targeted different exons or different locations in the same exon (Fig 7B and
7C). We then compared the cutting efficiency for each gRNA and chose the most efficient
gRNAs (ca10a-exon 3 gRNA and ca10b-exon 1 gRNA) for both genes based on the results of
the T7EI assay (Fig 7).
Similar to the MO injected larvae, the phenotype of ca10bmutated larvae was severe with
high mortality at 1 dpf and larvae did not survive beyond 2 dpf (Fig 8H). The ca10amutated
larvae showed a less severe phenotype (Fig 8G) with a lower mortality rate at 1 dpf. Larvae
injected with only gRNA showed normal phenotypes compared to uninjected controls. With
the T7 assay, we detected a cleavage efficiency of up to 86% for ca10b and up to 97% for ca10a.
For the assay, individual mutated larvae as well as mutated larvae pooled together were ana-
lyzed (Fig 7F).
Fig 7. Silencing of ca10a and ca10b in zebrafish larvae. A) Schematic presentation of matured ca10amRNA showing the site of translational blocking with
MO1 at the translation start site (arrow).B) Schematic structure of unprocessed mRNA for ca10a with a target region (horizontal bar) for a splice site blocking
morpholino (MO2) which knocks down the exon eight. C) Schematic depiction of unprocessedmRNA for ca10b and target sites for splice site interfering
morpholinos, MO1 and MO2 (black horizontal bars) and gRNA target regions (red horizontal bars). D)Gel electrophoresis showing RT-PCR analysis of
ca10amorphant mRNA injected with MO2. E) RT-PCR gel image of ca10bmorphant zebrafish mRNA injected with MO1 and MO2 targeting different exons.
The images show the reduction in the length of the mRNAs (Lane 2 in D and Lane 3 and 4 in E) compared with wild type mRNAs of ca10a and ca10b in wild
type fish (Lane 3 in D and lane 2 E). F) The efficiency of the CRISPR/Cas9 mediated mutagenesis in zebrafish embryos was evaluated with a T7
endonuclease assay. For both ca10a and ca10b, uninjected and gRNA control fish are shown and as well as two individual embryos with a mutated target site
and a pool of 5–10 mutated embryos. Representative cleaved PCR products of the expected sizes are shown as arrow heads. Cleavage percentage was
calculated from the band intensities of each lane.
doi:10.1371/journal.pone.0134263.g007
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Fig 8. The ca10a and ca10b genes play an important role during embryonic development in zebrafish.
Left panel:Developmental images of ca10a and ca10bmorphant zebrafish injected with two different sets of
antisense MOs (MO1 and MO2) over the period of 0 hpf to 5 dpf.A) The top row images show 0 hpf embryos
and lateral views of 1–5 dpf uninjected zebrafish larvae with a normal development of organs,.B) ca10a
morphant zebrafish injected with 200 μM translational blocking antisense morpholinos (MO1). C) Images of
ca10bmorphant zebrafish.D) and E) Images of ca10a and ca10bmorphants. The images in first panel of D
and E show the 1 dpf larvae with rhodamine fluorescence throughout the larvae (indicating successful MO
injection) and second panel (D and E) shows the 5 dpf larvae with abnormal appearance. Right panel:
Developmental images of ca10a and ca10b CRISPRmutated fish and gRNA controls. F) The top row images
show 0 dpf embryos and lateral views of 1–5 dpf gRNA injected zebrafish larvae (control) with a normal
development of organs.G) ca10amutated zebrafish injected with gRNA and cas9mRNA targeted to exon 3
(target site shown in Fig 7B). H) ca10bmutated zebrafish injected with gRNA and cas9mRNA targeted to
exon 1(target site shown in Fig 7C).
doi:10.1371/journal.pone.0134263.g008
Fig 9. The percent mortality of the morphant larvae at 24 hpf. The mortality rate of ca10a and ca10bMO
injected larvae was significantly higher than that of controls (P< 0.001). Larvae injected with p53-MOs along
with ca10a or ca10b -MOs and larvae injected with ca10a or ca10b -MOs alone did not show significantly
different mortality rates.
doi:10.1371/journal.pone.0134263.g009
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The ca10a and ca10bmorphant larvae showed morphological changes
in the tissues and apoptosis in the head region
The expression pattern of ca10amRNA suggests that CARP Xa protein plays an important
role in the brain, eye, and several other tissues. CARP Xb might play some roles in reproduc-
tion and brain functions. We studied morphological changes in the larvae injected with
200 μM ca10a-MO2 and ca10b-MO2 and compared the results with wild type larvae and larvae
injected with RC-MOs. We prepared semi-thin (5–10 μm) sections of 5 dpf control larvae, lar-
vae injected with 200 μM ca10a-MO2, and larvae injected with 200 μM ca10b -MO2 and
stained them with Hematoxylin and Eosin. The morphological examination showed gross
morphological changes in the head and eye regions of ca10a and ca10bmorphant larvae
(results not shown). Similarly, there was a clear difference between the somites of control larvae
and those of the ca10a-MO and ca10b-MO injected morphant larvae.
The TUNEL assay on sections of ca10a-MO2 injected 5 dpf zebrafish larvae showed apopto-
tic cells especially in the head and eye regions (Fig 10A and 10B). Similarly, large areas of apo-
ptotic cells were observed in the head region of 5 dpf ca10b-MO2morphant zebrafish larvae
(Fig 10C) and weaker signals were seen in the tail region (Fig 10D). The TUNEL assay did not
show any signs of apoptosis in wild-type larvae or larvae injected with RC-MOs (data not
shown).
Human CA10 and CA11mRNAs partially rescue the morphant
phenotypes
To confirm the specificity of the phenotypes produced by antisense MOs, we co-injected the
ca10a and ca10bMOs with capped human mRNAs for CA10 and CA11 genes. The morphant
Table 6. Phenotypes of zebrafish larvae knocked downwith different concentrations of ca10a and
ca10b antisense morpholinos.
ca10a/ca10b-
MO2s (μM)
Normal Mild Moderate Severe Dead Total
MO 300 11 (1.8)/ 9
(1.5)
16 (2.6) /7
(1.2)
46 (7.6) /37
(6.2)
70 (11.7) /73
(12.2)
457(76.2)
/474(94.8)
600
MO 300 + p53
300
2 (0)/ 0 (0) 3 (2.0) /0
(0)
4 (9.3) /1 (0.6) 29 (19.3) /8
(5.3)
112 (74.6)
/141 (94.0)
150
MO 150 22 (4.4)/ 13
(2.6)
43 (8.6) /32
(6.4)
82 (16.4) /47
(9.4)
121 (24.2) /96
(19.2)
232 (46.4)
/312 (62.4)
500
MO 150 + p53
225
19(3.8)/ 16
(3.2)
38 (7.6) /41
(8.2)
76 (15.2) /32
(6.4)
144 (28,8)
/119 (23,8)
223 (44.6)
/292 (58.4)
500
MO 100 4 (2.6)/ 2
(1.3)
21 (14) /14
(9.3)
27 (18.0) /16
(10.6)
92(61.3) /51
(34)
56 (37.3)/ 67
(44.6)
150
MO 50 102(68)/92
(61.3)
27(18.3)/34
(22.6)
7(4.6)/5(3.4) 3 (2)/4(2.6) 11(7.3)/15(10) 150
RC MO 422 (84.4) 2 (0.4) 4 (0.8) 11 (2.2) 61 (12.4) 500
Uninjected 446 (89.2) 0 (0) 6 (1.2) 8 (1.6) 40 (8) 500
The phenotypic data was obtained from a minimum of three independent sets of morpholino injections with
a minimum of 100–200 zebraﬁsh embryos in each group. The ca10a and ca10b morphant larvae examined
for each group is shown as percentage of total number of larvae studied at 24 hpf. Random control (RC)
morpholino injections were made according to the concentration of ca10a and ca10b MO1 in each set of
experiments. Larvae injected with 50 μM concentrations of either ca10a-MO2s or ca10b-MO2s had a
phenotype similar to uninjected larvae but showed abnormal swim patterns (S1 and S2 movies).
doi:10.1371/journal.pone.0134263.t006
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fish injected with 80 pg of mRNA per embryo along with 300 μM antisense MOs showed
observable improvement in the phenotype of morphant embryos as shown in Fig 11A–11D.
The partial rescue of ca10a and ca10bmorphant embryos with the injection of gene-specific
human mRNAs also confirmed the specificity of the ca10a and ca10b antisense MOs used in
the study.
Knockdown of ca10a and ca10b leads to abnormal movement pattern in
zebrafish larvae
The expression pattern of ca10a and ca10b genes suggested that the encoded proteins play
important roles in the brain. Therefore, we hypothesized that down regulation of these genes
with antisense MOs may lead to changes in behavior or motor coordination, which can be
investigated by monitoring the swim pattern of the morphant embryos. It is obvious that the
larvae with body and tail abnormalities, induced by high concentration of ca10a and ca10b
antisense morpholinos, would show abnormal swimming behavior. To see any neurological
effect on movement pattern as a result of down regulation of these genes, we needed morphant
larvae with no obvious phenotypic defects. To test this hypothesis, we injected the larvae with
lower concentrations (100 μM) of ca10a-MO2 and ca10b-MO2. With these concentrations, the
5 dpf larvae showed normal body and tail development with no visible phenotypic defects, sim-
ilar to RC-MO injected and uninjected larvae (S1–S3 Movies). In the experiment, 4 groups
(uninjected, 100 μM ca10a-MO injected, 100 μM ca10b-MO injected, and RC injected
embryos) of larvae were analyzed for movement patterns to observe movement of the body
while swimming and traced the movement of the fish (Fig 12). Similarly, we calculated the
total distance traveled for all larvae (details in the methods). Two-sample Kolmogorov-Smir-
nov statistical analyses were performed between each of the groups to determine if they could
Fig 10. Knockdown of ca10a and ca10b genes leads to apoptosis in the morphant zebrafish.Results of
the TUNEL assay detecting apoptotic cells in 5 dpf morphant embryos.A) head region of a ca10amorphant;
B) eye region of a ca10amorphant; C) head region of a ca10bmorphant; andD) tail regions of a ca10b
morphant. (Original magnification 100X).
doi:10.1371/journal.pone.0134263.g010
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have been drawn from the same distribution, shown in Fig 13. Both knockdown groups swam
significantly smaller distances than the random control and wildtype groups. The distances of
the two knockdown groups did not differ significantly. However, fish in the ca10b group
showed a tendency towards less movement (Fig 13). The distances traveled by fish in the ran-
dom control group were smaller than those of the wildtype controls. We assume that either the
impact of the injection procedure or the MOs themselves account for this difference.
Analysis of the actual swim pattern revealed that the large majority of morphant larvae did
not show movement during the 2 minute recording. Those that did, showed slow movements
of the tail and tended to remain in the periphery of the petri dish (S2 and S3 Movies and Fig
12A and 12B). Videos obtained through microscopic viewing revealed that ca10bmorphant
larvae had difficulties in balancing the body. The 5 dpf wild type zebrafish controls showed
normal swim pattern (S1 Movie, Fig 12D).
Discussion
The carbonic anhydrase related proteins (CARPs) VIII, X, and XI belong to the α-CA family
and are highly conserved across all species, even more so than the enzymatically active CA iso-
forms [6]. The expression studies of these proteins show that CARPs are predominantly
expressed in the CNS [6,10,11,44]. Spontaneously occurring mutations in CARP VIII lead to
ataxia and mental retardation in humans and mice [19,20,45]. Recently, we described the func-
tion of CARP VIII in zebrafish by knocking the ca8 gene down using antisense MOs [18]. In
addition to aberrations in early embryonic development and brain development, the knock-
down of ca8 led to an ataxic movement pattern, confirming its role in motor coordination [46].
These findings and the exceptionally strong conservation of the CA10-like genes prompted
us to study the expression of ca10a and ca10b in zebrafish. The quantitative expression analysis
of the ca10a gene in developing larvae (0–168 hpf), using RT-qPCR, showed that ca10a is
Fig 11. Partial rescue of ca10a and ca10b zebrafishmorphants. A) The ca10amorphant (5dpf) embryos;
B) The 5 dpf zebrafish ca10amorphant embryos rescued with injection of CA10mRNA;C) The ca10b
morphant (5dpf) embryos;D) Partially rescued 5dpf embryos with CA11mRNA.
doi:10.1371/journal.pone.0134263.g011
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expressed throughout the embryonic development and presents the highest level of expression
between the period of 96 hpf (4dpf) to 168 hpf (7 dpf). The expression pattern of ca10b gene
leads us to surmise that initially this gene product is at least partially of maternal origin, with
the highest level of ca10bmRNA at 0 hpf, consistent with its highest expression in the ovaries
of adult zebrafish. The level of ca10bmRNA decreased after 0 hpf before rising again at 48 hpf
and finally achieving a very high level at 168 hpf. The expression pattern of both genes during
development suggests that these genes are required for the embryonic development.
To date, there have been no systematic studies related to the expression of CA10 and CA11
genes during the development of a vertebrate animal. There are two studies available related to
the expression analysis of CARP X and CARP XI genes during embryonic development
[10,11]. In the first study, the expression was studied using RT-PCR method at four different
stages of embryonic development in a murine model (E7, E11, E15, and 17) and it was shown
that the signal for CA10 appeared in the middle of gestation (E15) [11]. The signal for CA11
was seen at an early stage of gestation and became faint as gestation progressed. In the second
study, the expression patterns of CA10 and CA11 gene products were investigated using immu-
nohistochemistry during five different gestational periods in the human fetal brain [10]. The
signal for CA11 gene product was seen as early as the day 84 of gestation. In contrast, the gene
product for CA10 was not observed until the 121st day of gestation. The signal for CARP X was
seen on day 141 of gestation in the neural cell cortex. Both studies on developmental expression
Fig 12. Displacement patterns of the morphant and control fish. Representative displacement
trajectories of the movement pattern are shown for A) larvae injected with ca10a-MO2, B) larvae injected with
ca10b-MO2 C) larvae injected with RC-MOs and,D) wildtype (uninjected) larvae. Groups of 13 to 22 fish
were video recorded in 90mm petri dishes over a 2 minute time period. ImageJ and MtrackJ plugin were used
to track the paths of all fish [39,40].
doi:10.1371/journal.pone.0134263.g012
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suggested that CA10 appears late in the development and CA11 is required early in the gesta-
tion period, which are in complete agreement with our results and support our hypothesis that
these genes play important roles in embryonic development in vertebrates. However, there is
still a need for the systematic investigation of expression pattern of CA10 and CA11 genes in a
mammalian model, such as mouse, during embryogenesis, at both mRNA and protein levels.
In the present study, we have completed a systematic expression analysis of ca10a and
ca10b gene using RT-qPCR in a panel of 14 adult zebrafish tissues. The quantitative analysis of
these genes showed that both genes are highly expressed in the brain, confirming the pattern of
expression observed in mouse and human. Surprisingly, the zebrafish ovary showed very high
expression of the ca10b gene, which has not been reported for the genes coding for CARPs in
Fig 13. Knockdown of ca10b and ca10b genes results in abnormal movement pattern in morphant zebrafish larvae. The swim patterns of 5 dpf larvae
injected with 100 μM antisense ca10a-MO2 or ca10b-MO2 were compared to the larvae injected with RC-MO and wildtype (uninjected) controls as described
in the methods. (In addition to the swim patterns and body movement videos of 10 larvae from each group created with a Zeiss microscope for close
observation as included in the supporting information). Distances traveled by 457 fish in the four groups are presented as boxplots as created with matplotlib
[43]. The results of two sample Kolmogorov-Smirnov statistical analyses are included between bracket linked groups.
doi:10.1371/journal.pone.0134263.g013
Abnormal Movement in Morphant Zebrafish
PLOS ONE | DOI:10.1371/journal.pone.0134263 July 28, 2015 22 / 27
either human or mouse. However, integrated expression data fromMediSapiens In Silico Tran-
scriptomics (http://ist.medisapiens.com/) shows a low-level expression of human CA11 in the
ovary. Interestingly, the two CARP X-like proteins in D.melanogaster have similar expression
patterns. CARP-A is exclusively expressed in the brain, whereas CARP-B is predominantly
expressed in female reproductive tissues followed by the CNS [8]. It is of interest to note that
despite three different histories of duplication, two copies of CARP X-like proteins seem to
have adapted to similar roles in mammals, fish, and insects: one exclusively in neural tissues,
and the other additionally in ovaries and/or in early embryonic development. Neural expres-
sion is seen in C. elegans as well. Both CARP X-like genes, cah-1 and cah-2, are expressed in
several types of neurons [47]. It appears that neural expression of CA10-like genes has been
conserved since the earliest bilaterian animals [41]. Taken together with the high level of
sequence conservation, the universal and ancient history of neural expression suggests some
fundamental role for CARP X-like proteins in the brain.
Even though earlier studies have recognized the presence of a signal peptide in CARP X and
CARP XI [3,9,12], one later study [10] suggests cytoplasmic localization for CARP X and XI
based on histochemical staining, whereas another study by the same authors [11] makes no
statements of the subcellular localization. To help resolve this apparent contradiction, we also
looked for other features that only have functional significance in secreted, extracellular pro-
teins, and therefore should only be conserved in extracellular proteins: namely disulfides and
N-glycosylation motifs. We confirmed that signal peptides are indeed a universal feature in all
CARP X-like proteins in seemingly all animal species, including both CARP isoforms in fruit
fly and C. elegans. Surprisingly, we also discovered a conserved pair of cysteines in nearly the
same location where all enzymatically active extracellular CA isoforms have a disulfide, and
confirmed by protein modelling that these cysteines could form a disulfide. The presence of a
third conserved cysteine, which would be unpaired in many CARP proteins, could be a means
to form dimers. In addition, we saw two conserved N-glycosylation motifs in positions which
are highly variable in other CA isoforms. The disulfide cysteines and the two glycosylation
motifs are found in all 61 sequences of our data set, again including both CARP isoforms in
fruit fly and C. elegans. We take these three lines of evidence (conservation of signal peptides,
disulfide cysteines, and N-glycosylation motifs) as strong evidence that CARP X, XI, Xa, Xb,
and their invertebrate orthologs are all secretory proteins.
Morpholino knockdown is commonly used in zebrafish to study gene specific functions in
embryonic development [48]. However, as possible off-target effects possess a major concern,
MO experiments need to be validated carefully [49]. To rule out the possibility of off-target
effects caused by p53 induced apoptosis [50], we co-injected the ca10a and ca10bMOs with
p53-MOs. The co-injection of p53-MOs did not show any marked difference on the observed
phenotype or on the mortality of the embryos, suggesting that these effects are likely not due to
p53 activation. To exclude other off-target effects, we targeted two different sites of the ca10a
and ca10b genes with MOs and observed that silencing either ca10a or ca10b with MO1 and
MO2 resulted in a similar phenotype between these two MOs. In addition, injection of RC
MOs, with concentrations similar to ca10a and ca10bMOs, did not have any effects on the
phenotype of the zebrafish embryos, also supporting gene specific silencing of ca10a and
ca10b. We also showed that the abnormal phenotype of morphant zebrafish could be partially
rescued by co-injection of human CA10 and CA11mRNAs. Finally, we validated the results
obtained from the MO knockdown of the ca10a and ca10b genes by silencing these genes using
the CRISPR/Cas9 mediated mutagenesis. The phenotypes of the ca10a and ca10bmutated lar-
vae were similar to those observed in the ca10a and ca10bmorphants.
The members of CARP subfamily (CARP VIII, X and XI) are predominantly expressed in
the CNS in both mouse and human, and their high level of sequence conservation suggests that
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the proteins play important roles there, and missense changes at the sequence level might lead
to serious phenotypic consequences. Indeed, this was the case with CARP VIII. Deletion muta-
tions in this gene lead to ataxia and mental retardation in the mice and humans [19,20,45]. The
suppression of ca8 in zebrafish using antisense MOs led to an abnormal swim pattern and
reduction in the cerebellar volume; similar to mouse and human where ataxic gait and reduced
cerebellar volume are also present [18,51]. In the present study, we examined the behavioral
consequences of the ca10a and ca10bmorphant zebrafish larvae. The swim pattern analysis of
the larvae at 120 hpf (5 dpf) showed abnormal swim pattern compared with the embryos
injected with RC-MOs and uninjected embryos. This finding suggested that even the partial
suppression of ca10a and ca10b genes lead to abnormal motor coordination. TUNEL assay
showed neuronal cell death in the head region in the morphant fish injected with ca10a and
ca10bMOs. Interestingly, the recently published report by Hsieh et al. [16] showed that the
expression and localization of CA11 is altered in a human patient with Spinocerebellar ataxia 3,
transgenic mice with Machado Joseph Disease, and cultured neuronal cells with a defect in
ataxin 3. In fact, all the three CARP transcripts were induced in the neuronal cells with defec-
tive ataxin 3 [16]. It has also been suggested that CARP XI, similar to CARP VIII, might inter-
act with inositol 1,4,5-triphospate receptor 1 (ITPR1) and control the release of calcium from
the intracellular reserves similar to CARP VIII [16,52], but in light of the evidence that CARP
XI would be an extracellular protein, this does not seem a very likely suggestion.
Conclusions
The present work describes new data on the CARP subfamily of proteins, namely CARP Xa
and CARP Xb, in embryonic development in zebrafish. Our work gives insights into the essen-
tial roles that ca10a and ca10b genes play during the embryonic development and how the lack
of either of these proteins leads to abnormal motility, similar to zebrafish knocked down for
ca8. Sequence analysis suggests that all of CARP X, Xa, Xb, XI, and their invertebrate orthologs
are secretory proteins, contrary to previously accepted ideas; have a cysteine disulfide; and are
potentially dimeric. To our knowledge, this is the first study to reveal that down-regulation of
ca10a and ca10b genes leads to abnormal pattern of movement and also the first one to suggest
that these genes are essential for early embryonic development in vertebrates. This study also
introduces novel zebrafish models to investigate the mechanisms of CARP Xa and CARP Xb
function.
Supporting Information
S1 Data. The data file S1 includes all novel protein and coding sequences based on our
improved gene models along with known protein and coding sequences from the Ensembl
database.
(FASTA)
S1 Fig. The modified gRNA design template.
(TIF)
S2 Fig. Silencing of egfp expression in tg(fli1a:egfp) zebrafish embryos using CRISPR/Cas9
mediated mutagenesis. A) Fluorescence microscopy was used to analyze the silencing of egfp
in tg(fli1a:egfp) zebrafish embryos at 2 dpf. The un-injected control (left) and egfp gRNA
injected control (middle) express egfp (green) in the vascular endothelium. The CRISPR-Cas9
mutated embryo (right) shows less fluorescence due to the disruption of the egfp gene. The red
channel was used to detect auto-fluorescence. B) T7 endonuclease I (T7EI) assay was used to
evaluate the egfpmutation efficiency in 2-day-old embryos. T7EI treated PCR products of un-
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injected and egfp gRNA injected control fish are shown in comparison to PCR products of two
individual embryos and a pooled sample of 5 egfp silenced embryos. The full length wild type
(WT) egfp product (470bp) is marked with an asterix. Arrows indicate the T7E1 cleaved PCR
products in the egfpmutated embryos.
(TIFF)
S1 Movie. The movie shows the swim pattern of wild type 5dpf zebrafish.
(MPG)
S2 Movie. The movie shows the swim pattern of ca10amorphant 5dpf zebrafish.
(MPG)
S3 Movie. The movie shows the swim pattern of ca10bmorphant 5dpf zebrafish.
(MPG)
S1 Table. CARP X-like sequences from different species. The table shows the details of the
sequences used in the phylogenetic tree.
(XLSX)
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Supplementary figure 2. Silencing of egfp expression in tg(fli1a:egfp) zebrafish embryos using CRISPR/Cas9
mediated mutagenesis. A) Fluorescence microscopy was used to analyze the silencing of egfp in tg(fli1a:egfp)
zebrafish embryos at 2 dpf. The un-injected control (left) and egfp gRNA injected control (middle) express egfp
(green) in the vascular endothelium. The CRISPR-Cas9 mutated embryo (right) shows less fluorescence due to
the disruption of the egfp gene. The red channel was used to detect auto-fluorescence. B) T7 endonuclease I
(T7EI) assay was used to evaluate the egfp mutation efficiency in 2-day-old embryos. T7EI treated PCR products
of un-injected and egfp gRNA injected control fish are shown in comparison to PCR products of two individual
embryos and a pooled sample of 5 egfp silenced embryos. The full length wild type (WT) egfp product (470bp)
is marked with an asterix. Arrows indicate the T7E1 cleaved PCR products in the egfp mutated embryos.
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2ABSTRACT21
Tuberculosis is a multifactorial bacterial disease, which can be modeled in the zebrafish (Danio rerio).22
Abdominal cavity infection with Mycobacterium marinum, a close relative of Mycobacterium23
tuberculosis, leads to a granulomatous disease in adult zebrafish, which replicates the different phases of24
human tuberculosis, including primary infection, latency and spontaneous reactivation. Here, we have25
carried out a transcriptional analysis of zebrafish challenged with low-dose of M. marinum, and identified26
intelectin 3 (itln3) among the highly up-regulated genes. In order to clarify the in vivo significance of27
Itln3 in immunity, we created nonsense itln3 mutant zebrafish by CRISPR/Cas9 mutagenesis and28
analyzed the outcome of M. marinum infection in both zebrafish embryos and adult fish. The lack of29
functional itln3 did not affect survival or the mycobacterial burden in the zebrafish. Furthermore,30
embryonic survival was not affected when another mycobacterial challenge responsive intelectin, itln1,31
was silenced using morpholinos either in the WT or itln3 mutant fish. In addition, M. marinum infection32
in dexamethasone-treated adult zebrafish, which have lowered lymphocyte counts, resulted in similar33
bacterial burden in both WT fish and homozygous itln3 mutants. Collectively, although itln3 expression34
is induced upon M. marinum infection in zebrafish, it is dispensable for protective mycobacterial immune35
response.36
3INTRODUCTION37
Tuberculosis is an epidemic multifactorial disease caused by Mycobacterium tuberculosis1. The38
susceptibility to tuberculosis depends on the M. tuberculosis strain  and  on  a  number  of  host-related39
factors such as environmental conditions, other underlying diseases as well as genetic variation2-4.40
Critical genes of the adaptive immunity required for the mycobacterial immune response such as41
interferon gamma (IFNG)5,  6 and interleukin 12 (IL12)7,  8 were identified already in the 1980´s and42
1990´s, respectively. The importance of these genes has later been verified in human tuberculosis43
patients9 and by using experimental gene knockout mouse models of tuberculosis10-13. More recently,44
pattern recognition receptor (PRR) gene polymorphisms of Toll-like receptors (TLRs)14-16 and C-type45
lectins17, 18, have been associated with M. tuberculosis susceptibility, delineating also the central role of46
the innate immunity in controlling the mycobacterial infection.47
Lectins are carbohydrate-binding proteins important for numerous biological processes such as48
intracellular glycoprotein secretion, leukocyte trafficking and in microbial recognition19, 20.49
Consequently, lectins act as recognition molecules inside cells, on the cell surface and in extracellular50
fluids20. Intelectins (ITLNs) are a distinct family of lectins, which were first identified in Xenopus laevis2151
and were later found in a number of chordates including human, mouse and zebrafish (Danio rerio)22-25.52
Although ITLN function has been linked to a number of processes such as iron absorption26, metabolic53
disorders27 as well as cancer development28, 29, their exact biological functions are elusive. Suggesting a54
role for ITLNs in the immune response, itln gene expression is highly up-regulated upon a bacterial55
infection in fish 25, 30-32. Moreover, human ITLN1 (also known as Omentin) has been shown to bind to56
the Mycobacterium bovis Bacillus Calmette-Guérin (BCG)24, and more specifically to exocyclic 1,2-diol57
glycan epitopes that are expressed selectively on microbial surfaces33.58
4The importance of ITLNs for immunity in vivo, however, is less clear. Previously, Voehringer et59
al., (2007) used transgenic mice with lung-specific ITLN1 and ITLN2 over-expression to study the60
effects of these proteins in the mouse infection models of the parasite Nippostrongylus brasiliensis and61
the M. tuberculosis bacterium34. In these settings, the authors could not detect enhanced pathogen62
clearance in the Itln transgenic mice. In contrast, a so called “natural deletion” of the Itln2 gene has been63
previously associated with a higher susceptibility against the parasite Trichinella spiralis in a C57BL/1064
mouse strain35. Recently, an Itln1 knockout mouse strain was created to study inflammatory bone65
diseases36. In the aforementioned study, the lack of Itln1 was associated with a proinflammatory66
phenotype characterized by elevated TNF and IL6 levels in bone tissue and in serum, and was shown to67
result in osteoporosis36.68
The  genome  of  the  zebrafish  (Danio rerio) was assembled for the first time in 2002 and the69
prevalent 11th assembly (GRCz11) is an invaluable tool for research using zebrafish as a disease model37.70
Over 70% of human genes have at least one zebrafish orthologue and for this reason, the zebrafish71
immune system is highly similar compared to humans37.  In  fact,  most  of  the  human  immune  cell72
populations such as T- and B-cells 38-40, neutrophils and macrophages41, dendritic cells42 as well as the73
complement system43 and immunoglobulins44, 45, are found in the zebrafish. Importantly, zebrafish can74
be modified genetically with the clustered regularly interspaced short palindromic repeats75
(CRISPR)/CRISPR-associated 9 (Cas9) mutagenesis46, 47, which allows disease modeling using reverse76
genetics, although some genes appear difficult to target successfully48.77
A Mycobacterium marinum infection of zebrafish is nowadays a commonly used model for78
studying tuberculosis in both larvae and adult fish49, 50. Compared to several other tuberculosis models,79
the mycobacterial model of zebrafish is considered safe, cost-effective and ethical51, 52. More importantly,80
M. marinum is  closely  related  to M. tuberculosis, and the two bacterial species have comparable81
pathogenic characteristics in the natural hosts; macrophage mediated intracellular multiplication as well82
5as the formation of granuloma structures53-55. The larval model enables studying specifically the innate83
immunity56, 57, whereas the adult zebrafish model allows studying also components of the adaptive84
immune system in both an acute mycobacterial infection58 as well as during mycobacterial latency55, 59.85
In order to identify candidate genes associated with the host response against mycobacteria, we86
conducted a gene expression microarray in M. marinum infected adult zebrafish. Here, we identified a87
zebrafish ITLN orthologue itln3 among the genes that were most induced upon infection. In order to gain88
more insights into the function of ITLNs, we used CRISPR/Cas9 mutagenesis to create knockout itln389
mutant zebrafish lines, and used the zebrafish M. marinum infection model to determine the in vivo90
significance of Itln3 in a mycobacterial infection.91
6RESULTS92
Genome-wide gene expression microarray analysis of M. marinum infected adult zebrafish93
In order to identify genes involved in the host immune response against mycobacteria, we used the94
zebrafish M. marinum infection model and conducted a genome-wide gene expression analysis using the95
microarray platform. To this end, we infected wild-type (WT) AB zebrafish with M. marinum (20 CFU;96
SD  6  CFU)  and  isolated  their  organ  blocks  (includes  all  the  organs  of  the  abdominal  cavity)  for  a97
transcriptomic analysis at 14 days post infection (dpi). From a total of 43603 probes used in the analysis,98
we found 93 probes, corresponding to 70 genes, that were up-regulated and 26 probes, corresponding to99
21 genes, that were down-regulated (log2 fold change >│3│) compared to the mock-treated (PBS)100
controls (Supplementary Table 1). Further evaluation of the up-regulated probes with a GOrilla gene101
ontology (GO) enrichment analysis60, 61 revealed 22 enriched (p<0.001) processes including response to102
carbohydrates (GO:0009743), cholesterol homeostasis (GO:0042632) and antigen processing and103
presentation (GO:0019882) (Supplementary Table 2). Among the up-regulated genes we found five104
genes; si:busm1-194e12.11 (mhc2 family gene), arachidonate 5-lipoxygenase b, tandem duplicate 3105
(alox5b.3), zgc:113912 (mhc2 family gene), CD59 molecule (cd59) and si:busm1-194e12.12 (mhc2106
family gene) with well-known immunological functions in antigen processing, inflammation and in the107
regulation of the complement system, respectively (Figure 1A, Supplementary Table 1). Of the 21 down-108
regulated genes, five were associated with the immune response; CD58 molecule (cd58), myeloid-109
specific peroxidase (mpx), complement factor b-like (cfbl), immunoresponsive gene 1, like (irg1l) and110
si:busm1-266f07.1 (mhc2 family gene) (Figure 1A, Supplementary Table 1). Interestingly,111
approximately 38% of the up-regulated probes i.e. parvalbumin 1 (pvalb1), alpha-tropomyosin (tpma),112
troponin I, skeletal, fast 2b, tandem duplicate 2 (tnni2b.2) and myosin, heavy polypeptide 1.1 (myhz1.1)113
were related to muscle associated biological processes including muscle contraction (GO:0006936),114
7muscle system process (GO:0003012) and myofibril assembly (GO:0030239) (Supplementary Table 1115
and 2). The GO-analysis of the down-regulated probes also showed a significant enrichment of another116
22 processes including response to external biotic stimulus (GO: 0043207) and cholesterol biosynthetic117
process (GO:0006695) and immunological processes, such as response to other organism (GO:0051707),118
response to bacterium (GO:0009617) and the induction of bacterial agglutination (GO:0043152)119
(Supplementary Table 2).120
121
Mycobacterial infection up-regulates itln3 expression in both zebrafish embryos and adult fish122
Previous studies in several animal models have shown the expression of the Intelectin (ITLN) gene to be123
induced upon a bacterial infection25, 30, 32. Accordingly, the expression of the zebrafish itln3124
(ENSDARG00000003523) was increased on average 3.3-fold (log2 change) upon a M. marinum125
infection in our microarray analysis (Figure 1A, Supplementary Table 1). In contrast, two other itln126
genes; itln2 (ENSDARG00000036084) and itln2-like (ENSDARG00000093796) were down-regulated127
compared to the PBS controls (-3.5 and -3.2 log2 fold change, respectively) (Figure 1A, Supplementary128
Table 1), suggesting a diverse regulation of itln genes in the M. marinum infected zebrafish. Since both129
ENSDARG00000036084 and ENSDARG00000093796 share the same gene name, itln2, in Ensembl130
genome browser, ENSDARG00000093796 is referred to as itln2-like throughout the text.131
To confirm the differential expression pattern of the itln family members in the zebrafish132
mycobacterial infection and to study the kinetics of the host response more carefully, we analyzed133
itln1 (ENSDARG00000007534), itln2, itln2-like and itln3 gene expression from the abdominal cavity134
organ blocks of M. marinum infected (6 CFU; SD 3 CFU) WT e46 background adult zebrafish with135
qPCR at 1 and 6 dpi, as well as at 4 and 9 weeks post infection (wpi) (Figure 1B-E). In line with our136
microarray data, itln3 was significantly induced at 4 wpi (3.8-fold, P=0.002) and 9 wpi (5.9-fold,137
P=0.003) (Figure 1E), whereas itln2 was down-regulated compared to the PBS controls both at  6 dpi138
8(0.3-fold, P=0.019) and 4 wpi (0.2-fold, P<0.001) (Figure 1C). No significant differences in the relative139
mRNA expression levels of the itln1 (Figure 1B) or itln2-like (Figure 1D) genes were observed between140
infected and the PBS injected adult fish at any of the measured time points.141
Next, we infected WT AB zebrafish embryos with mycobacteria and performed an expression142
analysis of the itln genes by qPCR. Here, M. marinum (39 CFU; SD 47 CFU) was microinjected into the143
yolk sac of the embryos and the gene expression was quantified daily between 1 and 7 dpi (Figure 1F-I).144
In the mycobacteria infected embryos we detected the up-regulation of both itln1 (1.8 to 6.4-fold,145
P=0.008-0.016) (Figure 1F) and itln3 (1.8 to 111.4-fold, P=0.008-0.032) (Figure 1I) starting at 2 dpi and146
continuing until 7 dpi, as well as the induction of itln2 at 7 dpi (21.6-fold, P=0.008) (Figure 1G) and147
itln2-like (Figure 1H) between 4 and 7 dpi (20.7 to 76.1-fold, P=0.008-0.032) compared to the PBS148
controls. Also, in line with previous reports suggesting that other infectious diseases up-regulate ITLN149
expression, a significant induction of itln3 expression (8.4-fold at 7hpi; 11.8-fold at 18hpi; 5.5-fold at150
24hpi; 4.4-fold at 48hpi, P=0.002 in all comparisons) was observed in Streptococcus pneumoniae (T4151
serotype) infected (296 CFU; SD 32 CFU) embryos (Supplementary Figure 1).152
In order to understand the infection-inducible nature of the zebrafish itln genes at steady state, we153
quantified the relative mRNA levels of itln1, itln2, itln2-like and itln3 in the liver, spleen, kidney and154
intestine of unchallenged WT e46 zebrafish by qPCR (Figure 2A-D). Here, we found that itln2 expression155
was restricted to the intestine (Figure 2B), whereas itln3 showed the highest relative expression in the156
liver and the highest overall expression compared to the housekeeping gene (eukaryotic translation157
elongation factor 1 alpha 1, like 1; eef1a1l1) (Figure 2D). Conversely, itln1 was expressed in all of the158
studied tissues with the second highest overall expression levels (Figure 2A), while itln2-like was159
primarily expressed in the zebrafish kidney and the intestine (Figure 2C). These results are in line with a160
previous qPCR analysis of the itln gene family members in unchallenged adult zebrafish25.161
162
9Creating itln3 mutant zebrafish using CRISPR/Cas9 mutagenesis163
The type II CRISPR/Cas system is an invaluable technology for targeted genome editing62, 63, and to date164
it  has  been  utilized  in  a  number  of  model  organisms.  We  and  others  have  used  the  CRISPR/Cas9165
mutagenesis method successfully in the zebrafish46, 48, 64, 65. Here, we used the CRISPR/Cas9 method to166
create zebrafish carrying nonsense itln3 mutations for our in vivo studies (Figure 3). To this end, we167
identified a functional gRNA targeting the second exon of the itln3 gene with an average mutagenesis168
efficiency of 39.5% (Figure 3A-B). After an outcross of parental mutation carriers (F0-generation) with169
wild-type TL zebrafish, we observed two germ-line transmitted frameshift mutations in the F1-progeny170
corresponding to a total loss of five base pairs (-5 bp; loss of GCATC) and to a total gain of eight base171
pairs (+8 bp; loss of GGAGCATC and gain of TGCTAGGTAAGTATCA) at the target loci (Figure 3C).172
Analyses with the Translate tool (Expasy; SIB, Swiss Institute of Bioinformatics)66 of both the -5 bp and173
+8 bp mutations confirmed the disrupted reading frames from amino acids 47 and 45 onwards resulting174
in premature stop-codons after 79 and 71 amino acids, respectively (Figure 3C). These two different itln3175
null mutant zebrafish lines were named itln3uta145 (-5 bp mutation) and itln3uta148 (+8 bp mutation). qPCR176
analysis of uninjected and M. marinum infected (422 CFU; SD 221 CFU, 2 wpi) adult zebrafish revealed177
diminished itln3 transcript levels in the homozygous itln3uta145/uta145 (residual expression less than 1%,178
P<0.001) and itln3uta148/uta148 mutants (residual expression less than 0.1%, P<0.001) compared to the WT179
controls (Supplementary Figure 2), suggesting that the indel-mutations lead to the nonsense-mediated180
RNA decay of the mutant mRNAs67. Furthermore, the inheritance of the mutations followed Mendelian181
ratios for both of the mutant lines, and the homozygous itln3uta145/uta145 and itln3uta148/uta148 mutants did182
not show any developmental defects nor phenotypical differences compared to their WT siblings183
(Supplementary Figure 3).184
185
186
10
Nonsense mutation in itln3 does not affect host resistance against M. marinum in zebrafish embryos187
The up-regulation of the expression of the itln3 gene in a M. marinum infection suggests a possible role188
for Itln3 in the host immunity against mycobacterial infections. To test if the resistance towards a189
mycobacterial infection is altered in homozygous itln3 mutant embryos, we first infected M. marinum190
(40 CFU; SD 30 CFU) into the yolk sac of the ungenotyped F2-progeny of heterozygous itln3uta145/+ and191
itln3uta148/+ zebrafish and followed their survival until 7 dpf (Figure 4A-B). Post-experiment genotyping192
revealed an average survival of 47% in the itln3uta145 background embryos and 48% in the embryos with193
the itln3uta148 background. However, any significant differences in the survival between the homozygous194
and heterozygous itln3 mutants or WT fish could not be observed in either itln3uta145 (Figure  4A)  or195
itln3uta148 fish lines (Figure 4B) before 7 dpi (7 dpf). Next, we quantified the mycobacterial burden in the196
embryos that had survived by qPCR using primers for M. marinum internal transcribed spacer197
(MMITS)55 (Figure 4C). The M. marinum quantification revealed bacterial copy number medians (log10)198
of 4.18 and 4.15 in 100ng of zebrafish DNA in the itln3uta145 and itln3uta145 WT groups, respectively.199
Comparably, heterozygous itln3uta145/+ and itln3uta148/+ fish had copy number medians of 4.02 and 4.22200
(in 100 ng of zebrafish DNA, log10), respectively, and the homozygous itln3uta145/uta145 and itln3uta148/uta148201
mutants 3.53 and 4.25 (in 100ng of zebrafish DNA, log10). Thus, there were no statistically significant202
differences in the mycobacterial burdens between the different genotypes in neither itln3uta145 nor203
itln3uta148 zebrafish.204
The site of the bacterial injection can affect the immune response in the embryos49. Therefore,205
we next treated the ungenotyped F2-progeny of itln3uta145/+ and itln3uta148/+ zebrafish by injecting206
M. marinum into  the  blood  circulation  valley  of  2-day-old  embryos.  In  these  fish,  the M. marinum207
infection (46 CFU; SD 31 CFU) was not able to cause any mortality prior to the experimental end-point208
of 5 dpi (7 dpf). However, this allowed us to quantify the M. marinum burden in all of the infected209
embryos at the end-point (Figure 4D). Here, the bacterial copy number medians (log10) in 100ng of210
11
zebrafish DNA were 3.61 (WT itln3uta145), 3.83 (WT itln3uta148),  3.63  (itln3uta145/+), 3.77 (itln3uta148/+),211
3.75 (itln3uta145/uta145) and 3.79 (itln3uta148/uta148). Similarly to the yolk sac infection, mycobacterial212
quantification did not reveal any differences between the individuals of the different genotypes in either213
the itln3uta145 or the itln3uta148 zebrafish background. Noteworthy, we also infected the ungenotyped F2-214
progeny of itln3uta145/+ and itln3uta148/+ zebrafish  with  S. pneumoniae (serotypes 1 and T4, blood215
circulation valley infection at 2 dpf) and followed the survival of the fish to 5 dpi68.  There  was  no216
difference between WT embryos and the itln3 mutants (Supplementary Figure 1).217
 Deleterious mutations may lead to genetic compensation, which in turn can affect the observed218
phenotype in gene knockout models69. To address this, we used a morpholino-oligonucleotide to silence219
itln1 in  our itln3 mutant zebrafish together with the yolk sac mycobacterial infection of zebrafish220
embryos. In order to ensure efficient termination of translation in all of the four zebrafish itln1221
(ENSDARG00000007534) transcripts, we targeted the second exon (E2) of the gene with a splice-222
blocking (SB) morpholino (Figure 5A). In our initial SB morpholino titration experiments, 2.8 ng of223
itln1-blocking morpholino did not reveal any adverse effects on the survival or on the phenotype of224
unchallenged  zebrafish  embryos  within  the  first  7  dpf.  However,  lower  WT itln1 mRNA levels were225
observed in the SB morphants with residual expression of 17.1% at 4 dpi, 21.8% at 5 dpi and 33.9% at 6226
dpi compared to the random control (RC) injected embryos (Figure 5B), demonstrating that this amount227
of  the  SB  morpholino  silences  the  expression  of itln1 efficiently during embryonic development. In228
addition, detectable itln1 expression levels were observed in the RC morphants already at 1 dpi, whereas229
in the SB morpholino injected embryos itln1 expression was evident later starting at 2 dpi based on qPCR230
(Figure 5B, Supplementary Figure 4). Next, we performed morpholino-M. marinum co-injections231
(20 CFU; SD 19 CFU) into the yolk sac of the un-genotyped F2-progeny of itln3uta145/+ and itln3uta148/+232
zebrafish (Figure 5C-E) and the F3-progeny of WT itln3uta148 (13 CFU; SD 10 CFU) (Figure 5C) and233
followed their survival up to 7 dpi. There were few dying embryos among uninfected embryos upon RC234
12
or itln1 morpholino injection (Supplementary Figure 4), whereas the mortality reached 77.8%-100% in235
the morpholino-M. marinum co-injected embryos. Noteworthy, the comparison between the infected RC236
and SB morpholino injected WT itln3uta145 and itln3uta148 embryos did not show any differences in survival237
(Figure 5C). Moreover, inhibiting itln1 expression in homozygous itln3uta145/uta145 and itln3uta148/uta148238
mutants lead to a similar mortality compared to the corresponding heterozygous and WT siblings of the239
same genetic background (Figure 5D-E), indicating that the simultaneous lack of itln1 and itln3240
functionality does not affect mycobacterial resistance in the zebrafish embryo. Consistently, we did not241
detect any differences in the mRNA levels of itln1, itln2 and itln2-like between the homozygous itln3242
mutants  and  the  WT  controls  either  in  uninjected  (4  dpf)  or M. marinum (25 CFU; SD 23 CFU,243
4 dpf/4 dpi) infected embryos (Supplementary Figure 5), suggesting that there is no transcriptional244
compensation by the other studied intelectin gene members in the itln3uta145/uta145 and itln3uta148/uta148245
mutant fish. Similarly, no transcriptional compensation by itln1, itln2 or itln2-like was observed in the246
adult itln3 mutant zebrafish either in steady state or upon M. marinum infection (Supplementary Figure247
2).248
249
Adult itln3 mutant zebrafish have a normal immune response towards a M. marinum infection250
In order to test the mycobacterial susceptibility of the itln3 mutants in adult zebrafish, we performed a251
low-dose (48 CFU; SD 5 CFU) mycobacterial inoculation into the abdominal cavity of the fish and252
followed their survival for up to 24 wpi (Figure 6A-B). After the follow-up, an average of 67% of the253
itln3uta145 background zebrafish had survived, corresponding to 74% of the WT, 73% of the itln3uta145/+254
and 59% of the itln3uta145/uta145 fish. In the itln3uta148 background fish, a combined survival percentage of255
81% was observed (78% in the WT, 82% in the itln3uta148/+ and 84% in the itln3uta148/uta148 fish). Similarly256
to the embryonic survival experiments, no statistically significant differences in the survival between the257
genotypes were observed.258
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We and others have previously shown that the outcome of a mycobacterial infection in adult259
zebrafish depends not only on the host genotype but also on the infection dose. While, a so called low-260
dose inoculate can result in latency and a chronic disease55, a higher dose leads to a fast progressing acute261
infection58, 70. We hypothesized that the effects caused by the lack of Itln3 could be more prominent in262
an infection with a higher mycobacterial dose. Consequently, we infected WT fish as well as263
heterozygous and homozygous itln3 mutants from both the itln3uta145 and itln3uta148 backgrounds with a264
higher M. marinum dose (422 CFU; SD 221 CFU) and quantified the bacterial burden at 2 and 4 wpi265
(Figure 5C-D). In these fish, we detected M. marinum copy number medians (log10) of 4.19 (WT266
itln3uta145),  3.76  (itln3uta145/+),  4.16  (itln3uta145/uta145), 3.69 (WT itln3uta148),  3.73  (itln3uta148/+) and 3.92267
(itln3uta148/uta148) in 100 ng of zebrafish DNA at 2 wpi and 4.72 (WT itln3uta145), 4.36 (itln3uta145/+), 4.60268
(itln3uta145/uta145), 4.10 (itln3uta148/+) and 3.72 (itln3uta148/uta148)  at 4 wpi. Noteworthy, no WT itln3uta148 fish269
were available at 4wpi for a bacterial quantification. Altogether, these data indicate that the loss of Itln3270
function is dispensable for the host resistance against abdominal cavity M. marinum infection in adult271
zebrafish.272
273
Dexamethasone mediated lymphocyte depletion in itln3 knockout zebrafish does not affect the274
survival or mycobacterial burden in a M. marinum infection275
We have recently published a zebrafish immune-suppression model for mycobacterial reactivation using276
orally administered dexamethasone59. The dexamethasone treatment decreases the total amount of277
lymphocytes by an average of 36% (from a relative proportion of 19.3% to 12.4%), and consequently278
leads to reactivation of the M. marinum infection. In turn, a number of studies have suggested that Itln3279
functions in microbial surveillance and therefore in the innate immunity23, 24, 33. In order to highlight the280
importance of innate immune mechanisms in the mycobacterial defense, we used the dexamethasone281
treatment to specifically deplete the lymphocyte population in the adult itln3 mutation carrying zebrafish282
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lines itln3uta145 and itln3uta148, and subsequently infected both WT and homozygous itln3 mutants with283
M. marinum (47 CFU; SD 4 CFU) (Figure 7A). Expectedly, our flow cytometric analysis demonstrated284
a significant decrease in the lymphocyte counts of both WT itln3uta145 and itln3uta148 fish (31.5 %, P=0.002285
and 23.7%, P=0.010, respectively) as well as the itln3uta145/uta145 and itln3uta148/uta148 mutants (31.5 % and286
40.5 %, P<0.001 in both comparisons) three weeks after initiating the dexamethasone administration at287
2 wpi (Figure 7B-D). In addition, neither the total cell count nor the amount of myeloid cells and blood288
cell precursors were affected by dexamethasone (Supplementary Figure 6). We did not detect any289
substantial mortality of either the itln3uta145 or the itln3uta148 mutants or WT fish during the five-week290
follow-up period. As is shown in the Figure 7D-E, the bacterial amounts did not differ between the291
groups; in 100ng of zebrafish DNA, mycobacterial copy number medians (log10) of 2.60 and 2.65 in292
WT itln3uta145, 2.55 and 3.10 in itln3uta145/uta145, 2.87 and 2.43 in WT itln3uta148 and 2.25 and 2.91 in293
itln3uta148/uta148 zebrafish were observed at 2 and 4 wpi, respectively.294
In conclusion, our data are in accordance with previous literature on the possible role for itlns in295
immunity, as the zebrafish itln3 is highly induced in a mycobacterial infection. However, M. marinum296
infection experiments using both zebrafish embryos and adult fish suggest that itln3 is dispensable for a297
protective mycobacterial host response. Moreover, itln1 does not seem to compensate for the lack of298
functional itln3 in the embryonic infection model. Of note, unlike has been reported for human ITLN1,299
we were unable to demonstrate direct binding of recombinant Itln3 to mycobacteria (or S. pneumoniae300
or Escherichia coli) in vitro (Supplementary Figure 7), which may explain the nonessential role of Itln3301
for zebrafish immunity in our models.302
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DISCUSSION303
The genetics of the host affect the outcome of a M. tuberculosis infection, i.e. the development of active304
tuberculosis4. Genome-wide expression analyses using microarray and RNA sequencing platforms are305
important for understanding complicated biological processes such as the host immune defense against306
pathogens. To date, a handful of transcriptome studies have been done in the zebrafish M. marinum307
infection model using microarray technology58, 71, 72, the digital gene expression (DGE) method73 and308
RNA sequencing74-76. Collectively, by using both zebrafish embryos and adult fish, these studies have309
provided important insights into the innate and adaptive host response against mycobacterial infections.310
We used the adult zebrafish M. marinum (ATCC 927) infection model together with a zebrafish311
gene expression microarray to identify novel candidate genes in a mycobacterial infection. From this312
data, we identified a total of 91 differentially expressed genes (log2 fold change >│3│) that were linked313
to 44 enriched processes, including genes associated with the immune response. Previous studies have314
shown  several  genes  of  the  complement  system  (e.g. complement component c3b, c3b; complement315
component 6, c6) to be up-regulated in an infection58, 71-73, 75, whereas the expression of some complement316
associated genes (e.g. complement factor b, cfb; mannose binding lectin, mbl) has been shown to be317
reduced71, 73. In line with previous results, we also saw an induction of cd59 (regulation of membrane318
attack complex formation) as well as reduced expression of cfbl (component of the C3 convertase).319
Conversely, although previous transcriptomic studies have shown the induction of genes that are320
involved in neutrophil and macrophage related functions (e.g. mpx and irg1l)72, 75, our data indicated321
down-regulation of these transcripts in an infection. In summary, the aforementioned similarities and322
differences between these transcriptomic studies can result from a number of factors including the323
developmental stage of the host (embryos vs. adult fish), the time points chosen for sample collection,324
the different outcomes of an infection (chronic vs. acute), the use of different bacterial strains (E11,325
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Mma20 or ATCC 927) and doses, and they can be due to differences in the technical execution of sample326
preparation and analyses.327
Interestingly, circa 38% of the up-regulated probes were related to muscle associated biological328
processes including muscle contraction (GO:0006936), muscle system process (GO:0003012) and329
myofibril assembly (GO:0030239). Supporting the relevance of this finding, a genome-wide expression330
analysis  in  the  fruit  fly Drospohila melanogaster identified several muscle specific genes such as331
actin88F (Act88F) and tropomycin 2 (Tm2) to be induced after a Pseudomonas aeruginosa infection77.332
Consistently, the down-regulation of muscle expressed genes (Troponin C41C, TpnC41C; Glutathione333
S-Transferase 2, Gst2) was later connected to an increased susceptibility to infection, suggesting an334
immunological role for muscle tissue78, 79. Although the differential expression of muscle specific genes335
can be indirectly linked to the immune response through the regulation of other physiological functions,336
as has been also suggested by Chatterjee et al., (2016)80, both mouse and zebrafish muscle tissues have337
also  been  reported  to  control  the  expression  of  inflammatory  cytokine  genes  (Tnfa and Il6) upon338
activation of the immune response81, 82. In addition, relatively recent studies in the fruit fly and zebrafish339
have confirmed the importance of immunological signaling pathways in the muscle in both the humoral80340
and the cellular79 immune responses against pathogens. Further studies are required to understand the341
significance of muscle expressed genes also in the host response against mycobacterial infections.342
Lee et al., (1997)21 described a new carbohydrate-binding lectin family, the Intelectins, with343
concomitantly proposed function in the innate immunity through microbial recognition23, 33, 83. Two ITLN344
genes (ITLN1 and ITLN2) have been identified in humans, whereas the exact number of protein coding345
itln genes in zebrafish is elusive varying between six (The Zebrafish Information Network, ZFIN) and346
nine annotated members (Ensembl genome browser). However, not all are expressed in significant347
amounts. Our genome-wide gene expression analysis showed the highest expression levels for itln1,348
itln2, itln2-like and itln3 in the PBS injected fish with an average log2 expression of 9.6, 11.9, 13.0 and349
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10.5, respectively (the lowest average log2 expression was 6.9 for probe A_15_P113269; ankyrin repeat350
and kinase domain containing 1, ankk1). This was consistent with Lin et al., (2009) who reported the351
highest expression levels for itln1, itln2 and itln325. Since their discovery, a large number of studies have352
reported the induction of the expression of ITLN genes in different species in bacterial25, 30-32, parasite84-353
86 and viral87 infections. In addition, although the publicly available transcriptomic data of M. marinum354
infected zebrafish embryos by Benard et al., (2016, Gene Expression Omnibus identifier: GSE76499)355
shows differential regulation of itln transcripts in this model57, to our knowledge itln up-regulation in a356
mycobacterial infection has not previously been extensively reported in the literature. In our microarray357
analysis of M. marinum infected adult zebrafish, three of the differentially expressed genes were358
members of the intelectin family (itln2, itln2-like and itln3). The observed decrease in itln2 expression359
as well as the induction of itln3 in these fish was also later confirmed by a qPCR-based quantification of360
samples from a separate mycobacterial infection experiment. In line with this, a qPCR analysis of M.361
marinum infected zebrafish embryos revealed a significant induction of itln3 expression post362
mycobacterial infection, a result which corresponds well with the data by Benard et al., (2016)363
(GSE76499)57.  In  embryos,  we  also  observed  up-regulation  of itln1, itln2 as  well  as  an itln2-like in364
response to a mycobacterial infection. While itln1 had identical induction kinetics to itln3 with significant365
up-regulation starting at 2 dpi, the itln2-like and itln2 genes were induced later in the infection at 4 and366
7 dpi, respectively. Of note, the expression of itln2 at 1 dpi (Figure 1G) was below the limit of detection367
in  the  qPCR.  Furthermore,  up-regulation  of itln3 was observed after an S. pneumoniae infection in368
zebrafish embryos, suggesting that this gene can be induced also in an immune response against369
pneumococcus. All in all, in this study we demonstrated the inducibility of intelectin genes  in  both  a370
mycobacterial and a S. pneumoniae infection  as  well  as  the  down-regulation  of itln2 and itln2-like371
transcripts after mycobacterial inoculation in adult zebrafish.372
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Transcriptomic analyzes have identified several so called classical liver-expressed acute phase373
protein (APP) genes such as c-reactive protein (crp) and serum amyloid a (saa) also in fish species88-90.374
In addition, bacterial infections in rainbow trout (Oncorhynchus mykiss)91, channel catfish (Ictalurus375
punctatus)31 as  well  as  in  zebrafish25 have resulted in liver-specific induction of certain itln gene376
members. Our mRNA expression analysis of unchallenged zebrafish confirmed the previously published377
tissue-restricted expression pattern of zebrafish itln genes25. While itln2 is expressed almost exclusively378
in the intestine, the highest relative expression compared to the housekeeping gene was in the liver for379
itln3. In the current study, we produced Strep-tagged® zebrafish Itln3 in a mammalian expression system380
to study whether Itln3 could act as a potential APP in microbial recognition. Similarly to human ITLN133,381
83, 92, zebrafish Itln3 was secreted into the culture media. However, although Tsuji et al., (2009) has382
reported the ability of human ITLN1 to bind to galactofuranosyl (Galf) residues on the mycobacterial383
cell membrane83, recombinant Itln3 did not bind readily to M. marinum in vitro. Similarly, Itln3 did not384
bind to E. coli or S. pneumoniae in our hands.385
To our knowledge, only two in vivo studies on the significance of Intelectins in the host response386
against pathogens have been conducted34, 35. While the lack of ITLN2 was associated with an increased387
susceptibility toward the parasite T. spiralis in C57BL/10 mice35, the over-expression of ITLN1 and388
ITLN2 in the lungs of transgenic mice could not restrict either a Nippostrongylus brasiliensis or  a389
Mycobacterium tuberculosis infection differently from the littermate controls34. While genes of the innate390
immune system can be studied autonomously in zebrafish embryos, which lack a functional adaptive391
immunity49,  adult  zebrafish  have  a  highly  similar  immune  system  compared  to  humans93.392
Correspondingly, the embryonic M. marinum infection model has revealed important insights into the393
mechanisms of the innate immunity in mycobacterial host resistance (reviewed in 49, 50) and the adult394
model has proven its usefulness e.g. in modelling a latent infection55 and disease reactivation55, 59. In395
order to obtain a more comprehensive view about the in vivo significance of ITLNs in a mycobacterial396
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infection, we used the itln3 deficient zebrafish together with both the embryonic as well as the adult M.397
marinum models. In these experiments, the comparison of survival and mycobacterial burden between398
itln3 mutant  fish  and  their  WT  siblings  did  not  reveal  any  differences  in  either  of  the  mutant  lines399
(itln3uta145 and itln3uta148). Also, it was demonstrated that this was independent of the site or timing of the400
microinjection in the embryos (yolk sac at 0 dpf vs. blood circulation valley at 2 dpf). Collectively, we401
conclude that zebrafish itln3 is not required for the resistance against a mycobacterial infection.402
Genetic compensation is a well-known phenomenon in model organisms with experimental gene403
knockouts69. In this process, the specific function of a knockout gene can be restored by additional404
naturally occurring mutations or transcriptional changes in other genes69. Here, we report the up-405
regulation of itln3 as well as another member of the intelectin family, itln1, in a M. marinum infection of406
zebrafish embryos with analogous induction kinetics. To overcome potential compensatory effects of407
itln1 in  our itln3 mutants, we knocked down itln1 by morpholinos and performed simultaneous408
M. marinum infections in the itln3 mutant embryos. Silencing itln1 in itln3 mutants during a M. marinum409
infection did not reveal any differences compared to controls, demonstrating that itln1 expression does410
not compensate for the lack of a functional itln3 in  a M. marinum infection. Moreover, our qPCR411
quantification of itln1, itln2 and itln2-like in the uninjected and M. marinum infected zebrafish embryos412
as well as adult zebrafish did not reveal transcriptional compensation for itln3 in the homozygous mutant413
background. Similarly, the depletion of lymphocytes in the adult zebrafish did not reveal the importance414
for Itln3 in the immunity against a M. marinum infection. All in all, our data indicate that despite being415
strongly induced by a mycobacterial infection, itln3 is dispensable for the immune response against M.416
marinum both in embryonic and adult zebrafish.417
418
419
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METHODS420
Zebrafish lines and maintenance421
The zebrafish maintenance and all of the experiments were in accordance with the Finnish Act on the422
Protection of Animals Used for Scientific or Educational Purposes (497/2013) as well as the EU Directive423
on the Protection of Animals Used for Scientific Purposes (2010/63/EU). Experiments were approved424
by the Animal Experiment Board of Finland (permit for zebrafish maintenance:425
ESAVI/10079/04.10.06/2015; permits for the experiments: ESAVI/2464/04.10.07/2017,426
ESAVI/10823/04.10.07/2016, ESAVI/2235/04.10.07/2015 and ESAVI/11133/04.10.07/2017). WT AB427
fish as well as in-house CRISPR/Cas9 produced F2-generation itln3uta145 and itln3uta148 mutant zebrafish428
were used in the embryonic experiments, whereas three- to seven-month-old AB, il10e46, itln3uta145 and429
itln3uta148 zebrafish were used in the experiments with the adult fish. Zebrafish embryos were maintained430
according to standard protocols in embryonic medium E3 (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2,431
0.33 mM MgSO4, 0.0003 g/l methylene blue) at 28.5°C until 7 days post fertilization. Maintenance of432
the adult zebrafish was as follows; unchallenged fish were kept in a conventional flow through system433
(Aquatic Habitats, Florida, USA) with an automated light/dark cycle of 14 h/10 h and fed once a day434
with Gemma Micro 500 (Skretting, Stavanger, Norway) or twice with SDS 400 (Special Diets Services,435
Essex, UK) feed. M. marinum infected adults were kept in a separate flow through system (Aqua Schwarz436
GMbH, Göttingen, Germany) with the above-mentioned light/dark cycle and fed once a day with Gemma437
Micro 500 (Skretting) or SDS 400 (Special Diets Services). Infected fish were monitored daily. Humane438
endpoint criteria pre-defined in the animal experiment permits were applied throughout the follow-up.439
440
Experimental M. marinum infections441
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M. marinum (ATCC 927 -strain) culture and the adult zebrafish inoculations were performed as described442
previously55. In the M. marinum infections  of  the  zebrafish  embryos,  a  total  volume  of  1-2  nl  was443
microinjected either into the yolk sac (0 dpf) or into the blood circulation valley (2 dpf) by using a444
borosilicate capillary needle (Sutter instrument Co., California, USA), a micromanipulator (Narishige445
International, London UK) and a PV830 Pneumatic PicoPump (World Precision Instruments, Florida,446
USA). 10 mM phosphate buffered saline (PBS) with 2% polyvinylpyrrolidone-40 (PVP) (Sigma-447
Aldrich) and 0.3 mg/ml phenol red (Sigma-Aldrich) was used as a mycobacterial carrier solution. Prior448
to circulation valley injections, the 2 dpf zebrafish were anesthetized with 0.02% 3-amino benzoic acid449
ethyl ester (Sigma-Aldrich). Embryonic infections were visualized with a Stemi 2000 microscope (Carl450
Zeiss MicroImaging GmbH, Göttingen, Germany) and the survival of the embryos followed daily. Adult451
zebrafish were first anesthetized with 0.02% 3-amino benzoic acid ethyl ester (Sigma-Aldrich, Missouri,452
USA), and then injected with 5 μl of M. marinum in a suspension of 10 mM PBS and 0.3 mg/ml phenol453
red (Sigma-Aldrich, Missouri, USA) into the abdominal cavity using a 30 gauge Omnican 100 insulin454
needle (Braun, Melsungen, Germany). The M. marinum amounts  from both  the  embryonic  and  adult455
infections were verified by plating bacterial inoculations on 7H10 agar (Becton Dickinson, New Jersey,456
USA) plates and counting the colony forming units (CFU) 5-days after plating.457
458
Gene expression microarray459
RNA was extracted from the zebrafish organ blocks (includes all the organs of the abdominal cavity)460
with TRIreagent (Molecular Research Center, Ohio, USA) following the manufacturer’s protocol.461
Microarray procedures were carried out by the Turku Centre for Biotechnology at the Finnish Microarray462
and Sequencing Centre by using a Zebrafish (V3) Gene Expression Microarray, 4x44K  (Agilent463
Technologies, California, USA). In short, 100 ng of total RNA was amplified and Cy3-labeled with Low464
Input Quick Amp Labeling kit, one-color (Agilent), processed using the RNA Spike-In Kit, one-color465
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(Agilent) and quality controlled with 2100 bioanalyzer RNA 6000 Nano kit (Agilent). Labelling and466
hybridization of the transcripts were done onto Agilent’s 4x44K Zebrafish v3 array (Design ID 026437)467
using GE Hybridization Kit (Agilent). Microarrays were scanned with an Agilent scanner G2565CA468
using a profile AgilentHD_GX_1Color. Numerical results were obtained with Feature Extraction469
Software v. 10.7.3 (Agilent) with the protocol GE1_107_Sep09 and the signal intensities normalized470
prior further analysis. Cut-off value (log2 fold change >│3│) for the up- and down-regulated genes was471
chosen in order to obtain approximately 100 differentially expressed candidate genes for further472
evaluation. Gene ontology enrichment analysis was performed using GOrilla60, 61 with two unranked lists473
of genes (Target list: log2 fold change >│3│, Background list: log2 fold change <│3│) using Danio474
rerio genome assembly.475
476
qPCR477
For gene expression analysis of the zebrafish embryo samples, genomic DNA (gDNA) removal and RNA478
isolation were performed using the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany) according to the479
manufacturer’s guidelines. Adult zebrafish RNA was extracted from the organ blocks, liver, spleen,480
kidney and intestine with TRIreagent (Molecular Research Center) following the associated protocol.481
The genomic DNA (gDNA) from the RNA samples of the adult fish was removed with RapidOut DNA482
Removal Kit (Thermo Fischer Scientific, Waltham, USA). RNA quality was controlled with either 1.5 %483
agarose Tris-acetate-EDTA (TAE) gel electrophoresis or by using Fragment Analyzer system (Advanced484
Analytical, Inc., Ankeny, USA) and the Standard Sensitivity RNA Analysis Kit (15 nt) (Advanced485
Analytical). All reverse transcriptions were done by using the SensiFASTTM cDNA synthesis kit486
(BioLine, London, UK), and the gene expression levels of the target genes were determined from the487
cDNA  with  quantitative  PCR  (qPCR)  using  the  PowerUp™  SYBR®  master  mix  (Thermo  Fischer488
Scientific) and CFX96™ detection system (Bio-Rad Laboratories, California, USA). CFX Manager489
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software (v. 3.1; Bio-Rad Laboratories) was used for data analysis. Target gene expression was490
normalized to the eukaryotic translation elongation factor 1 alpha 1, like 1 (eef1a1l1 or ef1a)94491
expression using the 2-ΔCt method. M. marinum burden from the zebrafish was determined from the total492
DNA by qPCR with MMITS-specific primers55. Embryo DNA for mycobacterial quantification was493
isolated with standard ethanol precipitation procedure utilizing the following lysis buffer: 10 mM Tris494
(pH 8.2), 10 mM EDTA, 200 mM NaCl, 0.5% SDS, 200 μg/ml Proteinase K (Thermo Fischer Scientific),495
whereas TRIreagent (Molecular Research Center) was used for the adult fish DNA isolations. No reverse496
transcriptase control samples were added to the gene expression analyses, and no template control (H2O)497
samples were included in all of the qPCR experiments to preclude contamination. Specificity and the498
correct size of the qPCR products were verified by melt curve analysis and 1.5% agarose TAE gel499
electrophoresis. Undetectable qPCR products with incorrect melt curves were given a Ct-value of 40 for500
the gene expression analyses, and the expression was considered to be below detection. qPCR primers501
used in the study are listed in Supplementary Table 3.502
503
CRISPR/Cas9 mutagenesis504
We have previously set-up our in-house zebrafish CRISPR/Cas9 mutagenesis method based on the505
protocol published by Hruscha and Schmid (2015)64, 95. First, guide RNA (gRNA) target sequences for506
itln3 (ENSDARG00000003523) were designed with the CRISPR design tool (http://crispr.mit.edu/), and507
validated with the Casellas laboratory sgRNA tool96 and the standard nucleotide BLAST analysis97. itln3508
exon 2 gRNA was produced by in vitro transcription using the MEGAshortscript T7 Transcription Kit509
(Ambion Life Technologies, CA, USA). 2000 pg of gRNA, 330 pg of cas9 mRNA (Sigma-Aldrich and510
Invitrogen, California, USA) and 1.5 ng of phenol red (Sigma-Aldrich) tracer were injected into one-511
cell-stage AB zebrafish embryos, and the success of mutagenesis was evaluated with the512
T7 endonuclease I (T7EI)- and the heteroduplex mobility assay (HMA) from isolated DNA of 2 dpf513
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embryos48. Gel images were obtained with ChemiDoc™ XRS+ system (Bio-Rad Laboratories) and514
analyzed with Image Lab software (v. 5.2; Bio-Rad Laboratories). To establish the itln3 knockout fish515
line, gRNA was microinjected into zebrafish embryos and the F0-generation fish grown to adulthood.516
Individual  outcrosses  of  the  F0-zebrafish  with  the  Tupfel  long  fin  (TL)  fish  allowed us  to  screen  for517
germline transmitted mutations and to identify nonsense mutations of interest in the F1-progeny. The F1-518
progeny screen was done from the tailfin DNA of the adult zebrafish with HMA followed by Sanger519
sequencing in our institutes core-facility (MED, University of Tampere). The F1-zebrafish carrying520
individual mutations of interest were spawn together to obtain F2-generation progeny for the521
experiments. In the end, a total of two different itln3 mutation (itln3uta145 and itln3uta148) bearing zebrafish522
lines were used in the study.523
524
PCR based genotyping525
F2-generation itln3uta145 and itln3uta148 zebrafish lines were mainly genotyped using PCR. To this end,526
template DNA was either isolated using a standard ethanol precipitation protocol, or with a rapid tissue527
lysis protocol98. Primers were designed for both the WT and the mutated sequences at the gRNA target528
region; WT itln3uta145 F: 5’-ATGCTAGGTTGAGGAGCATC-3’, mutant itln3uta145 F: 5’-529
ATGCTAGGTTGAGGAGCTCG-3’, WT itln3uta148 F: 5’-CTAGGTTGAGGAGCATCGCT-3’, mutant530
itln3uta148 R: 5’-CCGAGCTGATACTTACCTAGC-3’, and amplified with the appropriate flanking531
primer: F: 5’-GGAGCTGTCACTCCAAAGCC-3’ or R: 5’-GTGGTTGATCAACCATTCAGCAC-3’.532
To determine the genotypes of the itln3uta145 and itln3uta148 zebrafish, individual PCR reactions with both533
WT and mutant primer pairs were prepared for each fish and 1.5% agarose TAE gel electrophoresis was534
performed to analyze the PCR products.535
536
Morpholino injections537
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Splice-blocking morpholino (SB) for itln1 (5’-CTAATTCTGTACTTACTCGATTCAC-3’) was538
designed by and ordered from GeneTools LLC, (Philomath, Oregon, USA). The targeted genomic539
sequence was verified from our AB and itln3 knockout zebrafish lines by sequencing99. In order to ensure540
no adverse effects on survival or the phenotype of the morpholino injected embryos in later experiments,541
the oligonucleotide dosage was first titrated by using three different quantities (7.1 ng, 2.8 ng and 1.1542
ng), and the survival of the embryos was observed daily until 7 dpf. The embryos were imaged using543
Zeiss Lumar V12 fluorescence microscope. The selected microinjection volume was set to 2 nl544
containing 2.8 ng of SB or random control (RC) morpholino as well as 7 mg/ml of tetramethylrhodamine545
dextran (Thermo Fisher Scientific) or 0.3 mg/ml phenol red tracer suspended in PBS. In the morpholino-546
M. marinum co-injections, the previously described suspension with 2% PVP was used as a547
mycobacterial carrier solution. All of the morpholino injections as well as morpholino and M. marinum548
co-injections were done before the 16-cell-stage of development into the yolk sac of the embryos.549
Similarly than in the other M. marinum infection experiments, the mycobacterial counts in the injections550
were verified by plating. Primers used for the morpholino target site sequencing were F: 5’-551
TGCACAGGTATTCACCATTTTATGATG-3’ and R: 5’-AAGTTCTCTGCAGCTTCTTGC-3’ and for552
the verification of the morpholino functionality as well as quantification of the WT itln1 expression by553
qPCR: F: 5’-ATGATGCAGTCAGCTGGTTTTCTTCTG-3’ and R: 5’-554
GCAGTGACCGACTCTGGAAATTCTCC-3’.555
556
Flow cytometry557
Flow cytometry for the adult zebrafish kidney cells was performed as described previously70. Briefly,558
itln3uta145 and itln3uta148 fish were euthanized with 0.04% 3-amino benzoic acid ethyl ester and their559
kidneys isolated and suspended in PBS supplemented with 0.5% fetal bovine serum (Sigma-Aldrich).560
Prior  analysis,  the  kidney  cells  were  filtered  through  a  cell  strainer  cap  with  a  35  μm  mesh561
26
(Corning/Thermo Fisher Scientific). Relative amounts of lymphocytes, myeloid cells and blood cell562
precursors were determined with a FACSCanto II instrument (Becton, Dickinson, New Jersey, USA) and563
the  data  was  analyzed  with  the  FlowJo program (v.  7.5;  Tree  Star,  Inc,  Oregon,  USA).  Gating  of  the564
blood cell populations is based on previous publications59, 70, 100, 101.565
566
Dexamethasone mediated immunosuppression567
Similarly as described previously59, 25 mg of dexamethasone (Sigma-Aldrich) was mixed with gelatin568
(Sigma-Aldrich) and used to coat 10 g of SDS400 food (Special Diets Services). During the experiment,569
a daily dose of 10 μg of dexamethasone (4 mg of food) was given per fish for a total of 5 weeks. A new570
batch of dexamethasone food was prepared for usage every second week. Dexamethasone was571
administered for a total of five weeks and the well-being of the fish monitored daily.572
573
Statistical analysis574
Sample size calculations have been described in our previous publication100. Statistical analyses were575
done with the Prism v. 5.02 (GraphPad Software, California, USA). In the survival experiments a log-576
rank (Mantel-Cox) test  was used, whereas in the flow cytometry and qPCR analyses a nonparametric577
two-tailed Mann-Whitney analysis was performed. P values of < 0.05 were considered significant.578
579
Data availability580
Gene expression microarray data has been submitted to Gene Expression Omnibus (GEO) repository and581
can be found with the identifier code: GSE120552. Other generated and analyzed data is available on582
reasonable request from the corresponding author.583
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FIGURE LEGENDS846
Figure 1. Zebrafish intelectin genes are differentially expressed upon M. marinum infection. A) A847
genome-wide gene expression microarray was conducted in adult WT AB zebrafish injected with M.848
marinum (20 CFU, SD 6 CFU) (n=2) or PBS (n=3). Average numerical results (log2) for each probe in849
both infected fish (y-axis) and PBS controls (x-axis) are shown. Up- and down-regulated transcripts (log2850
fold  change  │3│)  in  the  organ  blocks  are  shown in  grey,  and  the  common immunological  genes  are851
annotated. Two itln3 probes as well as itln2 and itln2-like probes are highlighted. B-E) The expression852
of zebrafish itln genes (itln1, itln2, itln2-like and itln3) was measured with qPCR in the organ blocks of853
the M. marinum infected (6 CFU, SD 3 CFU) and PBS injected adult WT e46 zebrafish at 1 (n=12 and854
n=4, respectively) and 6 dpi (n=12 and n=8, respectively) as well as 4 (n=12 and n=11, respectively) and855
9 wpi (n=12 and n=10, respectively). F-I) The  expression  of itln1, itln2, itln2-like and itln3 was856
determined with qPCR in the M. marinum (39 CFU, SD 47 CFU) infected WT AB embryos (n=5 at all857
timepoints) and in PBS injected controls (n=5 at all timepoints) at 1-7 dpi. Note the different scales of858
the y axes in B-I. Gene expressions were normalized to eef1a1l1 expression and target genes were run859
once in the qPCR analyses. A two-tailed Mann-Whitney test was used in the statistical comparison of860
differences in B-I.861
862
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Figure 2. Expression of zebrafish itln genes in adult zebrafish tissues. Relative expression of A) itln1,863
B) itln2, C) itln2-like and D) itln3 was measured with qPCR in the uninfected adult WT e46 zebrafish864
liver (n=10),  spleen (n=10),  kidney (n=10) and the intestine (n=10).  Note the different scales of the y865
axes. Gene expressions were normalized to eef1a1l1 expression and target genes were run once in the866
qPCR analyses.867
868
Figure 3. Generation of itln3uta145 and itln3uta148 mutant zebrafish lines using CRISPR-Cas9869
mutagenesis. A) An appropriate guide RNA (gRNA) target site was identified in the second exon of870
itln3. B) 2.5% agarose TAE gel electrophoresis was performed to evaluate occurrence of target site871
mutations in zebrafish. The in vivo CRISPR/Cas9 mutagenesis efficiency was estimated with the T7EI872
assay in the gRNA and Cas9 mRNA injected embryos. The size of the uninjected WT control PCR873
product is 210 bp, whereas the PCR products of the mutated embryos are partially cleaved at the target874
site. The cleavage efficiency was calculated from the band intensities and the mutagenesis efficiency875
calculated according to following formula: % mutagenesis = 100 x (1 – (1- % of cleavage)1/2)63.876
GeneRuler 50 bp DNA Ladder (#SM0373, Thermo Fischer Scientific) was used as a molecular weight877
marker (MW). Gel image is cropped to exclude portions that do not contain experimental samples. C)878
gRNA target sites were sequenced from F1-generation mutant zebrafish and two frameshift mutations (-879
5 bp deletion, itln3uta145 and +8bp insertion, itln3uta148) detected, leading to truncated protein products of880
79 and 71 amino acids, respectively.881
882
Figure 4. The lack of itln3 does not affect the survival or the mycobacterial burden of M. marinum883
infected zebrafish embryos. A-B) M. marinum (40 CFU, SD 30 CFU) was injected into the yolk sac of884
the WT (itln3uta145) (n=31), itln3uta145/+ (n=74), itln3uta145/uta145 (n=22), WT (itln3uta148) (n=19), itln3uta148/+885
(n=27) and itln3uta148/uta148 (n=16) zebrafish embryos at 0 dpf and the survival recorded until 7 dpi. A log-886
rank (Mantel-Cox) test was used for the statistical comparison of differences. The data was collected887
from a single experiment. C) Mycobacterial burden was measured by qPCR from the yolk sac infected888
WT  (itln3uta145) (n=17), itln3uta145/+ (n=32), itln3uta145/uta145 (n=10),  WT  (itln3uta148) (n=9), itln3uta148/+889
(n=15) and itln3uta148/uta148 (n=7) embryos that were alive at 7 dpi. D) M. marinum (46 CFU; SD 31 CFU)890
was injected into the blood circulation valley of the WT (itln3uta145) (n=29), itln3uta145/+ (n=77),891
itln3uta145/uta145 (n=36),  WT  (itln3uta148) (n=31), itln3uta148/+ (n=57) and itln3uta148/uta148 (n=19) zebrafish892
38
embryos at 2 dpf and the M. marinum burden quantified at 5 dpi. Bacterial load is represented in panels893
C and D as bacterial copies (log10) in 100 ng of zebrafish DNA. A two-tailed Mann-Whitney test was894
used in the statistical comparison of differences in C and D.895
896
Figure 5. Morpholino mediated silencing of iltn1 expression does not alter the survival of the WT897
or itln3 knockout zebrafish in M. marinum infection. A) A schematic representation of the effects of898
the morpholino mediated silencing of itln1. A splice site blocking morpholino (SB) was used to prevent899
the normal splicing event between exon 2 and exon 3 in itln1. Morpholino binding to its target site leads900
to an alternative splicing event that deletes the start codon containing exon 2 from the transcript.901
Consequently, this prevents translation of the Itln1 protein. In order to quantify the relative amount of902
the WT itln1 transcript, qPCR primers were designed to specifically amplify only the WT itln1 mRNA.903
B) WT itln1 expression  was  quantified  with  qPCR  from  the itln1 SB morpholino (n=3) and random904
control morpholino (RC) injected zebrafish (n=3) at 1-7 dpf. Gene expression was normalized to eef1a1l1905
expression. All samples were run once as technical duplicates. C-E) Survival of the morpholino and M.906
marinum (20 CFU, SD 19 or 13 CFU; SD 10 CFU) co-injected embryos were followed until 7 dpi. In907
panel C, WT (itln3uta145 and itln3uta148) embryos injected with either SB (n=47 and n=53, respectively) or908
RC morpholino (n=29 and n=54) are shown, whereas in panels D and E the itln3uta145 background (n=45-909
73) and itln3uta148 background embryos (n=18-35) injected with SB morpholino are depicted,910
respectively. Note that the SB morpholino injected WT (itln3uta145) embryo group is shown in both C and911
D panels in order to simplify data representation. The data in panel C was collected from two individual912
experiments, whereas other data is from a single experiment. A log-rank (Mantel-Cox) test was used for913
the statistical comparison of differences. MO = morpholino.914
915
Figure 6. Adult itln3 mutant zebrafish have comparable survival and mycobacterial burden916
compared to WT fish upon M. marinum infection. A) The WT (itln3uta145) (n=38), iltn3uta145/+ (n=40),917
iltn3uta145/uta145 (n=38) and B) WT (itln3uta148) (n=38), iltn3uta148/+ (n=38), iltn3uta148/uta148 (n=38) zebrafish918
were infected with M. marinum (48 CFU, SD 5), and their survival followed for 24 weeks. A log-rank919
(Mantel-Cox) test was used for the statistical comparison of differences. The data was collected from a920
single experiment. C-D) The itln3uta145 and itln3uta148 background zebrafish were infected with M.921
marinum (422 CFU; SD 221 CFU) and bacterial burden (log10) in 100ng of zebrafish DNA determined922
39
at 2 and 4 wpi from the organ blocks (without the kidney). Group sizes at 2 and 4 wpi, respectively, were923
as  follows:  WT  (itln3uta145) n=10, n=8; iltn3uta145/+ n=12, n=12; iltn3uta145/uta145 n=12, n=12; WT924
(itln3uta148) n=9, n=N/A; iltn3uta148/+ n=9, n=14 and iltn3uta148/uta148 n=8, n=12.  All samples were run once.925
A  two-tailed  Mann-Whitney  test  was  used  in  the  statistical  comparison  of  differences.  N/A=no  fish926
available for analysis.927
928
Figure 7. Dexamethasone mediated immunosuppression does not alter the survival of itln3929
deficient zebrafish in a mycobacterial infection. A) A schematic representation of the performed930
experiment. M. marinum inoculate used in the infections were 47 CFU (SD 4 CFU). B) Representative931
flow cytometry plots in WT (itln3uta148) zebrafish at -1 wpi and 2 wpi used for quantifying lymphocyte,932
myeloid cell and precursor cell populations. FSC= forward scatter, SSC= side scatter. C-D) Lymphocyte933
fractions of the total cell populations for both WT and itln3 knockout zebrafish at -1 wpi and 2 wpi. Both934
the itln3uta145 (n=12 in all groups) and itln3uta148 background fish (n=8 in all groups) are shown. Blood935
cell samples were run as technical duplicates. E-F) M. marinum burden (log10) in 100ng of zebrafish936
DNA were measured at 2 wpi and 4 wpi by qPCR in the infected dexamethasone treated zebrafish organ937
blocks (without the kidney). All bacterial quantification samples were run once. Group sizes at 2 and 4938
wpi, respectively, were as follows: WT (itln3uta145) n=9, n=8; iltn3uta145/uta145 n=9, n=10; WT (itln3uta148)939
n=6, n=9 and iltn3uta148/uta148 n=7,  n=8.  A  two-tailed  Mann-Whitney  test  was  used  in  the  statistical940
comparison of differences.941
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Supplementary Figure 1. itln3 expression is induced in S. pneumoniae infected zebrafish embryos,
but itln3 is dispensable for embryo survival. A) The expression of itln3 was measured with qPCR from
zebrafish embryos infected with S. pneumoniae (serotype T4; 296 CFU, SD 32 CFU) 7 hpi to 90 hpi, and
compared to potassium chloride (KCl) injected control fish (n=6 in both groups at all timepoints). Gene
expressions were normalized to eef1a1l1 expression. All  samples were run once.  A two-tailed Mann-
Whitney test was used in the statistical comparison of differences. B-C) Both itln3uta145 (n=31-70) and
itln3uta145 (n=14-48) background zebrafish embryos were infected with S. pneumoniae (serotype T4; 380
CFU, SD 172 CFU) and their survival followed until 5 dpi. D-E) The itln3uta145 (n=45-91) and itln3uta145
background (n=42-91) zebrafish embryos were infected with S. pneumoniae (serotype 1; 48 CFU, SD 28
CFU) and their survival followed until 5 dpi. The data was collected from a single experiment in panels
B-E and a log-rank (Mantel-Cox) test was used for the statistical comparison of differences.
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Supplementary Figure 2. Expression of zebrafish itln genes in uninjected and M. marinum infected
adult itln3uta145 and itln3uta148 zebrafish. The expression of zebrafish itln genes (itln1, itln2, itln2-like
and itln3) was measured with qPCR in the organ blocks (without the kidney) of uninjected and
M. marinum infected (422 CFU; SD 221 CFU, 2 wpi) adult WT (itln3uta145) (n=12 and n=10,
respectively), itln3uta145/145(n=12 and n=12, respectively), WT (itln3uta148) (n=7 and n=9, respectively)
and itln3uta148/148 zebrafish (n=7-8 and n=9-10, respectively). Note the different scales of the y axes and
the divided axis in panel G. Gene expressions were normalized to eef1a1l1 expression. All samples were
run once. A two-tailed Mann-Whitney test was used in the statistical comparison of differences.
AB
Supplementary Figure 3. Homozygous itln3uta145/uta145 and itln3uta148/uta148 mutants develop
normally. A)  F3-progeny of itln3uta145/+ and itln3uta148/+ zebrafish were imaged at 1, 4 and 7 dpf. The
larvae were anesthetized for imaging with 0.02% 3-amino benzoic acid ethyl ester (Sigma-Aldrich) at 4
and 7 dpf, and the embryos collected for genotyping at 7 dpf. Representative images of itln3uta145/145 and
itln3uta148/148 mutants as well as the corresponding WT embryos are shown. Micrographs were taken with
Zeiss Lumar V12 fluorescence microscope and Axiocam MRm digital camera using a bright field
exposure of 2 ms. A 23.5x-magnification was used at 1 dpf and a 15.0x-magnification at 4 and 7 dpf.
B) 12-month-old WT (itln3uta145), itln3uta145/145, WT  (itln3uta148) and itln3uta148/148 female and male
zebrafish were anesthetized with 0.02% 3-amino benzoic acid ethyl ester (Sigma-Aldrich) and imaged
submerged in water using Canon EOS 7D Mark II camera with an exposure time of 8 ms. Brightness
was increased by 20% for all of the images in panel B using Windows Photo Viewer. All images in
panels A-B were cropped to exclude unnecessary empty background from the figure.
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Supplementary Figure 4. Itln1 splice site blocking morpholino knocks down the expression of itln1,
but does not alter the survival of the embryos. A) The expression of itln1 was measured with qPCR
in the splice blocking morpholino (SB MO) (n=3 at all timepoints) and the random control morpholino
(RC MO) (n=3 at all timepoints) injected WT AB zebrafish embryos between 0 dpf and 7 dpf (See Figure
5C).  The  qPCR  amplified  samples  were  run  with  1.5%  agarose  TAE  gel  electrophoresis  to  confirm
knockdown effects and to compare the intensities of the itln1 SB MO and RC MO injected  samples.
GeneRuler 50 bp DNA Ladder (#SM0373, Thermo Fischer Scientific) was used as a molecular weight
marker (MW). The housekeeping gene eef1a1l1 from the same samples was also amplified and analyzed
with gel electrophoresis. Images were obtained with ChemiDoc™ XRS+ system (Bio-Rad Laboratories)
and analyzed with Image Lab software (v. 5.2; Bio-Rad Laboratories). Gel images are cropped to exclude
portions that do not contain experimental samples. B) Survival of the morpholino and phosphate buffered
saline (PBS) co-injected (yolk sac injection) ungenotyped embryos from both the itln3uta145 (RC, n=42;
SB n=58) and itln3uta148 (RC, n=38; SB, n=72) background were followed until 7 dpi. The data was
collected from a single experiment. A log-rank (Mantel-Cox) test was used for the statistical comparison
of differences. RC= random control, SB= slice blocking, MO = morpholino.
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Supplementary Figure 5. Expression of zebrafish itln genes in uninjected and M. marinum infected
itln3uta145 and itln3uta148 zebrafish embryos. The expression of zebrafish itln genes (itln1, itln2, itln2-
like and itln3) was measured with qPCR in the uninjected (4 dpf) and M. marinum infected (25 CFU;
SD 23 CFU, 4 dpf/ 4 dpi) WT (itln3uta145) (n=5 in both groups), itln3uta145/145(n=4 and n=5, respectively),
WT (itln3uta148) (n=5 in both groups) and itln3uta148/148 zebrafish embryos (n=5 in both groups). Individual
embryos were used in the itln3uta145 background samples, whereas itln3uta148 background samples were
pooled from 4 to 6 embryos. Note the different scales of the y axes. Gene expressions were normalized
to eef1a1l1 expression. Target genes were run once. A two-tailed Mann-Whitney test was used in the
statistical comparison of differences.
Supplementary Figure 6. Quantification of myeloid cells, precursor cells and the total cell count in
the dexamethasone treated zebrafish. A-B) The fraction of myeloid cells from the total cell population
for the WT (itln3uta145) and itln3uta145/uta145 as well as WT (itln3uta148) and itln3uta148/uta148 were measured
with flow cytometry at -1 wpi and 2 wpi (n=12 for all of the itln3uta145 fish groups and n=8 for all of the
itln3uta148 groups). Flow cytometry was used to determine also the C-D) precursor cell and E-F) the total
cell counts from the same samples. Technical duplicates were run from all of the samples. A two-tailed
Mann-Whitney test was used in the statistical comparison of differences.
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Supplementary Figure 7. Recombinant Itln3 does not bind to M. marinum, S. pneumoniae or
E. coli. A) A schematic representation of the recombinant itln3 cloned into pVBoostFGII+Wpre-VSV-G
expression vector and of the expected 302 amino acid long Itln3-Strep-Tag®II protein product.
GmR = gentamycin resistance. ori = origin of replication. B) The recombinant Itln3 protein was produced
in Freestyle 293-F cells, and an approximately 40 kDa product was detected with Western Blot between
4 and 7 days post transfection (dpt) in the supernatant (S) but not in the pellet (P). C) Following affinity
chromatography with Strep-Tactin®XT Superflow® matrix, elution fractions 1-6 were run with SDS-
PAGE. D-G) Recombinant Itln3-Strep-tag®II and GFP-Twin-Strep-tag® were incubated with either
M. marinum, E. coli or S. pneumoniae (serotypes 1 and T4) in the presence (+CaCl2)  or  absence  of
calcium (+EDTA). Samples were analyzed with SDS-PAGE and Strep-tagged proteins detected from
blotted membrane at 700 nm using Strep-Tactin Oyster 645 conjugate. The lanes are numbered as
follows; control samples: 1. 20 μl of Itln3 containing cell culture medium, 2. 1 μg of Itln3-Strep-Tag®II,
3. 1 μg of GFP-Twin-Strep-tag®, and the bacteria containing samples: 4. 7.5 μg of Itln3-Strep-Tag®II
in binding buffer (+CaCl2), 5. 7.5μg of Itln3-Strep-Tag®II in the absence of calcium (+EDTA), 6. 7.5μg
of GFP-Twin-Strep-tag® in binding buffer (+CaCl2), 7. 7.5μg of GFP-Twin-Strep-tag® in the absence
of calcium (+EDTA). The PageRuler™ Unstained Broad Range Protein Ladder (#26630, Thermo Fisher
Scientific) was used in panels B-C as a molecular weight marker (MW), whereas Precision Plus Protein™
Dual Xtra (#161-0377, Bio-Rad Laboratories) was used in panels D-G. White lines indicate the borders
of the immunoblots. SDS-PAGE images are cropped to exclude portions that do not contain experimental
samples. In panels D-G the same acquisition values for 700 nm channel have been applied.
Supplementary Table 1. Zebrafish (V3) Gene Expression Microarray, 4x44K  (Agilent Technologies).
Up-regulated transcripts
Probe Name Systematic Name Gene Symbol Gene Name Average log2 Fold Change
A_15_P110361 NM_001004534 si:busm1-194e12.11 (mhc2) si:busm1-194e12.11 (mhc2) 5.43
A_15_P269921 EH455384 4.40
A_15_P695731 ENSDART00000151988 LOC559001 fatty acid synthase-like 4.33
A_15_P541012
A_15_P670021
A_15_P286336 NM_001017909 zgc:112992 zgc:112992 4.24
A_15_P151116
A_15_P772381 ENSDART00000054817 nansb N-acetylneuraminic acid synthase b 4.11
A_15_P676036 NM_001139464 ela2 elastase 2 4.06
A_15_P437360 NM_214751 pck1 phosphoenolpyruvate carboxykinase 1 (soluble) 4.00
A_15_P661356 NM_198815 scd stearoyl-CoA desaturase (delta-9-desaturase) 4.00
A_15_P727551
A_15_P176621
A_15_P170986 NM_001037420 ugt5a1 UDP glucuronosyltransferase 5 family, polypeptide A1 3.95
A_15_P117864 NM_001024408 ela3l elastase 3 like 3.95
A_15_P623151 NM_131516 pvalb2 parvalbumin 2 3.90
A_15_P163756
A_15_P208801 NM_001044323 zgc:152753 zgc:152753 3.88
A_15_P198561 NM_201173 cyp7a1a cytochrome P450, family 7, subfamily A, polypeptide 1a 3.88
A_15_P100059 NM_001020482 cpa1 carboxypeptidase A1 (pancreatic) 3.84
A_15_P749196 NM_205572 pvalb1 parvalbumin 1 3.84
A_15_P106696
A_15_P624116 NM_199605 zgc:66382 zgc:66382 3.79
A_15_P655936 NM_212783 pvalb4 parvalbumin 4 3.79
A_15_P132286
A_15_P666139
A_15_P209091 NM_001003737 zgc:92041 zgc:92041 3.72
A_15_P148011 NM_001076602 slc25a38a solute carrier family 25, member 38a 3.69
A_15_P118321 NM_200212 pvalb3 parvalbumin 3 3.69
A_15_P664371
A_15_P670531
A_15_P104996 NM_001003423 tnni2b.2 troponin I, skeletal, fast 2b, tandem duplicate 2 3.68
A_15_P111799 NM_183070 sst1.1 somatostatin 1, tandem duplicate 1 3.66
A_15_P420075 TC425078 3.63
A_15_P162301 NM_001025180 c6ast4 six-cysteine containing astacin protease 4 3.62
A_15_P382820 NM_131105 tpma alpha-tropomyosin 3.62
A_15_P754641
A_15_P142756 NM_001020578 alox5b.3 arachidonate 5-lipoxygenase 3.59
A_15_P151326 NM_001003488 pkmb pyruvate kinase, muscle, b 3.57
A_15_P674431 TC391723 3.57
A_15_P674096 NM_212618 ctrb1 chymotrypsinogen B1 3.51
A_15_P704401 ENSDART00000152233 si:ch1073-110a20.3 si:ch1073-110a20.3 3.51
A_15_P770551
A_15_P681766 TC398257 3.49
A_15_P108203 NM_213131 mdh2 malate dehydrogenase 2, NAD (mitochondrial) 3.48
A_15_P620081 NM_200370 zgc:64043 zgc:64043 3.43
A_15_P170876 NM_001001893 zgc:113912 (mhc2) zgc:113912 (mhc2) 3.40
A_15_P756000 NM_001004582 ctrl chymotrypsin-like 3.35
A_15_P102930 NM_001045194 zgc:153896 zgc:153896 3.34
A_15_P728736 NM_001159584 itln3 intelectin 3 3.32
A_15_P190506
A_15_P743431 NM_181653 tnnt3b troponin T3b, skeletal, fast 3.31
A_15_P101676 NM_001003426 zgc:92745 zgc:92745 3.31
A_15_P488730 ENSDART00000122221 nfe2l2b nuclear factor (erythroid-derived 2)-like 2b 3.28
A_15_P771326
A_15_P624916 NM_001115089 myhz1.1 myosin, heavy polypeptide 1.1, skeletal muscle 3.25
A_15_P331879
A_15_P657891
A_15_P542682
A_15_P665056 BC116547 myhz2 myosin, heavy polypeptide 2, fast muscle specific 3.24
A_15_P520672 NM_001003620 casq1a calsequestrin 1a 3.24
A_15_P107326 NM_200516 zgc:66286 zgc:66286 3.23
A_15_P740921
A_15_P764081 ENSDART00000126737 cd59 cd59 molecule 3.22
A_15_P545927
A_15_P152786 NM_205575 tnni2a.3 troponin I, skeletal, fast 2a, tandem duplicate 3 3.22
A_15_P101653 NM_001002119 tpm2 tropomyosin 2 (beta) 3.22
A_15_P664046 AF539738 tnni2a.3 troponin I, skeletal, fast 2a, tandem duplicate 3 3.20
A_15_P729090 NM_001177498 ugt5a4 UDP glucuronosyltransferase 5 family, polypeptide A4 3.19
A_15_P657486 BC124207 wu:fc45h08 wu:fc45h08 3.19
A_15_P161846 NM_001007206 si:busm1-194e12.12 (mhc2) si:busm1-194e12.12 (mch2) 3.19
A_15_P600272 ENSDART00000129396 LOC100536763 proline dehydrogenase 1, mitochondrial-like 3.18
A_15_P331241 NM_131619 mylz3 myosin, light polypeptide 3, skeletal muscle 3.18
A_15_P224231 NM_131563 tnnc2 troponin C type 2 (fast) 3.17
A_15_P150646 NM_001030262 plin2 perilipin 2 3.15
A_15_P107567
A_15_P176531 NM_201009 aacs acetoacetyl-CoA synthetase 3.15
A_15_P711187 ENSDART00000135295 3.14
A_15_P724331 NM_001110416 tnnt3b troponin T3b, skeletal, fast 3.14
A_15_P762231 ENSDART00000151970 3.13
A_15_P133581 BC051151 muc5b mucin 5b 3.13
A_15_P331464 NM_131188 mylpfa myosin light chain, phosphorylatable, fast skeletal muscle 3.13
A_15_P510237
A_15_P149696 NM_205678 myoz1a myozenin 1a 3.10
A_15_P658631 NM_131727 sst2 somatostatin 2 3.08
A_15_P120396 NM_152982 myhz2 myosin, heavy polypeptide 2, fast muscle specific 3.07
A_15_P319166 NM_001271308 acaca acetyl-Coenzyme A carboxylase alpha 3.07
A_15_P350165
A_15_P106920 ENSDART00000146702 tnni2b.2 troponin I, skeletal, fast 2b, tandem duplicate 2 3.05
A_15_P661781 NM_001083827 col10a1 collagen, type X, alpha 1 3.03
A_15_P205041 NM_001076723 ugt5a2 UDP glucuronosyltransferase 5 family, polypeptide A2 3.03
A_15_P116208 NM_199271 cpa5 carboxypeptidase A5 3.02
A_15_P102410 NM_001003729 zgc:92137 zgc:92137 3.01
Down-regulated transcripts
Probe Name Systematic Name Gene Symbol Gene Name Average log2 Fold Change
A_15_P558307 ENSDART00000110325 si:ch211-160b11.4 si:ch211-160b11.4 -3.01
A_15_P163501 NM_001098254 si:dkey-11f4.16 (cd58) si:dkey-11f4.16 (cd58 molecule) -3.20
A_15_P114150 NM_199856 tdo2b tryptophan 2,3-dioxygenase b -3.21
A_15_P117407 ENSDART00000173485.2 ENSDARG00000093796 (itln2-like) intelectin 2 -like -3.22
A_15_P299736 EH440031 -3.35
A_15_P132151 NM_212779 mpx myeloid-specific peroxidase -3.42
A_15_P158486
A_15_P637411
A_15_P164866 ENSDART00000018062 cfbl complement factor B-like -3.42
A_15_P144444 NM_001159541 itln2 intelectin 2 -3.47
A_15_P628696 NM_001001730 cyp51 cytochrome P450, family 51 -3.74
A_15_P727566 NM_001089487 zgc:162608 zgc:162608 -3.76
A_15_P176481
A_15_P181626 BC134957 -3.85
A_15_P678601 EB975183 -3.98
A_15_P365355 NM_001030096 tgm1l4 transglutaminase 1 like 4 -4.02
A_15_P631151
A_15_P731581 TC444503 -4.10
A_15_P529217
A_15_P163579 NM_001007167 si:busm1-266f07.1 (mhc2) si:busm1-266f07.1 (mhc2) -4.28
A_15_P176991 NM_001200021 LOC570474 5-hydroxyisourate hydrolase-like -4.59
A_15_P118284 NM_001077607 irg1l immunoresponsive gene 1, like -4.72
A_15_P695546 EH492309 si:ch211-66i15.5 si:ch211-66i15.5 -4.73
A_15_P205021 NM_001040359 zgc:136902 zgc:136902 -4.78
A_15_P357500 TC431869 -4.78
A_15_P309606 ENSDART00000064720 tgm1 transglutaminase 1 -4.94
Supplementary Table 2. Enriched processes from gene ontology analysis.
Up-regulated transcripts vs. background list.
GO term Description P-value
GO:0006936 muscle contraction 3.90E-6
GO:0003012 muscle system process 5.47E-6
GO:0006941 striated muscle contraction 8.58E-6
GO:0060048 cardiac muscle contraction 4.57E-5
GO:0003009 skeletal muscle contraction 6.05E-5
GO:0006508 proteolysis 7.21E-5
GO:0061959 response to (R)-carnitine 1.65E-4
GO:0072330 monocarboxylic acid biosynthetic process 2.35E-4
GO:0019882 antigen processing and presentation 2.78E-4
GO:0060359 response to ammonium ion 3.06E-4
GO:0032787 monocarboxylic acid metabolic process 3.38E-4
GO:0044283 small molecule biosynthetic process 3.60E-4
GO:0034284 response to monosaccharide 4.90E-4
GO:0033273 response to vitamin 4.90E-4
GO:0009743 response to carbohydrate 4.90E-4
GO:0009746 response to hexose 4.90E-4
GO:0009749 response to glucose 4.90E-4
GO:0097435 supramolecular fiber organization 6.12E-4
GO:0030239 myofibril assembly 7.05E-4
GO:0055092 sterol homeostasis 7.15E-4
GO:0042632 cholesterol homeostasis 7.15E-4
GO:0014823 response to activity 9.82E-4
Down-regulated transcripts vs. background list.
GO term Description P-value
GO:0051707 response to other organism 1.95E-6
GO:0051704 multi-organism process 2.70E-6
GO:0043207 response to external biotic stimulus 4.13E-6
GO:0009607 response to biotic stimulus 4.83E-6
GO:0009617 response to bacterium 2.58E-5
GO: 0006695 cholesterol biosynthetic process 3.51E-5
GO:1902653 secondary alcohol biosynthetic process 3.51E-5
GO:0009605 response to external stimulus 3.56E-5
GO:0044281 small molecule metabolic process 6.15E-5
GO:0016126 sterol biosynthetic process 1.26E-4
GO:1902652 secondary alcohol metabolic process 1.76E-4
GO:0008203 cholesterol metabolic process 1.76E-4
GO:0046165 alcohol biosynthetic process 2.21E-4
GO:0016125 sterol metabolic process 3.74E-4
GO:0006694 steroid biosynthetic process 4.39E-4
GO:0006952 defense response 4.58E-4
GO:0010310 regulation of hydrogen peroxide metabolic process 6.11E-4
GO:0043152 induction of bacterial agglutination 6.11E-4
GO:0033488 cholesterol biosynthetic process via 24,25-dihydroanosterol 6.11E-4
GO:1901617 organic hydroxy compound biosynthetic process 7.06E-4
GO:0042742 defense response to bacterium 7.94E-4
GO:0008202 steroid metabolic process 8.87E-4
Supplementary Table 3. Primers used in the qPCR analyses.
Gene Ensembl Identi fier Sequence 5´-3´ Reference
itln1 ENSDARG00000007534 F GACGACTACAAGAACCCTGG
R ATCGTTGCATGTACCTATGCC
itln2 ENSDARG00000036084 F TATGGGAATGGCTGCCTTTC
R TTTCAAGCTCATGGTTGCTG
itln2-like ENSDARG00000093796 F ACTGTTCAAGAAATTCCCTGTG
R ATGCCCAGTTGGTTTAGTGC
itln3 ENSDARG00000003523 F GTGCAACACAGGATGGCATG
R TTCTGCACTGCCAAACGTAG
eef1a1l1 (ef1a) ENSDARG00000020850 F CTGGAGGCCAGCTCAAACAT
R ATCAAGAAGAGTAGTACCGCTAGCATTAC
mmits - F CACCACGAGAAACACTCCAA
R ACATCCCGAAACCAACAGAG
-
(94)
(55)
-
-
-
Supplementary methods
Experimental S. pneumoniae infections
S. pneumoniae serotype 4 (T4, sequence type 205) as well as serotype 1 (sequence type 306) culture and
infections were performed as described previously1, 2. In brief, S. pneumoniae were streaked on 5 % lamb
blood agar plates (Tammer-Tutkan Maljat, Tampere, Finland) and cultured overnight. In the morning the
bacteria were inoculated into 5ml Todd Hewitt broth (Becton, Dickinson and Company, New Jersey,
USA) supplemented with 0.5% Todd-Hewitt yeast extract (Becton, Dickinson and Company) and
cultured until OD620 ≈ 0.40. 2-day-old zebrafish embryos were anesthetized with 0.02% 3-amino
benzoic acid ethyl ester (Sigma-Aldrich) and microinjected into the blood circulation valley using 2 nl
of bacteria suspended in 0.2 M potassium chloride (KCl) with 7 mg/ml of tetramethylrhodamine dextran
(Thermo Fisher Scientific) to visualize the injections. The survival of the embryos were monitored at
least  twice a day before 50 hours post  infection (hpi)  and at  least  once a day between 2 and 5 dpi. S.
pneumoniae counts (CFU) in each of the infections were counted by plating inoculates of bacteria on 5%
lamb blood agar plates overnight at 37°C with 5% CO2.
Recombinant Itln3 production
Recombinant zebrafish itln3 gene was initially synthetized by GeneArt (Invitrogen). AttB-sites for
Gateway cloning were added with PCR using the following primers
F: GGGGACAAGTTTGTACAAAAAAGCAGGCTTCACCATGCTGCGCTGCCTGTTTGTCTTCG
and R: GGGGACCACTTTGTACAAGAAAGCTGGGTTTTATTAACGATAAAACAGCAGAACTG
CGCTC. PCR product was Gateway cloned into a donor plasmid pDONRTM211 (Thermo Fisher
Scientific) and subsequently into the mammalian expression plasmid pVBboostFGII-Wpre-VSV-G3, and
gene of interest was verified by sequencing. Freestyle 293-F cells (Thermo Fisher Scientific) were
transiently transfected with 10 μg of expression plasmid using FreeStyle™ MAX Reagent (Thermo
Fisher Scientific). Cells were cultured for a total of 7 days and both the cells and medium were collected
for analysis and protein purification. Itln3 containing an N-terminal Strep-tag®II (Itln3-Strep-tag®II)
was purified with Strep-Tactin® XT resin (IBA Life Sciences, Göttingen, Germany) using excess of
biotin for elution. Purity and the molecular size of the Itln3-Strep-tag®II was analyzed by SDS-PAGE
and Western blot, respectively. Briefly, the protein containing fractions were ran with SDS-PAGE
(4-20% gradient gel, Bio-Rad Laboratories) or blotted from the gels on nitrocellulose membrane using
Trans-Blot® Turbo™ transfer system (Bio-Rad Laboratories). SDS-PAGE gels were stained with
PageBlue™ protein stain (Thermo Fisher Scientific). Immunoblot membranes were blocked in 1% BSA
in 0.05% Tween TBS for 30 min at room-temperature (RT) and washed three times with 0.05% Tween
TBS for 5 min. Strep-tagged proteins on the blots were detected with 2.5μg of Streptactin Oyster 645
conjugate (IBA Life Sciences, Göttingen, Germany) in 5ml of 0.05% Tween TBS and incubated for 1 h
at RT. SDS-PAGE images were obtained with ChemiDoc™ XRS+ system (Bio-Rad Laboratories) and
analyzed with Image Lab software (v. 5.2; Bio-Rad Laboratories), whereas blot imaging was done with
the  Odyssey® CLx (LI-COR Biosciences,  Nebraska,  USA)  at  700  nm at  169  μm resolution,  and  the
images were analyzed by using the Image Studio Lite (v. 5.2; LI-COR Biosciences).
Bacterial binding assay
M. marinum (ATCC 927) and S. pneumoniae (T4 and S1) were cultured as described above.
S. pneumoniae was cultured until OD620 = 0.25 (serotype S1) or 0.35 (serotypeT4), whereas M. marinum
was cultured until OD600 = 0.614 and 1 ml of the culture used for the bacterial binding assay. E. coli
was  inoculated  from a  glycerol  stock  into  5  ml  of  LB,  225  rpm 37°C.  100  μl  of  the  culture  (OD600
=1.614) was pelleted 3 min 10 000 g. Bacterial pellets were washed with 1 ml of sterile PBS, pelleted
again 3 min 10 000 g and 1 ml of the protein samples added on the pellet for the bacterial binding. For
this 7.5 μg of the Itln3-Strep-tag®II or 7.5 μg of the GFP-Twin-Strep-tag® negative control protein (IBA
Life Sciences) were used in either 1 ml of the binding buffer (20 mM HEPES, 150 mM NaCl, 10 mM
CaCl2, 0.1% BSA, 0.05% Tween-20, pH 7.4) or in the EDTA containing buffer (20 mM HEPES, 150
mM NaCl, 10 mM EDTA, 0.1% BSA, 0.05% Tween-20, pH 7.4). The samples were incubated 2 h in
rotation at 4°C and washed with 1 ml of PBS as above. The samples were suspended in 30 μl of PBS,
and 10 μl of 4xSDS sample buffer (0.2 M Tris-HCl pH 6.8, 8% SDS (w/v), 40% glycerol, 4% β-
mercaptoethanol, 0.05 M EDTA, 0.8 mg/ml bromophenol blue) and incubated 10 min 98°C with frequent
vortexing. Before loading onto the gel, samples were spinned to pellet bacterial debris and approximately
15 μl of the supernatant was run on two mini-Protean TGX-gels (Bio-Rad Laboratories, California,
USA). One gel was stained over night with Page Blue™ Protein Staining Solution (Thermo Fisher
Scientific) and the other gel was blotted using the Trans-Blot Turbo Transfer System (Bio-Rad
Laboratories). The blot was prepared for imaging and imaged as mentioned above. 1 μg of the Itln3-
Strep-tag®II, 1 μg the GFP-Twin-Strep-tag® (IBA Life Sciences) and 20 μl of the Itln3 containing
medium from the cell culture were used as positive controls on the gel.
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